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ABSTRACT
The placental weight ratio (PWR) is a common proxy for the balance between
fetal and placental growth, and is defined as the placental weight over the birth weight.
The objectives were (1a) to establish PWR distributions by gestational age for the overall
population and (1b) for small, average and large for gestational age infants and (2) to
determine what pregnancy related conditions were associated with the PWR. The data
were obtained using a hospital based retrospective cohort. Nonparametric quantile
regression was used for the first and multinomial logistic regression for the second
objective. The results show how the PWR changes across gestation. SGA infants had
higher PWR’s than AGA and LGA infants. The multivariable analyses showed that the
majority of risk factors were associated with a PWR>90th percentile. The overall curves
offer population standards, and the multivariable analysis suggests that the placenta may
have particular compensatory response, each with a distinct pathophysiologic
mechanism, but similar PWR outcome.
Keywords: Placenta Weight, Birth Weight, Placental Weight Ratio, Quantile Regression,
Fetal Growth, Pregnancy
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CHAPTER 1: INTRODUCTION AND OBJECTIVES
1.1

Background and Overview

Fetal Growth Restriction (FGR) is defined as a fetus that has not reached its
growth potential because of genetic or environmental factors. FGR is associated with an
increased risk for perinatal morbidity and mortality.1,2 Small for gestational age (SGA) is
widely used as an indicator for FGR, since FGR cannot be measured.3

Fetal growth depends on placental growth; the placental weight ratio (PWR) is a
common proxy for the balance between fetal and placental growth. Placental weight is
the most common way to characterize placental growth, and it is a summary of many
dimensions of placental growth. The placental weight measurement includes the laterally
expanding growth of the chorionic disc and arborization of the villous and vascular
nutrient exchange surface, which is reflected in the increasing thickness of the chorionic
disk. Placental weight has been found to be lower in SGA infants than in average for
gestational age infants (AGA) and large for gestational age infants (LGA).4–8

The PWR is defined as the placental weight divided by the birth weight, and it
changes across gestation as the placenta matures. The PWR decreases as gestational age
increases.9 Placental hypertrophy and reduced fetal growth have been postulated to be an
adaptation to maintain placental function in pregnant women with complications such as
malnutrition. If this is true, a pregnancy with impaired fetal growth, resulting in a SGA
infant, should have an increased PWR compared to those infants who are AGA or
LGA.4,10 However, other factors such as timing and severity of various pregnancy
complications can also alter the PWR.

Placental weight and placental weight ratio (PWR) have been found to be
predictive of maternal disease, obstetric outcome, perinatal morbidity and mortality, and
childhood growth and development.11–16 While percentile curves for birth weight are
available for a variety of jurisdictions and populations, percentile curves for the PWR are
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not. Many conditions that could affect placental growth and the PWR, such as
preeclampsia, have been minimally studied with regards to their effect on the PWR. More
specifically, the effects of maternal lifestyle conditions on placental weight between
different gestational age groups have yet to be studied. Mean birth weight and placental
weight significantly increase from SGA to LGA infants, yet the PWR is significantly
increased in SGA infants.5–7,17,18 Placental weight has been shown to be high in
comparison to birth weight when fetal nutrient or oxygen is reduced. This is believed to
be a compensatory mechanism.

A high PWR is significantly correlated with short-term adverse perinatal
outcomes.19 If the pattern of placental growth is associated with differences in the
efficiency of placental function, as reflected in the PWR, this may have physiological
implications. Since placental weights differ between SGA, AGA and LGA infants, size
distribution trajectories to determine when and how they differ across gestational ages
and percentiles will be useful for both research and clinical practice.
Thompson et al.20 created birth weight to placental weight ratio curves using the
Norwegian Birth Registry with all singleton live births in Norway from January 1999 to
December 2002 (n= 198, 971). These curves were a significant contribution to the
literature. Moreover, no population curves to date have looked at the differences between
SGA and LGA across gestational age. Searching the existing literature we found only one
additional set of PWR percentile curves in a Canadian population.9 However, the sample
size is small (n=20,309). Finally, previous studies that have looked at atypical PWRs
have not used a population standard to identify abnormal PWRs.17,21,22

1.2

Objectives

This thesis consists of two distinct, yet highly dependent investigations. Both
objectives were addressed using data from the perinatal database in London, Ontario. The
specific objectives are outlined below. Objective 1a and 1b are addressed in this thesis as
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one investigation and objective 2 as another. Therefore, they are presented separately in
the later chapters.

Objective 1:
a. To establish placental weight ratios (PWR) distributions by gestational age
in a Canadian sample.
b. To investigate whether the PWR distributions varies by fetal growth
adequacy, thus stratifying the PWR distributions by fetal size: SGA, AGA,
& LGA.

Objective 2:
To determine what pregnancy related conditions and lifestyle behaviours are associated
with the PWR.

1.3

Structure of Thesis Document

In accordance with the standards outlined by Western University School of
Graduate and Postdoctoral Studies, this thesis is presented in the integrated-article
format. A comprehensive overview of the related literature and the methods common to
both investigations is covered in Chapters 2 and 3, respectively. The work comprising the
specific investigations is presented as two manuscripts. Chapter 4, Population-Based
Placental Weight Ratio Distribution Curves, addresses Objective 1a) and 1b), as outlined
above, while Chapter 5, Determinants of Placental Weight Ratios, examines Objectives
2), also outlined above. Lastly, Chapter 6, Integrated Discussion, summarizes the main
findings of this thesis and their relationship to one another.
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CHAPTER 2: LITERATURE REVIEW
2.0

Overview

Fetal Growth Restriction (FGR) is defined as a fetus that has not reached its
growth potential because of genetic or environmental factors.1 Small for gestational age
(SGA) is widely used as an indicator for FGR, since FGR cannot be measured. Fetal
growth depends on placental growth; the placental weight ratio (PWR) is a common
proxy for the balance between fetal and placental growth. The PWR is defined as the
weight of the placenta divided by the birth weight. Placental weight has been found to
differ between SGA, average for gestational age infants (AGA) and large for gestational
age infants (LGA).2–6 Many conditions that could affect placental growth and the PWR
have been minimally studied with regards to their effect on the PWR. A list of
definitions relevant to this chapter can be found in Appendix A.

2.1.

Small for Gestational Age Infants

2.1.1. Fetal Growth Restriction and Small for Gestational Age

Fetal growth restriction (FGR) is a term used to define a fetus who has not met its
growth potential because of genetic or environmental factors. SGA is widely used as a
statistical indicator of FGR, since FGR is not measurable. The most common definition
of SGA refers to an infant that weighs less than the 10th percentile for their gestational
age and sex, as defined by the World Health Organization in the International
Classification of Diseases Version 10, as per code P05.1.7 However, this definition does
not distinguish between those who are constitutionally small and those who are growth
restricted.

From 1995 to 2004, the rate of SGA, relative to a fixed population standard,
decreased among singleton births in Canada. This may be due to the increase in maternal
size prior to pregnancy and weight gain during pregnancy, reduced cigarette smoking,
changes in sociodemographic factors,8 as well as more frequent use of ultrasound assisted
dating.9 Therefore, the prevalence of SGA in the Canadian population is currently
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estimated to be 7.2% in infants born after 37 weeks gestation, 6.5% in infants between 34
and 36 weeks gestation, and 11.5% in infants born before 33 weeks gestation.8 The
incidence of SGA varies among populations and increases with decreasing gestational
age.

Anthropometric data from infants born at different gestational ages have been
used to generate a multitude of cross-sectional growth curves, however they are
inconsistent and vary at each gestational ages based on differences in maternal
characteristics and inaccurate measurements of body size and estimates of gestational
age.10,11 The majority of the literature surrounding fetal growth suffers from one or more
methodological problems including errors in reporting gestational age using last
menstrual period, biologically implausible birth weights for gestational age, insufficient
sample sizes at low gestational age, non-generalizable samples,12–15 and inadequate
statistical modeling techniques such as a lack of smoothing of distribution curves.16,17
Therefore, Kramer et al.18 created sex specific birth weight distributions using the
Canadian national linked file of singleton births and infant deaths for births between 1994
and 1996, for which gestational age is based mostly on early ultrasound estimates. The
reference is based on singletons with gestational ages between 22 and 43 weeks and
comprises 347,570 males and 329,035 females. Kramer et al.18 assumed a normal
distribution for birth weight at each gestational age and used the expectationmaximization algorithm to exclude infants with gestational ages that were more
consistent with 40-week births than with the recorded gestational age. Distributions of
birth weight at the corrected gestational ages were then statistically smoothed. The means
and standard deviations were also tabulated to allow calculation of z scores in addition to
percentiles.18

The categorization into male and female specific curves is ideal because males
weigh more than females at each gestational age.18 However, in preterm births, the
average estimated fetal weight is greater than the average weight of term infants because
more SGA infants are born prematurely compared to AGA infants. Therefore, estimated
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fetal weight growth curves will classify more infants as SGA than birth weight
gestational standards.19

2.1.2.

Risk Factors for SGA

There are many risk factors for SGA infants which will be individually discussed
in more detail below. A conceptual model indicating the risk factors for SGA infants, a
decreased placental weight, and those covariates which are risk factors for both can be
found in Appendix C. Also, a table showing which risk factors increase or decrease the
placental weight, and are associated with either SGA or LGA, can be found in Appendix
F.

2.1.2.1.

Maternal Height

Maternal height has a proven positive association with infant birth weight. In a
large study of births from the Swedish Birth Register between 1992 and 2001, women
were categorized based on height into the following categories: <160cm, between 160cm
and 170cm, and >170cm. Birth weights decreased slightly but monotonically with
decreases in maternal height.20 Kramer et al.21 have also demonstrated that low maternal
height is a risk factor for decreased birth weight in a meta analysis using effect
magnitudes weighted for sample size.21 Therefore, it has been shown that SGA rates are
inversely proportional to maternal height.22

2.1.2.2.

Maternal Weight and Pregnancy Weight Gain

An association has been elucidated between pre-pregnancy weight and birth
weight. SGA rates are inversely proportional to maternal weight and a higher proportion
of neonates of small and light mothers were found to be SGA.22,23 Many studies have
found an association between pregnancy weight gain and infant birth weight. Maternal
weight at birth, pre-pregnancy weight and weight gain during pregnancy have been found
to be responsible for 10% of the variance in fetal weight.24 A low pregnancy weight gain
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is associated with a lower birth weight based on gestational age, despite various methods
of characterizing gestational weight gain. Also, mothers who were underweight before
pregnancy were more likely to deliver infants of a lower weight.25 Variations across
studies in exposure categories, outcome measures, and timing of measurement prevented
calculation of summary measures in a recent systematic review,26,27 yet there was strong
evidence to support associations between inadequate gestational weight gain and
decreased birth weight and fetal growth (SGA).28,29 Therefore, an infant’s birth weight
has clear associations with both a woman’s pre-pregnancy weight and pregnancy weight
gain.

2.1.2.3.

Nutritional Deprivation

Although it is not seen as a major problem in developed countries, severe
maternal deprivation during pregnancy can have a major impact on birth weight. During
the Dutch famine of 1944 to 1945, the mean caloric intake fell from 750 to 450
kilocalories per day, and correspondingly, the average infant birth weight fell 250 grams.
Also, during the World War II German siege, Leningrad suffered from a period of
prolonged starvation, more so than the Dutch Famine, with a diet of nearly no protein
which caused the average birth weight to fall 500 grams during this period.30

Modest degrees of nutrition deprivation also have an effect on birth weight. This
measure is typically captured through pre-pregnancy weight and pregnancy weight
gain.24 Furthermore, celiac disease, which is marked by malabsortion of nutrients, has
also been associated with FGR.31 Markers of nutritional deprivation associated with
lower fetal growth include low weight gain during pregnancy,32 inadequate daily calorie
intake, protein deficiency,33,34 and assorted micronutrient deficiencies including
calcium,33 iron,35,36 folate, 35–37 and zinc.38 In developing countries, nutritional
deprivation is the major source of SGA infants,39 but less of a concern in developed
countries where malnutrition is uncommon.

2.1.2.4.

Exercise during Pregnancy
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The evidence on the effect of exercise during pregnancy on fetal growth depends
not only on the type of exercise, but also on the timing of the exercise during pregnancy.
A study by our research group found that exercising five or more times a week during
pregnancy was associated with reduced fetal growth.40 Another study indicated that
vigorous exercise, defined as being out of breath or heavily breathing, was associated
with an approximate three-fold increase in SGA.41,42 These results are congruent with
previous research that shows that high intensity exercise is associated with reduced fetal
birth weight. This is possibly mediated by reduced uterine blood flow.43
In a Cochrane Review by Kramer et al.44 no effect was found on the risk of
delivering a SGA infant in women who were sedentary and then increased aerobic
exercise during pregnancy. Also, in women who were sedentary and then increased
aerobic exercise, a 49.49g mean difference was found in birth weight when compared
with controls. However, the difference was not significant. Also, when there was a
reduction in exercise in physically fit women birth weight decreased by 151g, but again
the difference was not significant. Increase, then reduction in exercise in physically fit
women had a significant increase in birth weight by 460g compared to women who
maintained their level of aerobic exercise. Reduction, then increase in exercise in
physically fit women resulted in a significant decrease in mean birth weight when
compared to women who maintained the same level of aerobic exercise. Increase in
exercise in overweight women resulted in a small (5g), but significant reduction in birth
weight when compared to controls.
On the other hand, Clapp et al.45 found that when women began regular,
moderate-intensity weight bearing exercise in early pregnancy their offspring were
significantly heavier compared to controls who did not exercise. The difference in birth
weight was the result of an increase in both lean body mass and fat mass.45 Furthermore,
another study by Clapp et al.46 found that the offspring of the women who were randomly
assigned to a high volume of exercise in mid and late pregnancy were significantly lighter
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(3.39 kg vs 3.81 kg) and thinner (8.3% fat vs 12.1% fat) than those offspring born of
women who were randomly assigned to reduce their exercise volume after the 20th week.

2.1.2.5.

Parity

Parity is associated with an increased risk of delivering a SGA infant. The growth
rate of the fetus of primaparous women is lower than that of multiparous women. When
based on a single population standard for SGA, primiparae had significantly higher rates
of SGA at all gestational ages. However, when SGA was defined based on parity specific
standards, primiparae did not have higher SGA rates than multiparae after 37 weeks.47

2.1.2.6.

Interpregnancy Interval

A short interpregnancy interval has been associated with low birth weight and
FGR. This association may be mediated through depletion in folic acid.48 The odds ratio
for SGA was statistically significant, and progressively increased, as the interpregnancy
interval shortened from 18 months to 6 months.49 However, a long interpregnancy
interval has also been associated with SGA infants. Interpregnancy interval longer than
60 months is also associated with a risk of delivering an SGA infant or an infant with low
birth weight, defined as weight below 2500 grams.49

2.1.2.7.

Maternal Age

FGR is the most common among pregnancies at both extremes of reproductive
bearing age.50,51

2.1.2.8.

Emotional Distress

The literature is divided on whether psychosocial stress is a risk factor for SGA,
yet the evidence for psychosocial stress as a risk factor is more convincing. It has been
shown that infant birth weight depends on the mother's mood during pregnancy. High
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levels of anxiety and depression during pregnancy influence the infant's development
through biological mechanisms of stress that include: prolonged exposure to
corticotrophin-releasing hormone, brief periods of exposure to glucocorticoids, and
decreased availability of substrate to the fetus. As a result, the infant is born smaller.52,53
The evidence arguing for a relationship between psychosocial stresses and SGA is more
persuasive. In contrast, in a cohort of more than 70,000 pregnant women in Norway, the
association between emotional distress during pregnancy and delivering a SGA infant
was estimated, after adjustment for a number of factors known to be associated SGA to
be non-significant with an adjusted OR of 1.6.54

Emotional distress activates the hypothalamic–pituitary–adrenal axis and the
sympathetic nervous system, which increases the secretion of corticotrophin-releasing
hormones.55 Elevated levels of corticotrophin-releasing hormone have been found to be
associated with intrauterine growth restriction and preterm birth.56,57

2.1.2.9.

Smoking

Cigarette smoking during pregnancy is well established within the literature as a
cause of fetal growth restriction.1,21,26,58,59 Smokers have an increased risk of having a
SGA baby with relative risks ranging from 1.3 to 10.0.60–62

A retrospective cohort study of 13,661 deliveries, which adjusted for confounding
variables of smoking including parity, age, ethnicity and BMI, found that the adjusted
odds ratio of smoking for the occurrence of growth restriction was 1.9 and that, if causal,
smoking accounted for 13.9% of SGA infants. Furthermore, progressive levels of
cigarette consumption resulted in a greater risk of growth restriction. A dose response
relationship, therefore, has been demonstrated between cigarette smoking during
pregnancy and growth restriction of the infant.63 Fetal growth may no longer be restricted
once smoking ceases depending on when the smoking cessation occurs in the
pregnancy.24,64 Results from observational studies show that if the mother stops smoking
during the first trimester then the rates of SGA are similar to that of non-smokers.65 Also,
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other studies indicate that if mothers stop smoking before the third trimester then the rate
of SGA is similar to that of non-smokers.61,64,66

Smoking is hypothesized to affect birth weight through a number of different
mechanisms. First, the carbon monoxide inhaled from the cigarette deprives both the
fetus and the placenta of oxygen, which creates hypoxic conditions for the fetus by
allowing carbon monoxide to bind to maternal haemoglobin in place of oxygen. Second,
carcinogens cross the placenta and further inhibit fetal growth. Nicotine also acts as an
appetite suppressant, which may lead to uterine vasoconstriction.21

2.1.2.10.

Alcohol Consumption

A recent meta-analysis that included thirty-six case studies and cohort studies
between January 1980 and August 2009 examined the effect of maternal alcohol
exposure on the risk of low birth weight and SGA. The findings indicated that the overall
dose–response relationship for low birth weight and SGA showed no effect up to 10g of
pure alcohol/day (an average of about 1 drink/day), but with level of alcohol exposure
above 10g of pure alcohol/day the relationship showed a monotonically increasing risk
for both low birth weight and SGA. Therefore, the dose-response relationship indicates
that heavy alcohol consumption during pregnancy increases the risks of SGA whereas
light to moderate alcohol consumption shows no effect on fetal growth.67 Results from
previous studies have agreed with Patra et al’s findings, but lacked large enough sample
sizes to make generalizable conclusions.1,68

2.1.2.11.

Toxins from Medications

Exposure to medications including warafin, anticonvulsants, antineoplastic agents
and folic acid antagonists have been shown to result in FGR infants.69,70 Evidence
regarding the effect of anti-hypertensive medications during pregnancy on the growth of
the fetus is divided. One recent systematic review found that taking anti-hypertensive
medications for mild to moderate hypertension did not increase the frequency of
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delivering an SGA infant.71 However, another meta-analysis showed that fetal growth
was significantly impaired by the reduction in mean arterial pressure induced by
antihypertensive therapy. They found that a 10 mmHg fall in mean arterial pressure was
associated with a 176 g decrease in birth weight. This effect was unrelated to the type of
hypertension or choice of medication.72

Results of epidemiological studies examining the effect of maternal caffeine
consumption on the risk of low birth weight or an SGA infant are conflicting. Several
studies observed that maternal caffeine intake ranging from 200 to 400 mg per day was
associated with a mean decrease in birth weight of about 100 grams,73,74 while other
studies either were not able to show any significant association with birth weight or
demonstrated reduction in mean birth weight only at caffeine intake exceeding 600 mg
per day.75–77 Many of the available epidemiologic studies have been criticized for
inadequately controlling for important risk factors for low birth weight, particularly
smoking. However, one well-designed large prospective study assessed caffeine
consumption from all known sources, objectively quantified intake, and adjusted for
smoking and alcohol use. This study found that mean caffeine consumption >200 mg/day
over the course of pregnancy was associated with reduction in birth weight of 60 to 70
grams. Also, the risk of FGR increased linearly in a dose-response relationship, with no
plateau, yielding odds ratios of 1.2 to 1.5 compared to women who consumed less than
100 mg caffeine per day.78 Another prospective cohort found that compared with mothers
who consumed fewer than two cups of coffee per day, the adjusted odds ratios of
delivering an SGA infant for mothers who consumed two to three, four to five, and six or
more cups of coffee per day were 1.38, 1.50, and 1.87, (P <0.01).79

2.1.2.12.

Chronic Hypertension

Cardiovascular disease, high blood pressure, and chronic hypertension have all
been linked to low birth weight.80 Chronic hypertension is also associated with an
increased risk of many vascular disorders of pregnancy, including preeclampsia and
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pregnancy induced hypertension, which are also strongly associated with reductions in
birth weight.81

Chronic hypertension is shown to exert its effects differently on both term and
preterm infants. A study by Catov et al.82, that adjusted for potential confounders, found
that chronic hypertension was associated with a 5.5-fold increased risk for preterm SGA.
The cause of this may involve an inadequate vascular response to pregnancy associated
with abnormal placentation and may represent a pathogenesis distinct from that leading to
term SGA. It has also been reported that chronic hypertension presented a 3.4-fold
increase in risk of preeclampsia among nulliparous women and a 5.4 fold increase of
preterm preeclampsia. Together, these results indicate a strong and convincing
relationship between chronic hypertension and risk for both preeclampsia and SGA,
especially for the more severe subtypes of each condition.82

2.1.2.13.

Gestational Hypertension

Pregnancy outcomes of patients with mild gestational hypertension are generally
favorable. The mean birth weight and rates of fetal growth restriction are similar to those
without gestational hypertension.83,84

However, pregnancies with severe gestational hypertension have increased rates
of SGA infants. These rates are significantly higher than the rates in the general
obstetrical population without gestational hypertension and similar to rates reported for
women with severe preeclampsia.83,85,86 A study by Buchbinder et al.83 compared
outcomes in women who developed severe gestational hypertension with women who
stayed normotensive or developed mild gestational hypertension or mild preeclampsia.
They found that the rate of delivery of SGA infants was 20.8 and 6.5 to 4.8 percent,
respectively for the 3 groups mentioned above. Since there were only 24 patients with
severe gestational hypertension, this small sample limits the interpretation of these
results.
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2.1.2.14.

Preeclampsia

Women with preeclampsia are more likely to deliver a SGA infant than in women
without preeclampsia.87

In preeclampsia, cytotrophoblast cells penetrate the decidual portion of the spiral
arteries, but fail to infiltrate the myometrial segment.88,89 The spiral arteries do not
succeed in developing into large, tortuous vascular channels. Instead of developing
normally, the vessels stay narrow, which results in placental hypoperfusion and potential
fetal asphyxia. This defect has been associated with preeclampsia with or without FGR,
FGR without maternal hypertension as well as second trimester fetal death, placental
infarcts, placental abruption, premature rupture of membranes, and preterm labor.90
Environmental, immunological, and genetic factors all appear to play a role in this
process.91

Preeclampsia is an etiologically diverse disorder that occurs in two subsets: one
with normal or enhanced placental function and another with placental dysfunction and
fetal growth restriction, which often occurs with asymmetric fetal body proportion. A
study has established that in newborns of women with preeclampsia, mean birth weight,
and ponderal index (PI) were lower than in women without preeclampsia.92 Early-onset
preeclampsia, defined as onset <34 weeks, is associated with placental vascular lesions
and reduced uteroplacental blood supply, leading to reduced birth weight. As a result,
preeclampsia and FGR in general might share a pathophysiologic mechanism.93,94 The
pathophysiology of early-onset preeclampsia differs from late onset disease in terms of
neutrophil function and cytokine levels.95

Birth weight in preterm preeclampsia is substantially lower than in term
preeclampsia.96–98 This may be due in part to the fact that SGA infants are
overrepresented in preterm preeclampsia. However, in term preeclampsia, both SGA and
LGA offspring appear to be over-represented compared to the distribution in women
without preeclampsia, yet mean birth weight does not differ greatly from that of
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normotensive pregnancies.97 The increase in LGA infants may possibly be related to
greater placental perfusion due to elevated cardiac output and blood pressure.92,99

2.1.2.15.

Residing at High Altitude

Living at a high altitude is associated with preplacental hypoxia and in turn a
lower birth weight. A direct relationship between increasing altitude and lower birth
weight was established in Denver, Colorado, Tibet and Peru.100–102 A study in Peru that
looked at the relationship between women living at different elevations and birth weight
established that for each 500 meter increase in altitude above 2000 meters birth weight
decreased 65 grams.101 This association may be due to the lower cardiac output of women
living at higher altitudes.103

2.1.3. Fetal Growth Restriction and Placental Weight

Placental weight has been shown to be directly correlated and associated with
birth weight.3–5,104 A higher proportion of SGA infants have placenta weights in the
lowest 10th percentile of placental weights than LGA and AGA infants. Also, SGA
infants have a lower number of placenta’s with weights above the 10th percentile than
both AGA and LGA infants.105

2.2.

Excess Fetal Growth and Large for Gestational Age

Measures of LGA typically include comparison of birth weight to the birth weight
distribution of another similar population, which will be used to determine LGA status in
this thesis. The most common definition of LGA refers to an infant that weighs greater
than the 10th percentile for gestational age and sex.7,18

2.2.1. Risk Factors for LGA
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LGA infants can be constitutionally large because of genetic factors. In addition, a
variety of maternal conditions, pregnancy complications, or fetal abnormalities can result
in increased growth. Some of the main risk factors for LGA such as obesity and
gestational diabetes have both been associated with poor pregnancy outcomes including
excess fetal growth, increased rates of caesarean section, higher incidences of shoulder
dystocia, congenital malformations, heart problems, hyperbilirubinemia, and
hypoglycaemia at delivery.106–109

A conceptual model indicating the risk factors for LGA infants, an increased
placental weight, and those covariates which are risk factors for both can be found in
Appendix D. Also, a table showing which risk factors increase or decrease the placental
weight and are associated with either SGA or LGA can be found in appendix F.

2.2.1.1.

Pre-Pregnancy Obesity
Studies have looked at maternal obesity’s effect on excess fetal growth, regardless

of maternal glucose tolerance, and have found that obesity is associated with excess fetal
growth. 110–112 Obese women with insulin resistance and hyperglycaemia are at a higher
risk for delivering LGA infants. Obese women with normal glucose tolerance tests also
have an increased risk for delivering an infant that has excessive fetal growth.113

2.2.1.2.

Gestational Diabetes

Increased risk of excess fetal growth has been associated with gestational
diabetes, especially when the diabetes is poorly controlled.113,114,115 In gestational
diabetes, the beta-cells are not capable of compensating for the increased insulin demand,
and hyperglycemia develops.109 During gestational diabetes, the level of diabetes control
by the woman determines the level of risk for excess fetal growth. In pregnancies
complicated by gestational diabetes, poor glycemic control is more likely to result in a
LGA infant than in those pregnancies with good glycemic control.113,115,116 High levels of

20
fetal insulin lead to excess fetal growth due to the subsequently high levels of growth
hormones, because of the storage of excess glucose.109

The mechanism involves excessive delivery of nutrients to the fetus, resulting in
fetal hyperglycemia, hyperinsulinemia, and increased growth, particularly of insulinsensitive tissues such as the liver, muscles, and subcutaneous fat.117,118 The risk of
developing gestational diabetes is higher in obese women than in women of normal
weight; both obesity and gestational diabetes, however, add independently to the risk of
excess fetal growth.108

2.2.1.3.

Maternal Weight Gain

Pregnancy weight gain has continually been shown to be associated with infant
birth weight. Excess weight gain during pregnancy has been associated with both insulin
resistance and higher birth weight infants.119 Literature consistently shows that higher
weight gains during pregnancy increase the risk of delivering a LGA infant.120,121 Only
about 35% of women actually gain the weight recommended by Institute of Medicine
(IOM) guidelines122 for all BMI categories. About 22% of women gain less weight than
is recommended for their pre-pregnancy weight, and 43% gain more. As maternal prepregnancy BMI increases, the correlation with infant birth weight weakens. For obese
women, there is no correlation between their weight gain during pregnancy and the
infant’s birth weight.122 Obese women have large infants regardless of how much weight
they gain during pregnancy.

2.2.1.4.

Obesity, Pre-PregnancyWeight and Pregnancy Weight Gain

When women have gestational diabetes, are obese pre-pregnancy and exceed
recommendations for pregnancy weight gain there is an increased risk of excess fetal
growth above that which would be expected from gestational diabetes alone.108
Therefore, while obesity and excess weight gain during pregnancy have similar
pathophysiologies and adverse pregnancy outcomes, they act in distinct ways. In
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pregnancies complicated by gestational diabetes an LGA infant can result even when
weight gain targets are achieved and not exceeded during pregnancy.108

2.2.1.5.

Pregnancy Nutrient and Diet
Maternal nutrition, defined by the mother’s diet, has an impact on the

environmental conditions experienced by the growing fetus. The specific effects of
maternal nutrition on the fetus depend on both the quality of the maternal diet and the
point at which nutrition was measured during pregnancy.123 The effects of malnutrition
differ depending upon the timing during gestation of the deprivation. If severe
macronutrient deprivation occurs during early pregnancy, infant birth weight is not
affected, but placental weight increases as described earlier. In contrast, macronutrient
deprivation during the last trimester of pregnancy results in both reduced placental
weights and reduced birth weights, as mentioned previously.124

2.2.1.6.

Parity

Macrosomia occurs more often at higher parities. In a study using birth certificate
data, the proportion of infants with birth weights greater than 4500 g was significantly
greater as parity increased from one to six or more.125 In another report, birth weight
typically increased from 80 to 120 g in each successive pregnancy up to five.126

2.2.1.7.

Sex

Male infants weigh more than female infants throughout gestation; as a result,
more macrosomic infants are male. In one report, males were more likely than females to
have increased birth weights.125,127

2.2.2. Excess Fetal Growth and Placental Weight
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Placental weight has been shown to be directly correlated and associated with
birth weight.3–5,104 A higher proportion of LGA infants have placenta weights in the
highest 10th percentile than SGA and AGA infants. Also, LGA infants have a lower
number of placenta’s with weights below the 10th percentile than both AGA and SGA
infants.105 Furthermore, LGA infants have been found to have lower PWRs than SGA
and AGA infants.128

2.3.

The Placenta

2.3.1. Structure and Formation of the Placenta

The placenta is a fetal organ that consists of an umbilical cord, membranes and
parenchyma. Many maternal and fetal disorders may begin with the placenta, since the
interface between the mother and the infant occurs at the placenta. Therefore,
examination of the placenta may provide information on the impact of maternal disorders
on fetal growth restriction.129 The development of the placenta is a highly regulated
process. The placenta serves various roles throughout a pregnancy including preventing
the rejection of the fetal allograft, enabling gas exchange, transporting nutrients,
eliminating fetal waste and secreting peptide and steroid hormones.129

The development of the placenta is a continuous process that begins at the time of
fertilization. The first three days of development occur in the fallopian tube and on the
fourth day the morula enters the uterus. By the 6th day post fertilization, the blastocyst
implants in the uterine lining, typically in the upper anterior or posterior wall of the
uterus. By the 13th day after fertilization, the trophoblast erodes deeper in the deciduas
and forms the lacunae. The lacunae then becomes the intervillous space. The progenitor
villous trophoblast cells proliferate throughout gestation and differentiate along two
pathways to form either extravillous trophoblast (EVT) or syncytiotrophoblast. EVT that
invades decidua is the interstitial EVT and EVT that invades and remodels the spiral
arteries is the endovascular EVT.129

2.3.2. Characterization of Placental Growth
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Placental weight is the most common way to characterize placental growth and it
is a summary of many dimensions of placental growth. The placental weight
measurement encompasses the laterally expanding growth of the chorionic disc and
arborization of the villous and vascular nutrient exchange surface, which is reflected in
the increasing thickness of the chorionic disk.130 The average human placental weight
varies between studies ranging from 438g to 680g.3,104,131,132

The expansion of the chorionic plate, beginning early in pregnancy, is the
principle determinant of the ability of the placenta to translate its mass into birth
weight.130 As chorionic disk area and thickness increase, birth weight and placental
weight also increase and the PWR increased after they adjusted for gestational age,
parity, race, and infant gender.133

2.3.3. The Placental Weight Ratio

The PWR, the ratio of placental weight to birth weight, changes across gestation
as the placenta matures. If the pattern of placental growth is associated with differences
in the efficiency of placental function as reflected in the PWR, then the PWR has both
physiologic and functional implications.130 When PWRs are compared between AGA and
SGA infants based on gestational age, SGA infants are found to have higher ratios than
AGA infants.2,134 This occurs since the ratio decreases with gestational age, so when fetal
weight increases the ratio decreases.2

The placenta has been shown to have a functional reserve capacity, but there is still a
higher PWR, defined as less than the 10th percentile, in SGA infants. Therefore, the PWR
may be a better indication of SGA fetuses than placental weight alone.135 The PWR has
been found to be predictive of maternal disease, obstetric outcome, perinatal morbidity
and mortality and childhood growth and development. A high PWR was associated with
increased risk of the aforementioned.136–141
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2.3.4. The Placenta and Fetal Growth
2.3.4.1.

The Role of Placental Function and Fetal Growth Restriction

The adequate transfer of oxygen to the fetus is dependent on both the
development of the uteroplacental and fetal placental circulations. Therefore, three
categories of fetal hypoxia have been proposed to explain the effect of the placental
function on both fetal and placental growth. The three categories: preplacental hypoxia,
uteroplacental hypoxia and post placental hypoxia are described in detail below.142,143

2.3.4.1.1.

Preplacental Hypoxia

Preplacental hypoxia is when the placenta and fetus become hypoxic because of
reduced oxygen content within maternal blood, such as a pregnancy at high altitude,
smoking144 and maternal anaemia. These conditions result in reduced intraplacental
oxygen content, predominately branching angiogenesis and reduced vascular impedance.
Interestingly, all of these complications are associated with excessive placental weight.142
Pregnancies at high altitude results in increased capillary volume fraction145–147
and increased capillary branching.148 The density of villous cytotrophoblasts is
increased.142 Similar findings occur in pregnancies complicated by maternal anaemia.
Endothelial proliferation is increased, resulting in excessive branching angiogenesis, and
decreased mean capillary diameter,149 but an increased capillary volume fraction.150
Consequently, the placenta maintains oxygen transfer through a thinning of the placental
barrier.151 Also, the proliferation of the villous cytotrophoblast decreases as the severity
of the disease increases.149

All of the conditions listed above are representative of typical cases of placental
adaptation to preplacental hypoxia. Hypoxia affects the entire organ, since the origin of
hypoxia is located before the placenta. A conceptual model showing these proposed
pathways can be found in appendix G.
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2.3.4.1.2.

Uteroplacental Hypoxia

Uteroplacental hypoxia is when normally oxygenated maternal blood has
restricted entry into the uteroplacental tissues due to either occlusion or failed trophoblast
invasion of the uteroplacental arterioles. This situation represents late onset FGR with
preserved end diastolic flow volume, and term preeclampsia. This condition results in
reduced intraplacental oxygen content, predominately branching angiogenesis and
reduced vascular impedance.142,143

A variety of pathways can cause restricted access of normally oxygenated
maternal blood into the uteroplacental tissues. These pathways include: damage to the
endothelium,152 focal villous placental ischemia and infarction,153 and release of
proinflammatory cytokines, interleukins 6 and 8.154 More detailed mechanisms can be
found in a conceptual model in appendix H.

2.3.4.1.3.

Postplacental Hypoxia

Postplacental hypoxia occurs when normally oxygenated blood enters the
intervillous space, either at normal or reduced rate, but there is a defect in the
fetoplacental perfusion. This defect prevents the fetus from receiving sufficient oxygen,
yet the placenta receives sufficient oxygen.143 There is a clear relationship between the
amount of uteroplacental flow reduction and both the fetal and placental size.155 In one
study that looked at placentas from pregnancies with abnormal umbilical artery Dopplers,
74% of the placental weights were below the 10th percentile.156

Histological studies of placentas from FGR infants have consistently shown
features that suggest a diminished fetal perfusion of the villous vessels. In many
pregnancies complicated by FGR it has been shown that they have an abnormal uterine
artery Doppler, which was indicative of increased resistance in the placental vascular bed.
This has been confirmed in many recent studies which have found similar results.157–160
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This relationship has been further evaluated through Doppler ultrasounds of the umbilical
vein, which have also shown a diminished perfusion in fetuses suffering from FGR.161,162

Placentas affected by FGR with abnormal uterine artery Doppler indices tend to
demonstrate morphological abnormalities of the terminal villi. There are two hypotheses
behind the reasoning for this. The first is that the abnormality is a defect in the terminal
villous tree which results in reduced capillary size, and therefore, increased
resistance.163,164 The second hypothesis and the one that receives more support is that the
primary event in most of these cases is a reduced uteroplacental flow leading to a
placental fetal stem vasoconstriction. Secondary to those changes are changes in the
terminal villous development and perfusion.165 This hypothesis was further developed to
include a reduction in placental vascularity as the cause of the increased vascular
resistance.166 This has been supported by evidence that the number of arteries in the
tertiary stem villi are due to an arrest in placental angiogenesis.143,167 These effects may
be further mediated by the effects of oxygen through the VEGF directed angiogenesis.168
Therefore, terminal villi from pregnancies complicated by fetal growth restriction and
absent or reverse end-diastolic flow tend to be thinner, elongated, poorly branched,
hypovascular, and have a reduction in their total volume.169–172 However, one study found
no significant correlation between uterine artery Doppler and terminal villi.173

Hypoxic conditions, such as decreased uteroplacental blood flow has been shown
to be associated with increased apoptosis or shedding of apoptotic nuclei.174,175 Evidence
also exists to support placental apoptosis as being greater in pregnancies complicated by
postplacental FGR than during normal pregnancies.176–180 Furthermore, decreased
uteroplacental blood flow has also been associated with placental infarcts,181–183 which is
in turn is associated with a reduction in fetal size.181

There has been considerable support from clinical experiments regarding the link
between fetal and maternal circulation. A reduction in maternal blood flow to the
placenta results in an increased vascular resistance within the fetal placental vasculature
as well as a decreased fetal perfusion of the villi.184 Therefore, it has been concluded that
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growth restricted infants with absent or end-diastolic artery Doppler indices most likely
have a high placental flow resistance due to vasoconstriction, and decreased placental
weight. More detailed mechanisms can be found in a conceptual model in Appendix I.

2.3.4.2.

The Role of Placental Weight and Fetal Growth Restriction

Placental weight has been shown to be directly correlated and associated with
birth weight.3–5,104 Using 317, 688 births from the Medical Birth Registry of Norway, it
has been demonstrated that in pregnancies with SGA offspring, approximately 60% of
pregnancies were in the lowest deciles of placental weight, but offspring that were not
SGA were evenly distributed throughout the remaining placenta deciles.185 Other studies
have found similar results, indicating a significant association between birth weight and
placental weight.186–188 An association has also been found between small placental
volumes in the second trimester based on ultrasound examination and the subsequent
birth of an SGA infant.4,5

On the other hand, previous studies have also demonstrated that SGA infants have
a higher proportion of placental weights at both extremes.3–5,104,105 This is postulated to be
an indication of an inefficient placenta with a reduced ability to maintain fetal growth.
Salafia et al.130 have demonstrated that there are four additional measures other
than placental weight, the most common dimension, to define placental growth including
placental disk thickness, placental disk shape, placental chorionic disk diameter, and the
location of the umbilical cord. These growth measures were created to capture different
aspects of placental growth that are related to placental function. After categorizing disk
thickness and area into three categories: ≤10th percentile, ≥90th percentile, and between
the 10th and 90th percentiles for each chorionic plate area category, it was found that as
the disk thickness increases, the PWR decreased.130

It should be noted that the placenta and fetus follow different growth patterns
during gestation. The human placenta follows an S-shaped growth curve whereas fetal
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growth follows an exponential pattern with most growth occurring in the third trimester.
The placental reaches its peak growth between 28-30 weeks gestational and the fetal does
not reach its highest growth until close to term gestation.2 Thus, the PWR decreases
during gestation.

Most studies have indicated that fetal growth is dependent on the weight of the
placenta.2–5 However, a few studies state that this implies that the placenta has no
functional reserve capacity. Studies indicate that the placenta can undergo thirty to forty
percent inactivation of its villous population without any effect on fetal growth or
development. Consequently, the placenta has a significant functional reserve capacity.189–
192

Gruenwald suggests that since the placenta is a fetal organ it shares in growth

depressions. Therefore, the small fetus not only has a small liver and heart, but also a
small placenta. Thus, the placenta is small because the fetus is small, and not vice
versa.193 This was supported by Lang et al.155 when he showed that a restriction in
uteroplacental blood flow resulted in a significant decrease in placental weight, as well as
reductions in the fetal heart, liver, lungs and thymus weight,155 significant of
postplacental hypoxia. Consequently, Gruenwald193 concludes that the placenta mass
cannot directly limit the fetus weight, but rather the placenta is small because the fetus is
small.

2.3.4.3.

Placental Function and Placental Weight

Reduction in placental size in pregnancies complicated by FGR is postulated to
operate through a reduction in uteroplacental blood flow rather than as a result of an
intrinsic defect in placental growth.135 Lang et al. 155 have found that moderately
restricted uteroplacental blood flow results in a lower placental weight (302±24) than
normal blood flow, and severely restricted uteroplacental blood flow in an even smaller
placenta (274±61).155

Chronic maternal under-perfusion of the fetal villi, postplacental hypoxia, often
results in a placenta that weighs less than the 10th percentile based on population norms.
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In this ischemic placenta, the villi become smaller and smaller as the ischemia progresses
and many large syncytial trophoblastic knots form.129,194–196 Furthermore, a decrease in
placental blood flow has been shown to be associated with a decrease in placental
weight.197 Finally, animal models have shown that an increase in placental apoptosis
results in a decrease in placental weight.198,199 As previously mentioned an increase in
apoptosis is characteristic of postplacental hypoxia which results in early onset FGR.

On the other hand, clinical situations such as preeclampsia that result in impaired
oxygen delivery to the placenta result in excess peripheral villous capillarization. Other
conditions that result in excess branching angiogenesis include pregnancy at high
altitude, maternal smoking and maternal anemia. All of these categories are associated
with excessive placental weight. Increased development of the peripheral villous tree may
be the reason why these pregnancies are associated with normal umbilical artery Doppler.
FGR presenting in late gestation is associated with accelerated maturation of the
placenta.142

2.3.4.4.

The Role of the Placental Weight Ratio, Placental Function and
Placental Weight

Fetal body weight in late gestation correlates positively with placental weight
during both normal pregnancy conditions and also when placental weight is reduced
experimentally either by direct placental manipulations or by indirect alterations of
environmental conditions during development.132,200 When placental growth is
compromised experimentally, more fetus is often produced per gram of placenta than in
normal circumstances; therefore, there is a lower PWR.201,202

In pregnant sheep and rats, placental efficiency, which is measured using the
PWR, is increased in late gestation when fetal and placental weight are reduced by
maternal heat stress, glucocorticoid administration, under- and overnutrition and by
restriction of placentation or uterine blood flow.203–206 A large placenta per fetal weight
appear to be less efficient regardless of whether overgrowth is produced genetically or by

30
environmental manipulations.207 In recent mouse experiments, it has been proven that the
lightest placenta in the litter is the most efficient, as reflected in the PWR, than the largest
placenta in the litter.208 They showed that 30% more fetus was produced by the lightest
placenta than the heaviest placenta in the litter. However, longitudinal measurements of
the PWR were not available in the study, but the fetal growth trajectory during the late
gestation appeared to differ with regards to placental size. This study is consistent with
other studies that show that fetal weight is positively correlated with birth weight at 17
days of pregnancy, but not later. They concluded that the naturally smaller placenta is
able to support the growth spurt of the mouse during late gestation.208
SGA infants have a higher proportion of placental weights at both extremes.3–
5,104,105

This is postulated to be an indication of an inefficient placenta with a reduced

ability to maintain fetal growth. Therefore, this body of literature concludes that small
fetuses have small placentas. However, low PWR’s are indicative of an increased
efficiency of the placentas of the smaller fetuses, whereas, high PWR’s are indicative of a
potential failed compensation.

2.3.4.5.

Animal Models relating Fetal Weight, Placental Weight and Placental
Function

The sheep has been extensively studied as an experimental model for FGR with
poor placental substrate supply to the fetus induced using a range of methods, including
ablation of the majority of the endometrial caruncles prior to conception, induction of
hyperthermia, ligation of an umbilical artery or embolization of the placenta in late
gestation and maternal overnutrition in the pregnant adolescent ewe. The extent and
range of fetal physiologic adaptions to chronic placental insufficiency are determined by
the duration of the exposure and the degree of the severity of substrate supply restriction.
A reduction in placental size or transport capacity leads to an impairment of transfer
between the mother and fetus. It is well established that in sheep variations in placental
weight explain up to 80% of the variation in fetal weight from early in gestation.134,209,210
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Uterine carunclectomy results in fetuses that have a reduced placental mass
resulting in chronic fetal hypoxia and hypoglycaemia across late gestations and growth
restriction.211–213 The fetus responds to the reduction in substrate availability by activation
of the HPA axis and sympathetic nervous system.214,215

Ambient temperatures during pregnancy also influence fetal growth, specifically
high ambient temperature in the first trimester of pregnancy have been shown to be
associated with lower birth weight.216 There is a reduction in both absolute uterine and
umbilical blood flow in the hyperthermic fetus.217 Both placental and fetal weight are
reduced by approximately 50% in growth restricted fetuses of hyperthermic ewes at 135
days of gestation, and the PWR is significantly increased.218 The reduction in placental
weight is not due to a decrease in the number of the placentomes, but instead due to a
reduction in the size of the placentomes.218 Key changes occur in placental vascular
growth factors and their receptors and may reflect a compensatory response that
contributes to the decrease in placentome size. These smaller placentomes have a reduced
capacity for oxygen and nutrient transport to the fetus.218

Single umbilical artery ligation causes reduced placental blood flow and,
therefore, a reduction in substrate transfer from the ewe to the fetus. Relative to fetal
weight, there is a decrease in umbilical blood flow with increasing gestational age.219
This results in chronic hypoxia and a growth restricted fetus. Single umbilical artery
ligation fetuses are about 22% smaller than control fetuses.220 The fetal adaptations to this
insult included early activation of the HPA axis.221 Placental embolization results in acute
decreases in placental substrate supply leading to fetal hypoxia and growth
restriction.222,223

Increased nutrient intake during pregnancy in adolescent ewes results in increased
maternal weight gain, but decreased placental growth and a growth restricted fetus.224
Increased food intake results in reduced uterine and umbilical blood flow.225 Both
placental and fetal weights are decreased from as early as 95 days of gestation. The
decrease in placental weight is due both to a decrease in the number and the weight of the
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placentosomes.226 In addition, the fetus is hypoxic and exhibits brain sparing.225 There is
a decrease in umbilical uptake of both oxygen and glucose in the FGR fetuses of high
compared with moderate nutrient intake adolescent ewe fetuses.226 However, there is no
difference in the glucose transfer capacity on a placental weight basis between the two
groups.225 In addition, there is no difference in placentome GLUT-1 or GLUT-3 mRNA
expression in FGR fetuses at 81 or 133 days gestation.226 This finding is important
because it suggests that the FGR fetus is the result of a small placenta rather than altered
placental function. Adolescent overfeeding leads to decreased placental size, not
placental function, which results in reduced fetal substrate supply and FGR. In response
to the reduced substrate supply, the fetus does not activate the HPA axis, contrary to
observations in the other four sheep models of FGR, possibly due to a more moderate
degree of chronic fetal hypoxia.226

2.3.5. Risk Factors for Abnormal Placental Weights

A variety of risk factors for extreme placental weights have been identified in the
literature. Many maternal anthropometric measurements have been found to be positively
associated with placental weight including: maternal height,227 early or pre-pregnancy
maternal weight,5,227,228 early or pre-pregnancy body mass index (BMI),229,230 and
maternal weight gain.227,228,230 A number of medical conditions have also been shown to
be associated with placental weight, and they include: diabetes mellitus which results in a
larger placenta,231–233and hypertension234 and decompensated cardiac disease235 which are
both associated with lower placental weights.
Parity is positively associated with placental weight,227,228,3 as is maternal life
stress.236 Results are divided on the proposed association between maternal age and
placental weight,228,237 and infant sex and placental weight.2,3,230 However, placental
weight is higher in African Americans228 and lower in those of Asian ethnicity238 when
compared to all other ethnic groups.
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Some placental factors, such as placenta abruption, placental previa and
antepartum hemorrhage are not individually associated with placental weight,229 but as a
group are associated with a decreased PWR.188 Also, both abnormal cord insertion,
marginal and velamentous, and cord length below 25cm are associated with a decreased
placental weight.2,229 In addition, a single umbilical artery is also associated with a
reduced placental weight.229 Furthermore, abnormal cord insertion has also been found to
be associated with a high PWR.239 However, other factors were not controlled for in the
aforementioned study. Eccentricity of cord insertion is associated with a sparser chorionic
vascular distribution, and, ultimately, with a reduced transport efficiency of the placental
vasculature. The latter results in a reduced birth weight for a given placental weight.
Velamentous and even marginal cord insertion has been moderately associated with small
placentas and small fetuses. 239

Some of the more complex associations and their mechanisms are described
below including the roles of pregnancy nutrition, gestational diabetes, psychosocial
stress, smoking, preeclampsia and anaemia on placental weight. Two conceptual models
indicating the risk factors for SGA and LGA infants, an increased or decreased placental
weight, and those covariates which are risk factors for both fetal and placental growth can
be found in appendix C and D. Also, a table showing which risk factors increase or
decrease the placental weight and are associated with either SGA or LGA can be found in
appendix F. Finally, a conceptual model showing proposed pathways for an abnormal
PWR can be found in appendix E.

2.3.6. Mechanisms for Risk Factors of Abnormal Placental Weights
2.3.6.1.

Pregnancy Nutrition

Placental weight correlates with nutrition during pregnancy, but the effects of
maternal under-nutrition depend on the timing and duration of the nutritional deprivation.
A highly cited example that outlines this is the Dutch Famine of 1944-1945 in which
women who were subjected to starvation during their third trimester had low placental
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weight. However, the PWR’s were unaltered when compared to women who were not
malnourished.124

Animal models of maternal nutritional deprivation confirm that nutritional
deprivation is able to limit placental growth, thereby limiting fetal growth. However, it
has been found that placental total glucose transport capacity was normal when expressed
based on a unit weight-specific placental basis. Therefore, the investigators concluded
that the major limitation to fetal growth is the small size of the placenta rather than
alterations in its nutrient metabolism or transfer capacity.6

Both under- and over-nutrition during pregnancy affect placental size, although
the specific effects depend on the severity, duration and gestational age at the onset of
nutritional change.124,240 In sheep, moderate undernutrition during the peri-conceptual
period alone has no effect on placental weight in late gestation,241,242 but when the period
of undernutrition is during the period of rapid placental growth, placental weight is
frequently increased near term.243–245 This overgrowth appears to act as a compensatory
mechanism for the reduced nutrient availability early in gestation as fetal weight is
normal, or even enhanced, in late gestation after normal nutrition has been restored.246
Similar compensatory increases in placental weight have been observed in response to
undernutrition in pregnant pigs, rats and humans.124,247 By contrast, moderate
undernutrition during mid to late gestation when the placenta has formed tends to reduce
placental weight near term.243–245 When nutrient deprivation occurs throughout pregnancy
in sheep and rats, fetal and placental weights both decrease, but usually more fetus is
produced per gram of placenta than in normally nourished animals; therefore, the PWR is
lower.240,247,248 Similar increases in placental efficiency are observed when placental and
fetal growths are retarded by glucocorticoid administration during late gestation.205,249
Exposure to poor nutrition or glucocorticoids at critical stages of placental development,
therefore, appears to increase the efficiency with which the small placenta transfers
nutrients to the fetus.250 Therefore, placental weight may be increased or decreased
depending on the timing or duration of the maternal under or over nutrition based on a
combination of epidemiological and animal studies.
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2.3.6.2.

Gestational Diabetes

It has been noted by several authors that the placentas from women with
gestational diabetes are often increased in weight when compared to women who had
only one abnormal oral glucose tolerance test.234,251–255

A high PWR has also been found in women with gestational diabetes, which the
authors indicated is from an increased placental weight rather than a decreased birth
weight.252 However, another study has found a significantly lower PWR for women with
gestational diabetes compared to women with no glucose intolerance.256 Nevertheless, a
significantly higher placental weight was found in this study, so the decreased ratio is the
result of lower birth weights. These findings were based on a placental weight of one
standard deviation away from the established value for appropriate-for-gestational age
infants from non-diabetic pregnancies.

There is a modification in placental glucose transporters, yet there is an
unchanged transplacental glucose transport in gestational diabetes.257 Amino acid
transport may also be altered in diabetes.258 Furthermore, the placental structure is altered
in diabetes. The surface and exchange areas are enlarged as a result of the
hypoproliferation and hypervascularization. Therefore, the maternal-placental oxygen
supply is reduced, and the fetal oxygen demand is increased.259,260 This phenomenon
could be explained by aerobic metabolism which is stimulated by fetal
hypersinsulinemia. The low oxygen level upregulates transcriptional synthesis of leptin,
vascular endothelial growth factor (VEGF) and fibroblast growth factor which promotes
placental endothelial cell proliferation. The result is enhanced vascularisation of the
placenta.261,262 The hyperglycemia can induce a reduction in trophoblast proliferation
which delays placental growth and development, especially in early gestation. It has also
been shown that matrix metalloproteinases (MMP), MMP14 and MMP15, are increased
in diabetes and are associated with invasion, angiogenesis and proliferation.263
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2.3.6.3.

Smoking

Cigarette smoking is associated with a decreased fetal weight, but of the few
studies that have looked at maternal smoking and placental weight, there has been no
significant effect found.228,264–268 However, some studies that investigated the PWR found
a significant difference between the ratios in smokers versus non-smokers. The PWR
were significantly higher in smokers than in non-smokers in two prospective cohort
studies.227,266 On the other hand, another study found a significantly lower PWR for
smokers than non-smokers.264 Therefore, the results are divided on the effect of smoking
on the PWR, but the above studies lack a large sample size and are dated.

When a mother smokes during pregnancy the placenta and fetus become hypoxic
because of reduced oxygen content within maternal blood, referred to as preplacental
hypoxia. This condition results in reduced intraplacental oxygen content, predominately
branching angiogenesis, and reduced vascular impedance. The increase in branching
angiogenesis and thereby reduced vascular impedance, is an adaptive mechanism to the
hypoxic state. Interestingly this mechanism is associated with excessive placental
weight.144

2.3.6.4.

Preeclampsia

Placentas from women with preeclampsia tend, on average, to be smaller than
those from pregnancies that are uncomplicated.105,185,228,269 However, the decrease is only
slight and the relationship between the two is weak. Also, the PWR is often increased in
pregnancies that are complicated with preeclampsia,231,270 which suggests that there is
compensatory growth of placental villi in an attempt to overcome an unfavourable
maternal environment.208,271 However, the duration of the disease, and the severity of
preeclampsia are important determinants of placental abnormality. In a large population
study, it was found that low placental weight was strongly associated with preterm
preeclampsia, but less strongly associated with term preeclampsia. Surprisingly, term
preeclampsia was associated with both low and high placental weights.272
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According to current knowledge, preeclampsia is initiated by a hypoxic placenta
which is the consequence of reduced trophoblast invasion and impaired transformation of
the decidual spiral arteries. Alterations in trophoblast differentiation occur in many
pathophysiological conditions of pregnancy including both FGR and preeclampsia. The
mechanism behind this is postulated to be associated with a defect in EVT invasion.
Some of the spiral arteries are not invaded and some are superficially invaded, which
leads to a reduced blood flow in the intervillous space and a hypoxic placenta.273

EVT apoptosis is seen in normal pregnancy, but in preeclamptic pregnancies 15 to
50 percent of cells are apoptotic, which is a finding associated with macrophages around
the spiral arteries.273 Furthermore, during normal pregnancy, syncytiotrophoblast
fragments are dispersed into the mother’s circulation as a result of apoptosis. However,
the rate of syncytiotrophoblast apoptosis is increased from 2 to 3 percent in a pregnancy
not complicated by preeclampsia and from 5 to 6 percent in pregnancies complicated by
preeclampsia.274
The mechanism behind term preeclampsia’s effect on FGR is that normally
oxygenated maternal blood has restricted entry into the uteroplacental tissues due to
either occlusion or failed trophoblast invasion of the uteroplacental arterioles. This
situation represents late onset IUGR with preserved end diastolic flow volume. This
condition results in reduced intraplacental oxygen content with increased predominately
branching angiogenesis and reduced vascular impedance as an adaptation to the reduced
oxygen entering the placenta.142

2.3.6.5.

Anaemia

Many researchers have noted that placentas tend to be heavy in pregnancies
complicated by both severe and mild maternal anaemia, with the fetus often being small,
and therefore the PWR increased.228,275–277 The increased placental weight, and therefore
ratio indicate that anaemia, rather than underlying iron deficiency, is the cause for an
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increased placental ratio.278–280However, many of these studies suffer from the
methodological issue of too few placentas being examined. In contrast, in two large
studies the weight of the placenta was found to be inversely proportional with the
maternal haemoglobin concentration.281,282

The increased size of the placenta has been understood as a compensatory
mechanism to overcome the lack of oxygen in the maternal blood, again referred to as
preplacental hypoxia, as well as the increased trophoblastic proliferation and placental
angiogenesis that result from anaemia.283 In response to a lack of oxygen, the extravillous
trophoblast of the placenta bed shows an increased depth of invasion.284

2.3.7. Outcomes Associated with Abnormal Placental Weight Ratios

Both an abnormally low and abnormally high PWR are associated with adverse
outcomes. A PWR below the 10th percentile has been found to be significantly associated
with fetal distress.285 Alternatively, placental weight above the 90th percentile was found
to be significantly associated with newborns requiring neonatal intensive care
admission.104

There are numerous adverse short term outcomes associated with abnormal
PWR’s. Infants with a high PWR had increased incidence of meconium stained liquor,
hypocalcaemia, hypomagnesaemia and phototherapy. The incidence of these outcomes
was maintained even after exclusion of the preterm infants.286 The neonates with a high
PWR had increased incidence of low 1-minute Apgar score, treatment for neonatal
jaundice and infection, and respiratory complications. After adjusting for the effects of
preterm birth and vaginal delivery, a high ratio was still associated with low Apgar score,
respiratory complications, and treatment for infection.287
There are several long term outcomes associated with both abnormal PWR’s and
abnormal placental sizes. Placental insufficiency, as defined by reduced uterine
perfusion, in the pregnant rat results in low birth weight offspring predisposed them to
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the development of hypertension.288 Barker and his colleagues noted in 1990 that an
increased placental weight was associated with an increased risk of hypertension in adults
between 46 and 54 years of age.289 In addition, a large prospective cohort found that after
45 years of follow-up, the sex- and cohort-adjusted hazard ratio for the highest versus the
lowest third of the PWR was 1.38. Therefore, the authors concluded that a high PWR was
associated with increased risk of cardiovascular disease and death from cardiovascular
disease.137Also, a reduced placental weight and surface area is associated with
hypertension in later life, and the effect was strongest among women who were short and
had a low socioeconomic status. In the offspring of tall, middle class mothers, who were
likely to have been the best nourished, hypertension was predicted by large PWR. The
odds ratio rose from 1.0 if the PWR was 0.17 or less to 1.9 if the ratio was more than
0.21. The authors suggested that the risk of developing hypertension relative to your
PWR was dependant on the maternal nutritional state.290 Two studies have found that in 8
and 9 year old children an increased placental weight at birth is associated with increased
systolic blood pressure.291,292

2.4.

Summary and Rationale for this Study

SGA infants are an important population to examine because mortality and
morbidity are increased in SGA infants compared to those who are AGA.92 Short term
complications include still birth, abnormal EFH, hypoglycemia, hypocalcemia,
polycythemia, depression, meconium, 1 minute apgar less than 6, 5 minute apgar less
than 6, 1 minute apgar less than 3, and in hospital death, all of which increase with
increasing severity of growth restriction.106,293–295

A decreased birth weight shares many of the same risk factors as a decreased
placental weight. However, some risk factors have differing effects on both placental
weight and birth weight, but the literature has yet to elucidate these differences.
Therefore, by determining the risk factors associated with an abnormal PWR, it will
provide a clearer understanding of the variables that are associated with the relationship
between fetal and placental growth.
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Birth weight is correlated with placental weight, yet SGA infants often have high
PWR ratios indicative of more grams of placenta per gram of birth weight. This is
postulated to occur as the result of a compensatory mechanism in response to a decrease
in nutrient or oxygen delivery through the placenta to the fetus. Nevertheless, the timing
and duration of the reduced nutrient or oxygen supply plays an integral role in both fetal
and placental growth.

PWR distributions will make a substantial contribution to the literature. While it
is suspected that PWR may be an important indicator of fetal health, there are few
population standards for comparison. There are only one other set of PWR percentile
curves in a Canadian population, and their sample sizes are much smaller than our
sample. Therefore, our percentiles provide more accurate predictions, especially at the
extremes296 Determining the differences in PWR’s between SGA, AGA and LGA infants
will provide a better understanding of the relationship between fetal growth and placental
growth. To date, they will be the first of their kind in the literature. Also, the placenta and
birth weights follow different patterns of growth during gestation. The creation of
distributions based on gestational age will provide a better understanding of the
differences in the ratio of these two measures across gestational age. They will be a
useful tool to provide standards in the literature for other researcher and clinicians to use.
Therefore, by creating gender specific PWR distributions by gestational age, it will
provide deeper insight into critical periods for both fetal and placental growth.
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CHAPTER 3: METHODS

3.0

Introduction

This chapter describes the generic methods for the entire thesis including descriptions of
covariates and outcomes variables and their recoding for analyses, as well as details on
the specific methods used for each objective. More specifics will be provided in the
subsequent manuscript chapters.

3.1

Design and Data Source
This was a retrospective cohort study, using a hospital database of all singleton

birth records from St. Joseph’s Health Care and Victoria Hospital in London, Ontario.
The administrative perinatal database housed at Victoria Hospital contained information
on 58,004 births for the study date range. The perinatal database contains information on
maternal demographics, perinatal risk factors, and maternal and fetal outcomes.
Guided by definitions in the Vital Statistics Act, the database prospectively
collected data on all infants whose birth weight was greater than or equal to 500g or
whose gestational age was greater than 20 weeks. Relevant data abstraction from the
medical records was performed and input into the database.
3.2

The Study Population

3.2.1

Inclusion and Exclusion Criteria
The first objective included all singleton births from St. Joseph’s Health Care and

Victoria Hospital in London, Ontario between April 1, 2001 and March 31, 2011. The
second objective included all singleton births from both hospitals between June 1, 2006
and March 31, 2011 due to the availability of covariates of interest in the database. The
mothers were from London, Ontario and the surrounding area of Southwestern Ontario.
St. Joseph’s Health Care and the London Health Sciences center are tertiary care centers,
and therefore data represent mainly urban residents, as well as high risk transfers from
rural areas that amount to approximately 20% of births at the hospitals. Mothers were
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predominately from Middlesex County; however, there were mothers from the
surrounding area.
Women who delivered an infant before 22 or after 42 weeks were excluded due to
the small sample sizes present in these categories. Also, unknown or ambiguous genders
were excluded from the analysis, as the distribution curves were stratified into males and
females. Infants with major congenital abnormalities and stillbirths were also excluded.
Lastly, multiple pregnancies were excluded from the analyses. These exclusions are
highlighted separately for each objective in the study flow charts in Figures 3.1 and 3.2.

3.2.2

Missing Information

For both the first and second objective, any observation with a missing placental
weight ratio (PWR) or gestational age was excluded from the analyses. For objective two,
there was missing information for smoking status, preeclampsia, anaemia, placenta
delivery method, parity, maternal age, and maternal height. Any individual with missing
information was excluded for this objective.

3.3

Data Collection and Coding

3.3.1

Predictor Variables

The following variables were chosen to be extracted from the perinatal database,
according to the conceptual model, to be considered as predictors of the placental weight
and/or birth weight. The categorization process is described below for each of the
predictor variables, where these variables and their coding are summarized in Table 3.1.
3.3.1.1 Baseline Variables
3.3.1.1.1

Maternal Height

Maternal height was treated as a continuous variable because categorizing
continuous variables is a subjective process that leads to variables with less statistical
information.1 All measurements were converted to metric units for analysis.
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3.3.1.1.2

Parity

The number of live births to this mother (counting twins and triplets as 2 and 3
births, respectively) was used for the parity count. For this study, parity was
dichotomized for the analysis into nulliparous versus multiparous with women
completing their first pregnancies as the reference group.
3.3.1.1.3

Smoking Status

Smoking status was entered as a binary variable, whether the person smoked
during the pregnancy or whether they did not. This variable did not account for the
number of cigarettes smoked. The women who did not smoke were treated as the
reference group.
3.3.1.1.4

Maternal Pre-Pregnancy Weight

The perinatal database considered it acceptable to use weight at presentation, if
gestational age was 16 weeks or less at presentation. The pre-pregnancy or early
pregnancy weight from the antenatal record was entered if gestational age was 16 weeks
or younger, but preferably pre-pregnancy weight was used. The data holds greater
validity if it can be cross-referenced against other documentation in the chart. The prepregnancy or early pregnancy weight from the antenatal record was not entered unless it
could be cross-referenced against the Nursing Admission sheet and/or the first
Obstetrician consult note on Power Chart and/or the Obstetrician or general practitioner
appointment on the second page of the antenatal history and/or the history taken by the
clerk on admission. The Nursing Admission sheet shows the weight at admission and the
self-reported weight gain during the pregnancy. If this corroborated with the other weight
information the abstractor noted in the chart, then it was entered as pre-pregnancy or
early pregnancy weight. It was also entered if in the chart it was specifically documented
as pre-pregnancy weight. If the weight in the antenatal record was taken at gestations
greater than 16 weeks it was not used and the field was left blank. Therefore, maternal
pre-pregnancy weight was treated as a continuous variable, and all measurements were
converted to metric units for analysis.
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3.3.1.1.5

Maternal Age

When the mother’s age at time of delivery was entered into the database it was
calculated by subtracting the mother’s date of birth from the infant’s date of birth. Age
remained was categorized into mothers <21 years of age, between 22 and 34 years of age
and <34 years of age for the analyses.
3.3.1.1.6

Maternal BMI

Maternal BMI was not directly collected in the database, but the maternal weight
and height variable were used to calculate maternal pre-pregnancy body mass index
(BMI) using the equation BMI= weight (kg) / height2 (m2). BMI was then categorized
according to the Health Canada Guidelines into four categories: underweight (< 18.5),
normal weight (18.5-24.9), overweight (25.0-29.9), and obese (30.0+).2 Those
observations with a normal BMI were used for the reference category.
3.3.1.1.7

Maternal Asthma Status

Maternal asthma status was coded as a binary variable. The mother was either
asthmatic or not asthmatic based on information in the patients chart. The mothers who
did not have asthma were the reference group.
3.3.1.2 Mid-Pregnancy Variables
3.3.1.2.1

Gestational Hypertension

Gestational hypertension was defined as diastolic blood pressure > 90 mm Hg, on
at least two occasions at 20 weeks gestation or older, no proteinuria and blood pressure
elevation detected for the first time during pregnancy. It was coded as gestational
hypertension even if the physician only noted “elevated blood pressure” in their notes, as
directed by the Chief of Obstetrics, Dr. Natale. If the diagnosis on the chart was unclear
then the mentioned guidelines were used to define gestational hypertension.
An expansion of the definitions was provided in April 2010, as help for coding a
chart with inconsistent documentation. For example, if the physician noted that the
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patient had gestational hypertension but lab results showed proteinuria, then the database
coded preeclampsia, as per Dr. Natale.
3.3.1.2.2

Preeclampsia

Severity of hypertensive disorder was recorded as a categorical variable. The
patient either had no hypertension and proteinuria or gestational hypertension with a
diastolic pressure >90 mm Hg, on a least two occasions at 20 weeks gestation or lower,
no proteinuria, and blood pressure elevation detected for the first time during pregnancy.
The patient could also have been categorized as having mild preeclampsia defined as
diastolic blood pressure between 90 and 110mm Hg with proteinuria less than 3+ or
severe preeclampsia defined as diastolic pressure of 110 mm Hg or higher and/or 3+
protein and/or any end-organ involvement and treatment with magnesium sulfate or
eclampsia when seizures occur or unknown. In cases where a physician noted that a
patient had gestational hypertension but, lab results showed proteinuria, then the data
abstractor recorded preeclampsia. These guidelines were used when the diagnosis on the
chart was unclear. If any proteinuria was present it was coded as preeclampsia up to and
including the third day postpartum based on the diagnostic criteria from the SOGC
recommendation IIIC from March 2008. Codes followed classification in CreasyResnick, maternal-fetal medicine, 6th edition.3 For any case with preeclampsia
superimposed on chronic hypertension, chronic hypertension was defined based on the
criteria provided in the hypertension section, and then the appropriate code for
preeclampsia severity was also entered. For this thesis the data were coded as a binary
variable, preeclampsia or no preeclampsia present. The group with no preeclampsia was
treated as the reference group.

3.3.1.2.3

Gestational Diabetes

Carbohydrate disorders were defined using a categorical variable in the perinatal
database. Mothers were defined according to the following set of criteria: no
carbohydrate disorder, carbohydrate intolerance defined as one abnormal reading on a 75
gram oral glucose tolerance test, gestational onset and diet controlled, gestational onset
with insulin control or overt diabetes. When cases of gestational onset diabetes were
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commented on by the doctor as “missed”, it was coded as gestational onset with insulin
control unless a specific diagnosis of overt diabetes was indicated. In this study,
gestational diabetes was coded as a binary variable, present or absent. Mothers' with no
gestational diabetes were used for the reference group.
3.3.1.3 Umbilical and Placental Conditions
3.3.1.3.1

Umbilical Cord Risk Factors

In the database, cord complications were defined categorically depending on the
presence or absence of a cord complication and the type of complication. For the analysis
in this study, no complications acted as the reference group. An infant was placed into
one of the following three categories: no complications, a cord around the neck, in a knot,
around the body, prolapsed or lacerated or having a short, 2-vessel or velamentous
umbilical cord.
3.3.1.3.2

Placental Abruption

Placental abruption was defined in the database as premature separation of a
normally implanted placenta after the 20th week of gestation and before the fetus was
delivered. Placental abruption was categorized as either none, mild, moderate or severe in
the perinatal database. If the placental abruption was recorded as chronic on the mother’s
chart, then it was coded as a mild abruption. This addition to the coding manual for
chronic abruption was added in May/June of 2010. For the purpose of this thesis, the data
were coded as a binary variable, either abruption (mild, moderate or severe) or no
abruption. The observations with no placental abruption were used as the reference.
3.3.1.3.3

Placental Previa

Placental previa was categorized into five different categories. Placental previa is
either indicated as not present, marginal, partial, complete or resolved before delivery.
The database defines placental previa as implantation of the placenta low in the uterus
either overlying or reaching the vicinity of cervical opening. Prior to May/June of 2010
the final category listed above, resolved before delivery, was not one of the categories for
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placental previa. For this thesis, placental previa were treated as a binary variable, and
women with no placental previa were treated as the reference group.
3.3.1.4 Late Pregnancy and Delivery Variables
3.3.1.4.1

Pregnancy Weight Gain

Weight gain during pregnancy was only documented as a risk factor in the
perinatal database, and not as an exact weight value. Therefore, a mother was defined as
having a low pregnancy weight gain if by 30 weeks gestation the mother has gained <10
pounds or if at delivery the mother has gained <20 pounds. Furthermore, the pregnancy
weight gain was indicated as high if the mother gained >40 pounds during her current
pregnancy at the time of delivery. Women who gained within the normal range for
weight gain during pregnancy were not indicated, so women who were not categorized as
having a low or high weight gain were presumed to be within normal ranges. Also, the
exact weight gain was not indicated, but instead recorded as a categorical variable. The
women with normal weight gain were used as the reference group.
3.3.1.4.2

Anemia

In the perinatal database admission hemoglobin was recorded. If admission
hemoglobin was <100g/L then the patient is defined as anemic. This variable was coded
as a binary variable, present or absent. Patients with admission hemoglobin within normal
limits were treated as the reference category.
3.3.1.4.3

Sex of the Infant

Sex was defined as either: ambiguous, male, female or unknown if the data was
missing. Therefore, the sex of the infant was categorized as a binary variable, either male
or female, for all statistical analysis. Unknown or ambiguous genders were excluded from
the analysis, as previously mentioned.
3.3.1.4.4

Placental Delivery

The database coding manual indicates that a good indication of problems with
delivery is the interval of time from the infant date of birth to the delivery of placenta,
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usually 30 minutes or more of placental retention. The placental delivery was categorized
into spontaneous, expressed or assisted, manual, if 30 minutes or more after vaginal
delivery of baby and always manual if the delivery was a cesarean section, retained, if
dilation and curettage, or by scraping or curettage, and finally unknown. This variable
remained as a categorical variable based on the aforementioned categories, and a
observations with a spontaneous placenta delivery were used as the reference.
3.3.1.4.5

Congenital Abnormality

Congenital abnormality was recorded as a categorical variable, with the following
categories: no abnormalities, minor abnormalities or major abnormalities. Any major
congenital abnormalities were excluded from the analyses.
3.3.2

Outcome Variables

3.3.2.1 Gestational Age

Gestational age was a key variable for this research, as it allowed an infant to be
classified as SGA, AGA or LGA and played an integral role in establishing PWR
distributions by gestational age. Gestational age was recorded in the database as the
number of completed weeks and the number of completed days. For the purpose of this
analyses, gestational age remained as a continuous integer variable, but only the
gestational week was used, not the number of days.
According to clinical practice, gestational-age estimation in the database was
derived from the last menstrual period if either first trimester ultrasound was within ± 4
days of the estimated date of confinement or second trimester ultrasound was within ± 10
days of the estimated date of confinement. Otherwise, gestational age was corrected on
the basis of ultrasound measurements that are routinely obtained for all pregnant women
in the province of Ontario for pregnancy dating.

3.3.2.2 Birth Weight for Gestational Age
In the database, infant birth weight was recorded in grams as a continuous
variable. One of the primary outcome measures of interest for this thesis was the birth
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weight or size for gestational age of the infant at birth. Size for gestational age is a
categorization based on the normal distribution of birth weights, controlling for infant sex
and gestational age, in the population. For this study, the continuous birth weight variable
was categorized into small, average and large for gestational age infants (SGA, AGA and
LGA) for the analysis. This thesis used the population standards published by Kramer et
al. in 2001.4 A SGA infant was defined as one whose birth weight fell into the lowest
10% of Canadian births, for their sex and gestational age. LGA infants were defined as
those whose birth weight fell into the highest 10% of Canadian births, for their sex and
gestational age. Infants who did not fall into either the lowest or the highest 10% of birth
weights were considered to be AGA. AGA infants were used as the reference category
for this analysis.

3.3.2.3 Placental Weight

Another primary outcome measure of interest for this thesis was placental weight.
Placental weight was entered into the database in grams, and if unknown was left blank.
This variable has been collected since the beginning of the database at St. Joseph’s
Hospital, but only since November of 2003 in the LHSC, Victoria Hospital database. For
objective one of this thesis, placental weight was treated as a continuous variable in order
to produce accurate distributions. For objective two of this thesis, it was categorized into
≤10th percentile, ≥90th percentile or in between the 10th and the 90th percentile based on
the results from objective one, using the overall standards that were created.

3.3.2.4 Placental Weight Ratio

The PWR was calculated by dividing the birth weight by the placental weight for
each infant that has a birth weight and a placental weight.

3.4

Data Analysis

3.4.1

Data Cleaning

83
Exploratory univariate analyses detected implausible values, missing values or
other questionable or extreme values that required attention. Additional work was done to
clean and quantify the predictor and outcome variables to ensure that implausible values
were not included. Variables such as maternal height, age and pre-pregnancy weight were
trimmed at the 1st and 99th percentile in order to remove implausible values. Birth weights
greater than three standard deviations from the mean were removed, as they were
presumed to be implausible. The calculation for this can be found in Appendix J.
Placental weights < 100g or >2500g were also removed, as they were presumed to be
incorrect. Due to the large size of the population, the implausible or extreme values could
not be cross checked with the chart information. A diagrammatic representation of this
can be found in the study flow chart in Figures 3.1 and 3.2.

3.4.2

Statistical Analyses

3.4.2.1 Placental Weight Ratio Distributions
3.4.2.1.1

Justification and Explanation: Quantile Regression

Quantile regression (QR), which was introduced by Koenker and Bassett is way
to create growth charts.5 One of the main advantages of QR is that it does not make any
distributional assumption beforehand. It is able to model data with heterogeneous
conditional distributions.6 It is also relatively easy to accommodate other covariates
besides age; however, this function will not be required for the specific aims of this
thesis. Computationally, QR is fast and stable. It also generalizes the concept of a
univariate quantile to a conditional quantile given one or more covariates.7 Another
advantage of QR, is that it is robust to extremes of the response variable.6

Ordinary least-squares regression models the relationship between one or more
covariates X and the conditional mean of a response variable Y given X = x. In contrast,
QR models the relationship between X and the conditional quantiles of Y given X = x, so
it is especially useful in applications where extremes are important, such as growth
studies where upper and lower quantiles are critical from a diagnostic perspective.8 QR
also provides a more complete picture of the conditional distribution of Y given X = x
when both lower and upper, or all quantiles, are of interest. The main advantage of QR
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over least squares regression is its flexibility for modeling data with heterogeneous
conditional distributions, such as the PWR ratio.8 QR provides a complete picture of the
covariate effect when a set of percentiles is modeled, and it makes no distributional
assumption about the error term in the model.

There have been several methods used to construct such age dependent growth
charts. Early methods fit smoothing curves on sample quantiles of segmented age groups.
However, these methods are not robust to outliers. Large sample size is needed in order
to estimate the percentiles in each age group with appropriate precision. The
segmentation may lose information from nearby groups. To avoid segmentation, Cole
and Green9 developed a Box-Cox transformation-based semiparametric approach from
the LMS (Lamda-Mu-Sigma) method introduced by Cole. The semiparametric LMS
method solves penalized likelihood equations.10

Generally there is reasonable agreement between LMS curves and QR. However,
it has been shown that especially in infants, the more parsimonious LMS curves lack the
flexibility of QR. Also, the LMS method has been shown to overfit in comparison to QR.
While there is a relatively good agreement between the two methods, LMS imposes more
structure but QR is more stable and is able to reveal departures from underlying
assumption of parametric models.8

QR, which solves the optimization problem with a general simplex algorithm, is
computationally expensive. Faster methods have been developed. The worst-case
performance of the simplex algorithm shows an exponentially increasing number of
iterations with sample size. Since the general QR fits adequately into the standard primaldual formulations of linear programming, the interior point algorithm can be applied. The
worst-case performance of the interior point algorithm has been proven to be better than
that of the simplex algorithm.6,7

Several methods for computing confidence intervals of the regression quantiles
have been proposed in the literature. They can be classified into three categories: the
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direct method, which computes the confidence intervals, based on the asymptotic
normality of the estimated regression quantiles; the rank-score method, which computes
the confidence intervals based on the inversion of the rank-score test; and the resampling
method, which uses the bootstrap technique.

3.4.2.1.2

Application: Quantile Regression

The first objective to construct PWR distribution curves by gestational age for
males and females and then to stratify by SGA, AGA and LGA status was accomplished
using QR. The QUANTREG procedure in SAS 9.3 computes the fitted values of the
quantile only for a single quantile at a time. Therefore, since fitted values were required
for multiple quantiles in this analysis, a macro was created. The macro allowed for
computation of the 3rd, 5th, 10th, 25th, 50th, 75th, 90th, 95th and 97th percentiles
simultaneously in one output. The FITPLOT graph option in QUANTREG was used to
generate the graphs displayed in the results section which show the smoothed and fitted
curves without any of the data points. The macro used is displayed in Appendix K.
QR is a type of regression analysis that aims to estimate either the conditional
median or other quantiles of the response variable. QR was performed using the interior
point algorithm with a tolerance of 1E-4 and a step length of 0.25. Markov chain
marginal bootstraps (MCMB) were implemented to compute confidence intervals for the
regression quantiles.7,11
The PWR was used as the outcome variable and a quadratic term for gestational
age was used as the covariate. Using a quadratic term for gestational age produced the
same results as when cubic B-splines were used with knots at the boundaries (22 and 42
weeks gestation). Therefore, a quadratic term was used as it allowed for an easier
interpretation of the significance level of the results at each percentile.

3.4.2.2 Determinants of an Atypical Placental Weight Ratio
3.4.2.2.1

Application: Multinomial Logistic Regression
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The second objective that aimed to identify risk factors for abnormal PWR’s was
completed in SAS 9.3 using multinomial logistic regression with the PROC LOGISTIC
function. The outcome for this analysis was a PWR ≤10th percentile, between the 10th and
the 90th percentile or ≥90th percentile, with a PWR between the 10th and 90th percentile as
the reference group. The PWR standards created in objective 1 (Chapter 3) for overall
infants were used to establish 10th and 90th percentile cut-offs for use as the outcome
variable. Variables were entered in chunks,12 and the collapsibility criteria were used to
determine if any of the odds ratios (OR) changed by greater than 10% when another
chunk was added. Variables were entered in chunks, in temporal sequence, into the
model. These chunks were: baseline variables; early pregnancy variables; placental and
cord complication variables; and late pregnancy and post partum variables. Using
temporally entered chunks allowed associations between variables from different chunks
to become evident through the model building process, which allowed for a better
understanding of the associations in the data.12 Multinomial logistic regression allowed us
to use infants with a PWR between the 10th and 90th percentile as the reference group in
an analysis that simultaneously estimated the odds of a PWR≤10th percentile or ≥90th
percentile. Entering chunks allowed associations between variables from different chunks
to become evident through the model building process, which allowed for a better
understanding of the associations in the data.
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Table 3.1: Study Variables and Recoding for Analysis
Variables Available in
Database
Birth Date

Coding in the Database

Recoding for Analysis

Birth Weight

Recorded as a year and a
month
Measured in grams

Gestational Week

Measured in weeks

Categorical
0=SGA
1=AGA
2=LGA
Continuous (Integer)

Placental Weight

Measured in grams

Continuous

Maternal Age

Measured in years

Maternal Height

Measured in inches

Categorical
<21 years of age
21-34 years of age
>34 years of age
Continuous

BMI

Not recorded by prepregnancy weight and
maternal height were used to
create this variable

Parity

Recorded as a continuous
variable

Admission Hemoglobin

Measured in grams per Liter.

Sex

A=Ambiguous
F=Female
M=Male
U=Unknown (missing
information)
0=No
1=Carbohydrate intolerance
(1 abnormal reading on a 75
gram oral glucose tolerance
test (GTT)
2=Gestational onset, diet
controlled

Gestational Diabetes

Categorical
0=BMI <18.5
1=18.5≤BMI<24.9
2=24.9≤BMI<29.9
3=BMI≥29.9
Binary
0=primiparous
1=multiparous
Binary
0=not anaemic (If
admission hemoglobin in
≥100g/L)
1=anaemic (If admission
hemoglobin is <100g/L)
Binary
0=Male
1=Female

Binary
0=No (If previously coded
as 0 , 1 or 4 in the database)
1=Yes (If previously coded
as 2 or 3 in the database)
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Preeclampsia

Smoking Status

Umbilical Cord
Complications

3=Gestational onset, insulin
controlled
4=Overt. Note: cases of
gestational onset with
comment of “missed” by Dr.
should be coded as 3 unless a
specific diagnosis of overt
diabetes has been made.
0=No
1=Gestational hypertension,
diastolic > 90 mm Hg, on at
least 2 occasions at 20 weeks
gestation or older, no
proteinuria, blood pressure
elevation detected for the first
time during pregnancy.
Code as gestational
hypertension even if
physician only notes
“elevated blood pressure”, as
directed by Dr. Natale.
2=Mild preeclampsia,
diastolic between 90 and 110
mm Hg with proteinuria less
than 3+
3=Severe preeclampsia,
diastolic 110 or higher,
and/or 3+ protein, and/or any
end-organ involvement and
treatment with magnesium
sulfate
4=Eclampsia, seizures occurs
-8=unknown
0=No (during pregnancy)
1=Yes (during pregnancy)
0=None
1=Neck
2=Knot
3 =Body
4=Prolapsed
5=Laceration
6=Short
7=2-vessel
8=Velamentous
9=Other

Binary
0=No (If previously coded
as 0 or 1 in the database)
1=Yes (If previously coded
as 2, 3 or 4 in the database)

Binary
0=No
1=Yes
Categorical
0=None
1=Neck, body, prolapsed,
lacerated, and other
2=short, 2-vessel and
velamentous
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Placental Abruption

Placental Previa

Placenta Delivery

0=No
1=Mild (may be recorded on
chart as “chronic”)
2=Moderate
3=Severe
0=No
1=Marginal
2=Partial
3=Complete
4=Resolved before delivery
1=Spontaneous
2=Expressed or assisted
3=Manual, if 30 minutes or
more after vaginal delivery
and always manual if C/S
delivery
4=Retained, if D&C or by
scraping or curettage only
-8 =unknown

Binary
0=No (If coded in database
as 0)
1=Yes (If coded in
database as 1, 2 or 3)
Binary
0=No (If coded in database
as 0)
1=Yes (If coded in
database as 1, 2, 3 or 4)
Categorical
1=Spontaneous
2=Expressed or assisted
3=Manual, if 30 minutes or
more after vaginal delivery
and always manual if C/S
delivery
4=Retained, if D&C or by
scraping or curettage only
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Figure 3.1: Flow chart illustrating the process by which the study population was
obtained for Objective 1
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Figure 3.2: Flow chart illustrating the process by which the study population was
obtained for Objective 2
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CHAPTER 4: POPULATION BASED PLACENTAL WEIGHT RATIO
DISTRIBUTIONS
4.1

Introduction
Placental weight is the most common way to characterize placental growth, and it

is a summary of many dimensions of placental growth. The placental weight
measurement includes the laterally expanding growth of the chorionic disc and
arborization of the villous and vascular nutrient exchange surface, which is reflected in
the increasing thickness of the chorionic disk. The expansion of the chorionic plate,
beginning early in pregnancy, is the principle determinant of placenta transfer capacity to
facilitate the genetic growth potential of the conceptus.1

Fetal growth depends on placental growth. Fetal growth restriction (FGR) is the
failure of a fetus to reach his/her biological growth potential, most probably due to a
pathological slow down in the fetal growth rate. Small birth weight for gestational age
(SGA) is widely used as a statistical indicator of FGR, since FGR is not measurable.
SGA is defined as birth weight < 10th percentile for gestational age and sex based on a
population standard.2 Placental weight is lower in SGA infants than in average for
gestational age (AGA) and large for gestational age infants (LGA).3,45

The placental weight ratio (PWR) is a common measure of the balance between
placental and fetal growth. The PWR is defined as the placental weight divided by the
birth weight, and decreases across gestation as the placental growth slows and fetal
growth accelerates.6 Placental hypertrophy and reduced fetal growth have been postulated
to be an adaptation to maintain placental function in pregnant women with complications
such as malnutrition.7 If this is true, a pregnancy with impaired fetal growth, resulting in
a SGA infant, should have an increased PWR compared to those infants who are AGA or
LGA.1,8

Placental weight and the PWR have been found to be predictive of maternal
disease, obstetric outcome, perinatal morbidity and mortality, childhood growth and
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development, and fetal origins of adult disease.9–14 While percentile curves for birth
weight are available for a variety of jurisdictions and populations, percentile curves for
the PWR are not. Thompson et al.15 created birth weight to placental weight ratio curves
using the Norwegian Birth Registry with all singleton live births in Norway from January
1999 to December 2002 (n= 198, 971). These curves were a significant contribution to
the literature. Further, no population curves to date have looked at the differences
between SGA and LGA across gestational age. Searching the available literature, we
found only one other set of PWR percentile curves in a Canadian population.6 However,
the sample size was small (n=20,309). Also, previous studies that have looked at atypical
PWRs have not used a population standard to identify abnormal PWRs.16–18

If the pattern of placental growth is associated with differences in the efficiency
of placental function, and therefore fetal growth, as reflected in the PWR, this may have
physiological implications. Therefore, it would be useful to have standardized curves in
order to ascertain normal from abnormal PWR. Accordingly, the first objective of this
study was to develop standard curves for the PWR across gestational ages in a
population-based birth cohort. Since literature evidence suggests that placental weights
differ between SGA, AGA and LGA infants, a second objective was to examine this in
order to refine the potential applications of the PWR trajectories. Having the knowledge
of the expected norms of PWR will provide a useful standard for further research.

4.2

Methods
The study included all singleton births from St. Joseph’s Health Care and Victoria

Hospital in London, Ontario between April 1, 2001 and March 31, 2011. The perinatal
database provides targeted information on all births occurring at the hospitals. Anomalies
(n=881), still births (n=422), and multiple gestations (n=2876) were excluded from the
analyses. All remaining singletons were included (n=41,441).

Data in the database were entered from the medical chart, delivery records, and
neonatal records by a dedicated research assistant. Placentas and infants were weighed by
nursing assistants with an electronic weight scale. Placentas were weighed with

95

membranes and umbilical cord, including the segment of cord used for cord blood
sampling. No attempt was made to remove placental blood before weighing. Placental
weight was not collected at both hospitals for the entire duration of the study therefore,
there were 13,084 missing values. Missingness for categorical variables is outlined in
Appendix L.

Gestational ages of births recorded in the database ranged from 20 to 44 weeks,
but only births between 22 and 42 weeks gestation were included in the analyses.
Gestational age was truncated to the number of completed weeks based on the
recommendations from World Health Organization and International Classification for
Disease, and was based on ultrasound or last menstrual period. Birth weight was
categorized into SGA, AGA and LGA based on Kramer standards.19
Descriptive analyses were performed on all study variables. Implausible values
and potential errors were excluded from the analyses. Birth weights above or below the
mean by three SD’s were removed from the analyses. Placental weights that were ≤100 g
or ≥2500g were also excluded from the analyses. Maternal age, maternal height and prepregnancy weight were all trimmed at the 1st and 99th percentiles to remove any
erroneous values. Any unknown or ambiguous sexes were also excluded from the
analyses.
Placental and birth weight distribution curves, and PWR curves, by gestational
age were produced stratified by sex. Initially, estimates were restricted to the population
who reside in London-Middlesex excluding regional referrals from outside LondonMiddlesex. This sample, hereinafter referred to as the “city-wide” sample, would be
expected to produce estimates with high internal validity because they represent a “whole
population” perspective. A second analysis was done in which PWR curves were
estimated for the entire sample of births, including referrals from outside LondonMiddlesex. Inclusion of the referrals would be necessary for later analyses, stratified by
fetal size, in order to produce adequate sample sizes at lower gestational ages. The citywide PWR distributions were compared to the PWR distributions inclusive of referrals in
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order to assess their similarity. Finally, the latter sample was used to create PWR
distribution curves separately for SGA, AGA and LGA infants, again stratified by sex.
Following the Center for Disease Control and Prevention standards, we created
growth charts at the 3rd, 5th, 10th, 25th, 50th, 75th, 90th, 95th and 97th percentiles. We used
parametric quantile regression with quadratic terms on gestational age. Non-parametric
quantile regression was used for the placental and birth weight distributions, but
quadratic splines at 22, 32 and 42 weeks gestation were used as opposed to a quadratic
term for gestational age. Quantile regression does not impose any parametric assumptions
on the response distributions which make it appropriate for the anthropometric
measures.20 Due to the large sample size, the interior point algorithm was used,21 and
resampling was performed using the Markov chain marginal bootstrap.22
4.3

Results

The final sample were 21255 males and 20186 females (total n=41,441). Of these, 33582
were residents of London-Middlesex while 7,859 were regional referrals.
The characteristics of the study sample are given in Appendix L. The mean
gestational age for the population studied was 38.8 weeks (SD=2.1 weeks), with median
and mode, respectively, of 39 and 40 weeks gestation. The mean birth weight was
3,398.6g (S.D=594.8g, minimum 279g, maximum 5,300g). The mean placental weight
was 675.67g (SD=161.18, minimum 103 g, maximum 2,095g). The PWR had mean of
0.20 (SD=0.044, minimum 0.023, maximum 1.17). There were 4,259 (7.9%) SGA
infants, 43,697 (81.2%) AGA infants and 5,878 (10.9%) LGA infants in the study
sample. The distributions of birth weight, placental weight and gestational age can be
found in Appendix M.
Placental Weight, Birth Weight and PWR Distributions
Figures 4.1 (a) and (b) present placental weight and birth weight distributions for
males and females, respectively. It can be seen that, because these curves are for the last
half of gestation, placental growth has to some degree leveled off while fetal growth
continues at an accelerated pace. PWR standards for the city-wide population are shown
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in Tables 4.1 and 4.2. All of the percentiles reached a statistical significance of p<0.001.
Tables 4.3 and 4.4 present the PWR standards when inclusion criteria are relaxed to
include regional referrals in the sample.
Comparing the city-wide population to the total sample revealed them to be
similar, with minute differences presenting themselves at the extreme percentiles at the
earlier gestational ages. Furthermore, comparing the 10th and 90th percentiles which are
often used as cut-off points revealed almost no differences, even at the earlier gestational
ages. The distributions of the PWR curves for the city-wide population are illustrated in
Figures 4.2 (a) and (b). A visual presentation of the PWR curves, inclusive of regional
referrals, for males and females are shown in Figures 4.3 (a) and (b), respectively.
All of the percentiles reached statistical significance of p<0.001. For males, the
median PWR is 0.1938 and the mean is 0.1994 (SD=0.0428). For females, the median
PWR is 0.1981 and the mean is 0.2038 (SD=0.0446). The PWR decreases as gestational
increases and there is more dispersion between the percentiles at earlier gestational ages
than at later gestational infants.
In general, the females have higher PWR’s than males. The slightly higher PWR
in females than in males is consistent across percentiles. For instance, females have
slightly higher PWRs at both the 3rd and 97th percentile across all gestational ages than do
males. Using the 50th percentile, the range of values between 22 and 42 weeks gestation
is 0.2681 for females and 0.2443 for males. Therefore, there is a greater range in values at
the mean for females. Furthermore, the ranges for these values are greatest at the highest
percentiles. For both males and females, the ranges at the 90th percentile are more than 2
times as wide as at the 10th percentile. At the 10th percentile the ranges for males and
females between 22 and 42 weeks gestation are 0.1622 and 0.1728, and the ranges at the
90th percentile for males and females are 0.3514 and 0.4667. Tables 4.3 and 4.4 show the
exact values at each gestational age by percentile.
Placental Weight Ratio Distribution Curves Stratified by SGA, AGA and LGA status
PWR distributions for the entire sample, inclusive of regional referrals, were used
in an analysis of SGA, AGA and LGA. The proportion with PWRs <10th percentile,
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between the 10th and the 90th percentile and >90th percentile are presented in Table 4.5.
There are a higher proportion of SGA infants for both males and females in the extreme
PWR groups. Furthermore, there are fewer LGA infants in the lowest PWR group. More
detailed descriptions and graphics of the SGA and LGA PWR curves can be found in
Appendix N with their accompanying tables and diagrams.
The median PWR curves for each of SGA, AGA and LGA are presented in
Figures 4.4 (a) and (b). These show graphically how the PWR changes across gestation
between SGA, AGA and LGA infants at the median. Specifically, they show that there is
a greater dispersion in the PWR in SGA infants than in AGA and LGA infants, especially
in the earlier gestational ages. When comparison is made between LGA and AGA infants
the AGA infants show more dispersion at the earlier gestational ages than do the LGA
infants. It can then be concluded that the dispersion at the earlier gestational ages is
greatest in SGA infants than in both LGA and AGA infants.
Furthermore, at the earlier gestational ages both male and female SGA infants
have higher PWR’s than male and female AGA and LGA infants. The differences in
PWR’s were the most pronounced at the higher percentiles and at the earlier gestational
ages, as shown in Appendix N. SGA infants had much higher PWR’s in early gestation
than both SGA and AGA infants at the early gestation. On the other hand, LGA infants
have lower PWR’s at the earlier gestational ages when compared to AGA infants.
However, the PWR’s at term gestations are nearly identical in both SGA and
LGA infants. In fact, LGA infants have slightly higher median ratios at term than both
SGA and AGA infants. Due to the greater dispersion at the earlier gestational ages in
SGA infants, the ranges of PWR’s between the 22 and 42 week of gestation is higher in
SGA infants than the AGA and LGA infants. This range difference is the greatest at the
highest percentiles, but the range in PWR’s between 22 and 42 weeks at the lower
percentiles is also the greatest in SGA infants. Therefore, as gestational age increases the
PWR’s become more similar between SGA, AGA and LGA infants, yet the PWR is still
higher in SGA infants, especially at the higher percentiles.
AGA Placental Weight Ratio Distribution Curves
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There are 16,994 males and 16,764 females who met the criteria for classification as
AGA. All of the percentiles attained a significance level of p<0.001.
Males have a median PWR of 0.1933 and a mean PWR of 0.1990 (SD=0.0424).
Females have a median PWR of 0.1977 and a mean PWR of 0.2032 (SD=0.0441). Again,
the PWR decreases as gestational increases and there is more dispersion between the
percentiles at earlier gestational ages than at later gestational infants.
Figures 4.5 (a) and (b) show the distributions graphically, and Tables 4.6 and 4.7
provide exact PWR values for each of the aforementioned percentiles by gestational age.
Using Tables 4.6 and 4.7, it is evident that there is a greater range in PWR’s between the
22 and 42 weeks of gestation at the 50th percentile for females than males. The range for
males is 0.2507 and 0.2646 for females. The same pattern holds at the extreme values,
such as the 10th and 90th percentiles.
4.4

Discussion
The results of this study contribute to the current literature by creating gender-

specific PWR percentile curves which will be a useful tool in further research. While
PWR is an important indicator of fetal health, there are few population standards for
comparison. Compared to the only other available set of PWR percentiles in a Canadian
population,6 our results complement this literature and now provide more precise PWR
predictions, particularly at the extreme percentiles, due to our larger sample size.
4.4.1 Comparisons with Previous Research
In this sample of Canadian births, the mean weight of the placentas was 675 g,
and the mean PWR was 0.20. Comparing these results with other studies can be
confusing because variation in methods of preparation and storage can alter mean
placental weights.23 Benirschke and Kaufman estimate the mean weight of placenta at 38
weeks gestation, without cord and membranes, as 470 g24; our figure for term placentas is
675g but includes the cord and membranes after the cord was cut. The Canadian study
that used similar sample preparation had a median placental weight of 680g for boys and
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668g for girls. The decline in PWR with increasing gestational age seen here is similar to
that described by many others.23,25,26
Our birth weight curves differ from the Kramer et al.27 birth weight distributions
in that our birth weights are somewhat larger. Our population includes more recent data
and it has been demonstrated that, generally birth weights are increasing.28 This might be
expected since we use more recent data and birth weight is increasing over time due to
increases in maternal anthropometry, reduced cigarette smoking, and changes in
sociodemographic factors.28 Also, Kramer’s curves did not include the Ontario
population due to poor data quality27; therefore, the characteristics of the study
populations are different.
Searching the available literature, we came across a small number of studies that
present the relation between placenta weight to birth weight and only two of these
reported percentiles curves for the PWR.6,15 Thompson et al.15 reported placental
percentile curves for a Norwegian population, and Almog et al.6 presented PWR curves
for a Canadian population. Comparison of our results that include regional referrals with
Almog’s Canadian standards reveals close resemblance between the two populations,
such as median 40 week PWRs (0.1938 and 0.19 for males and 0.1981 and 0.20 for
females respectively). The differences between PWRs for males and females, which
repeat in both studies as well as ours, may reflect different metabolic programming
between the sexes. Dombrowski et el.25 published data on placental weight and placental
to birth weight ratio in North American population. However, their study is based on data
from 1984 to 1991, over two decades ago, and contained data mostly a black population
(81.4%), so the results cannot reasonably be compared.

Our standards also include earlier gestational ages than both of the
aforementioned studies. Both of the abovementioned studies have gestational age
standards starting at 24 weeks; however, our standards provide estimates at 22 and 23
weeks as well. Comparison of our results to Thompson’s are not possible, as he examined
the ratio of the birth weight to the placental weight, and our results examined the inverse
ratio. However, comparisons of our results inclusive of regional referrals to Almog’s
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curves reveal very similar standards. Our results have slightly lower PWRs at all
gestational ages and percentiles.6
The placenta and fetus follow different growth patterns during gestation.3 The
placenta follows an S-shaped growth curve whereas fetal growth follows an exponential
pattern in mid pregnancy, with most growth occurring in a linear fashion during the third
trimester.3 In the earlier gestational ages the birth weight is low in comparison to the
placental weight as a result of the higher growth rate of the placenta earlier in gestation.
Moreover, our placental growth curves show how the majority of placental growth occurs
before 33 weeks gestation. This accounts, at least in part, for the higher PWRs at earlier
gestations. Previous authors have shown that the placenta responds to the interruption of
the fetal villous circulation in the first half of gestation by initiating compensatory
hyperplasia.29 In conclusion, because placental growth occurs at the earlier gestational
ages this is where the greatest differentiation of PWRs is expected to be observed.

Of interest, the PWR curves are similar whether inclusive or exclusive of the
referral population. This may be because, at earlier gestations, the vast majority of
regional births occur in this tertiary referral center. Thus, the lower gestations represent a
“whole population”. At later gestational ages, where one might expect the referral
population to represent a biased sample of higher risk births, the actual numbers
contributed by regional referrals are much smaller and thus would not substantially affect
the percentile estimates for term and near-term births. Since the larger sample does not
exclude regional referrals, it is not speculated to be biased.

Stratification by Fetal Growth Adequacy

This research is also novel in its examination of percentile curves stratified by
fetal growth adequacy, specifically focusing upon how PWRs may change across
gestational age between SGA, AGA and LGA infants. However, previous studies have
indicated that overall, SGA infants have higher PWR’s,3,5 and that SGA infants have a
higher proportion of placental weights at both extremes, but none of these studies have
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looked at the relationships across gestation or between percentiles.4,17,30–32 Alternatively,
the literature suggests that a higher proportion of LGA infants have placenta weights
above the 90th percentile and a lower share of placental weights below the 10th percentile
than SGA and AGA infants.32 Furthermore, PWRs have been found to be the lower in
LGA infants than in AGA and SGA infants.33

Our curves show that there is a greater dispersion in the PWR in SGA infants than
in AGA and LGA infants, especially at the earlier gestational ages. As gestational age
advances, the PWRs become more similar between SGA, AGA and LGA infants, yet the
PWR is still higher in SGA infants. At the earlier gestational ages across all percentiles
the SGA standards are much higher than the AGA standards. Our results agree with the
literature, since SGA infants have higher PWRs than their AGA counterparts. The results
go beyond what the previous literature indicates, and demonstrate how the PWR differs
throughout gestation between SGA and AGA infants between the percentiles. The SGA
infants with PWRs within the highest percentiles may represent the group of infants with
failed compensation and, therefore, a high PWR. Finally, our results show that, at earlier
gestational ages in male infants, LGA infants generally have lower PWRs than AGA
infants. This pattern holds true across all percentiles until the 33rd week of gestation,
when the LGA and AGA standards become more similar. However, the differences
between the LGA and AGA standards are not as pronounced as the differences between
the SGA and AGA standards.

The SGA group studied had PWRs that were generally higher than the respective
AGA values, whereas values for infants in the LGA groups were not altered, particularly
at term. Therefore, the SGA infant can generally be seen as under grown in relation to
placental size, suggesting functional rather than size constraints for the placenta.
Salafia et al.1 showed that an elevated PWR may be an indication of an inefficient
placenta with a reduced ability to maintain fetal growth. Indeed Kingdom and
Kaufmann34 report that preplacental or uteroplacental hypoxia with adaptive placental
growth is a primary cause for growth restriction at term. However, the nonplacental
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chorion and amnion also contribute to overall placental weight, and more so for SGA
infants;26 this may also account, at least in part, for the higher PWR of infants in the SGA
group. On the other hand, low PWR’s are indicative of an increased efficiency of the
placentas of the smaller fetuses, whereas, high PWR’s are indicative of a potential failed
compensation.35–41 Therefore, it is suggested that the PWR can be used as a predictor for
placental functional efficiency. The literature on this subject concludes that small fetuses
have small placentas. Based on these conclusions and the fact that our results show that
SGA infants have a higher PWR than AGA and LGA infants, we propose that this may
be due to a failed compensation of the placenta in SGA infants.

4.4.2

Study Strengths and Limitations
A major strength of the study is the available sample size. The perinatal database

provided a large number of observations with matching placental weight, birth weight
and gestational age. This allowed for the creation of accurate standards, and for the
resulting percentile curves to be stratified by fetal growth adequacy standard. The internal
validity of the study is strong because every birth at St. Joseph’s Hospital and Victoria
Hospital was captured.
Birth weights vary widely from country to country27,42 and as such it might be
considered appropriate that birth weight percentiles should be based on data from the
actual country or at least from a comparable country. This is often not the case and can
lead to inappropriate use of the percentiles in a population where the distribution of birth
weight is shifted, particularly to the left. Therefore, our results are generalizable to other
tertiary care centers in Canada, and possibly the United States of America. Also, the
study of placental weight at the time of delivery is a crude measure of placental growth
and development. However, when it is collected in a routine manner and related to birth
weight, it provides information of biological importance.

4.4.3

Conclusions and Future Directions
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These PWR distribution curves make a substantial contribution to the literature, as
they indicate how the PWR changes across gestation by percentile for SGA, AGA and
LGA infants. The curves that are stratified by fetal growth adequacy are the first of their
kind. They demonstrate that PWR declines across gestation by percentile, yet distinctly,
they further show that overall the PWRs are higher for SGA than AGA infants, and that
the PWRs are lower for LGA infants than for AGA infants. These trends are most
pronounced at the highest percentiles (>90th percentile) and at the earlier gestational ages
(22-28 weeks).
The PWR distribution curves provide a standard that researchers can apply as a
reference standard to identify infants who have abnormal PWRs. Depending on the
purpose of the analysis, researchers may chose to use the population distribution curves
or may use the AGA curves as their reference population. Identifying infants with high
PWRs is important for patient care in both the short and long term. Neonates with a high
PWR had increased incidence of low 1-minute Apgar score, require treatment for
neonatal jaundice and infection, and respiratory complications.43 Furthermore, in recent
years, birth weight, sometimes in conjunction with placental weight, has been associated
with the development of a series of diseases later in life.9 These analyses have included
birth weight, placental weight and even the PWR; however, the relative magnitude of the
latter, in terms of percentiles, has not been previously available for all gestational ages in
a Canadian population.
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Table 4.1: City-Wide Male Placental Weight Ratios by Gestational Age for the 3rd through the 97th Percentile
Gestational
Age
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

3rd
Percentile
0.2549
0.2443
0.2342
0.2246
0.2154
0.2068
0.1986
0.1909
0.1837
0.1770
0.1708
0.1651
0.1599
0.1552
0.1510
0.1472
0.1440
0.1412
0.1389
0.1371
0.1359

5th
Percentile
0.2769
0.2648
0.2533
0.2423
0.2319
0.2220
0.2127
0.2040
0.1958
0.1882
0.1811
0.1746
0.1686
0.1632
0.1584
0.1541
0.1504
0.1472
0.1446
0.1425
0.1410

10th
Percentile
0.3050
0.2910
0.2776
0.2649
0.2529
0.2415
0.2308
0.2207
0.2113
0.2026
0.1944
0.1870
0.1802
0.1740
0.1685
0.1637
0.1595
0.1560
0.1531
0.1509
0.1493

25th
Percentile
0.3714
0.3520
0.3335
0.3161
0.2995
0.2839
0.2693
0.2557
0.2430
0.2313
0.2205
0.2107
0.2018
0.1940
0.1870
0.1811
0.1761
0.1720
0.1689
0.1668
0.1656

50th
Percentile
0.4333
0.4098
0.3875
0.3664
0.3464
0.3276
0.3099
0.2934
0.2780
0.2638
0.2508
0.2389
0.2281
0.2186
0.2101
0.2029
0.1968
0.1918
0.1880
0.1854
0.1839

75th
Percentile
0.5052
0.4764
0.4491
0.4232
0.3988
0.3758
0.3543
0.3343
0.3157
0.2985
0.2828
0.2686
0.2558
0.2445
0.2346
0.2261
0.2192
0.2136
0.2096
0.2069
0.2058

90th
Percentile
0.5711
0.5377
0.5061
0.4761
0.4479
0.4213
0.3965
0.3734
0.3521
0.3324
0.3145
0.2982
0.2837
0.2709
0.2598
0.2505
0.2428
0.2369
0.2326
0.2301
0.2293

95th
Percentile
0.6556
0.6142
0.5750
0.5380
0.5033
0.4707
0.4404
0.4123
0.3863
0.3626
0.3411
0.3218
0.3047
0.2898
0.2771
0.2667
0.2584
0.2524
0.2485
0.2469
0.2474

97th
Percentile
0.7267
0.6786
0.6330
0.5901
0.5498
0.5121
0.4771
0.4446
0.4148
0.3876
0.3630
0.3410
0.3216
0.3049
0.2908
0.2793
0.2704
0.2642
0.2605
0.2595
0.2611
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Table 4.2: City-Wide Female Placental Weight Ratios by Gestational Age for the 3rd through the 97th Percentile
Gestational
Age
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

3rd
Percentile
0.2274
0.2209
0.2146
0.2085
0.2026
0.1969
0.1915
0.1862
0.1811
0.1762
0.1715
0.1670
0.1627
0.1586
0.1547
0.1510
0.1475
0.1442
0.1412
0.1383
0.1356

5th
Percentile
0.2668
0.2565
0.2466
0.2372
0.2282
0.2196
0.2115
0.2038
0.1965
0.1897
0.1833
0.1773
0.1718
0.1667
0.1620
0.1578
0.1540
0.1506
0.1476
0.1451
0.1431

10th
Percentile
0.3011
0.2880
0.2756
0.2638
0.2525
0.2418
0.2318
0.2223
0.2134
0.2051
0.1974
0.1903
0.1838
0.1779
0.1726
0.1679
0.1638
0.1602
0.1573
0.1550
0.1532

25th
Percentile
0.3692
0.3507
0.3332
0.3165
0.3007
0.2858
0.2718
0.2587
0.2465
0.2352
0.2247
0.2152
0.2065
0.1988
0.1919
0.1859
0.1808
0.1766
0.1733
0.1708
0.1693

50th
Percentile
0.4344
0.4115
0.3897
0.3690
0.3495
0.3310
0.3137
0.2975
0.2824
0.2684
0.2555
0.2438
0.2331
0.2236
0.2152
0.2079
0.2018
0.1967
0.1928
0.1900
0.1883

75th
Percentile
0.5427
0.5101
0.4792
0.4499
0.4224
0.3966
0.3724
0.3500
0.3292
0.3102
0.2929
0.2772
0.2633
0.2510
0.2404
0.2316
0.2244
0.2190
0.2152
0.2131
0.2127

90th
Percentile
0.5960
0.5610
0.5277
0.4962
0.4665
0.4386
0.4124
0.3881
0.3655
0.3448
0.3258
0.3087
0.2933
0.2797
0.2679
0.2579
0.2496
0.2432
0.2386
0.2357
0.2346

95th
Percentile
0.6651
0.6256
0.5882
0.5526
0.5190
0.4874
0.4577
0.4300
0.4042
0.3804
0.3586
0.3387
0.3208
0.3048
0.2908
0.2787
0.2686
0.2604
0.2542
0.2500
0.2477

97th
Percentile
0.6891
0.6490
0.6109
0.5748
0.5405
0.5083
0.4779
0.4496
0.4231
0.3986
0.3761
0.3555
0.3369
0.3202
0.3054
0.2926
0.2818
0.2729
0.2659
0.2609
0.2578
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Table 4.3: Inclusive of Regional Referrals Male Placental Weight Ratios by Gestational Age for the 3rd through the 97th
Percentile
Gestational
Age
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

3rd
Percentile
0.2646
0.2526
0.2413
0.2305
0.2204
0.2108
0.2018
0.1934
0.1855
0.1783
0.1716
0.1655
0.1600
0.1551
0.1507
0.1470
0.1438
0.1412
0.1392
0.1378
0.1370

5th
Percentile
0.2925
0.2783
0.2648
0.2519
0.2398
0.2285
0.2178
0.2078
0.1985
0.1900
0.1821
0.1750
0.1686
0.1628
0.1578
0.1535
0.1499
0.1470
0.1448
0.1434
0.1426

10th
Percentile
0.3127
0.2976
0.2832
0.2696
0.2568
0.2446
0.2332
0.2225
0.2126
0.2034
0.1949
0.1872
0.1802
0.1739
0.1683
0.1635
0.1594
0.1561
0.1535
0.1516
0.1504

25th
Percentile
0.3685
0.3495
0.3314
0.3142
0.2980
0.2827
0.2684
0.2549
0.2425
0.2309
0.2203
0.2106
0.2019
0.1941
0.1872
0.1813
0.1763
0.1722
0.1691
0.1669
0.1657

50th
Percentile
0.4281
0.4052
0.3835
0.3629
0.3435
0.3251
0.3079
0.2917
0.2767
0.2628
0.2501
0.2384
0.2279
0.2184
0.2101
0.2030
0.1969
0.1919
0.1881
0.1854
0.1838

75th
Percentile
0.5069
0.4780
0.4505
0.4244
0.3998
0.3767
0.3551
0.3349
0.3162
0.2989
0.2832
0.2688
0.2560
0.2446
0.2347
0.2262
0.2192
0.2137
0.2096
0.2070
0.2059

90th
Percentile
0.5803
0.5461
0.5136
0.4829
0.4540
0.4268
0.4014
0.3777
0.3557
0.3355
0.3171
0.3004
0.2854
0.2722
0.2608
0.2511
0.2431
0.2369
0.2325
0.2298
0.2288

95th
Percentile
0.6849
0.6405
0.5985
0.5589
0.5216
0.4867
0.4541
0.4240
0.3961
0.3707
0.3476
0.3269
0.3086
0.2926
0.2790
0.2678
0.2590
0.2525
0.2483
0.2466
0.2472

97th
Percentile
0.7777
0.7239
0.6731
0.6252
0.5802
0.5382
0.4991
0.4630
0.4298
0.3996
0.3723
0.3479
0.3265
0.3081
0.2925
0.2800
0.2703
0.2637
0.2599
0.2591
0.2613
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Table 4.4: Inclusive of Regional Referrals Female Placental Weight Ratios by Gestational Age for the 3rd through the 97th
Percentile
Gestational
Age
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

3rd
Percentile
0.2763
0.2639
0.2522
0.2410
0.2304
0.2203
0.2108
0.2019
0.1935
0.1857
0.1785
0.1718
0.1657
0.1602
0.1552
0.1508
0.1469
0.1436
0.1409
0.1388
0.1372

5th
Percentile
0.2886
0.2759
0.2637
0.2522
0.2412
0.2308
0.2209
0.2117
0.2030
0.1949
0.1873
0.1804
0.1740
0.1681
0.1629
0.1582
0.1541
0.1506
0.1477
0.1453
0.1435

10th
Percentile
0.3266
0.3106
0.2955
0.2810
0.2674
0.2545
0.2424
0.2311
0.2205
0.2107
0.2017
0.1934
0.1859
0.1792
0.1733
0.1681
0.1637
0.1601
0.1572
0.1552
0.1538

25th
Percentile
0.3777
0.3585
0.3402
0.3229
0.3064
0.2909
0.2764
0.2627
0.2499
0.2381
0.2272
0.2172
0.2082
0.2000
0.1928
0.1865
0.1811
0.1766
0.1731
0.1704
0.1687

50th
Percentile
0.4566
0.4312
0.4070
0.3841
0.3625
0.3421
0.3230
0.3052
0.2886
0.2733
0.2593
0.2465
0.2350
0.2248
0.2158
0.2081
0.2017
0.1965
0.1926
0.1900
0.1886

75th
Percentile
0.5596
0.5252
0.4926
0.4618
0.4327
0.4055
0.3801
0.3564
0.3346
0.3145
0.2963
0.2798
0.2651
0.2523
0.2412
0.2319
0.2244
0.2187
0.2148
0.2127
0.2124

90th
Percentile
0.7037
0.6563
0.6114
0.5690
0.5292
0.4919
0.4572
0.4250
0.3953
0.3682
0.3436
0.3215
0.3020
0.2850
0.2705
0.2586
0.2492
0.2424
0.2380
0.2363
0.2370

95th
Percentile
0.8268
0.7691
0.7144
0.6628
0.6142
0.5687
0.5262
0.4867
0.4503
0.4170
0.3866
0.3594
0.3351
0.3139
0.2958
0.2806
0.2686
0.2595
0.2535
0.2506
0.2507

97th
Percentile
0.8995
0.8348
0.7736
0.7159
0.6616
0.6108
0.5635
0.5196
0.4792
0.4422
0.4087
0.3787
0.3521
0.3290
0.3093
0.2931
0.2804
0.2712
0.2653
0.2630
0.2641
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Table 4.5: Placenta Weight Ratio Distributions for SGA, AGA & LGA Infants based upon the Inclusive of Regional Referrals
Standards
Inclusive of Regional
Referrals Standards
>90th
10-90th
<10th

Expected %
10%
80%
10%

SGA
13.18%
74.42%
12.10%

Males
AGA
9.74%
80.22%
10.04%

LGA
9.82%
81.64%
8.53%

SGA
11.68%
77.56%
10.76%

Females
AGA
9.66%
80.22%
10.12%

LGA
11.69%
80.14%
8.16%
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Table 4.6: Inclusive of Regional Referrals AGA Male Placental Weight Ratios by Gestational Age for the 3rd through the 97th
Percentile
Gestational
Age
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

3rd
Percentile
0.2685
0.2561
0.2443
0.2332
0.2227
0.2127
0.2034
0.1947
0.1867
0.1792
0.1724
0.1661
0.1605
0.1555
0.1511
0.1473
0.1442
0.1416
0.1397
0.1384
0.1377

5th
Percentile
0.2919
0.2779
0.2646
0.2520
0.2400
0.2287
0.2182
0.2083
0.1991
0.1905
0.1827
0.1756
0.1691
0.1634
0.1583
0.1539
0.1502
0.1472
0.1449
0.1432
0.1423

10th
Percentile
0.3167
0.3013
0.2865
0.2725
0.2593
0.2468
0.2351
0.2241
0.2139
0.2045
0.1958
0.1878
0.1806
0.1742
0.1685
0.1636
0.1594
0.1560
0.1534
0.1514
0.1503

25th
Percentile
0.3713
0.3520
0.3336
0.3162
0.2997
0.2842
0.2696
0.2560
0.2433
0.2316
0.2208
0.2110
0.2021
0.1942
0.1872
0.1812
0.1761
0.1719
0.1688
0.1665
0.1653

50th
Percentile
0.4342
0.4106
0.3882
0.3670
0.3469
0.3279
0.3102
0.2935
0.2781
0.2638
0.2507
0.2388
0.2280
0.2183
0.2099
0.2026
0.1965
0.1915
0.1877
0.1850
0.1836

75th
Percentile
0.5047
0.4759
0.4486
0.4228
0.3984
0.3754
0.3539
0.3339
0.3153
0.2981
0.2824
0.2682
0.2554
0.2440
0.2341
0.2257
0.2186
0.2131
0.2090
0.2063
0.2051

90th
Percentile
0.5832
0.5483
0.5152
0.4839
0.4544
0.4268
0.4009
0.3769
0.3547
0.3343
0.3157
0.2989
0.2839
0.2707
0.2594
0.2499
0.2421
0.2362
0.2321
0.2299
0.2294

95th
Percentile
0.6764
0.6330
0.5919
0.5531
0.5166
0.4824
0.4505
0.4210
0.3937
0.3687
0.3460
0.3256
0.3075
0.2917
0.2781
0.2669
0.2580
0.2514
0.2471
0.2451
0.2454

97th
Percentile
0.7461
0.6961
0.6489
0.6043
0.5624
0.5232
0.4867
0.4528
0.4217
0.3932
0.3675
0.3444
0.3240
0.3063
0.2913
0.2789
0.2693
0.2623
0.2581
0.2565
0.2576
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Table 4.7: Inclusive of Regional Referrals AGA Female Placental Weight Ratios by Gestational Age for the 3rd through the
97th Percentile
Gestational
Age
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

3rd
Percentile
0.2763
0.2639
0.2522
0.2410
0.2304
0.2203
0.2108
0.2019
0.1935
0.1857
0.1785
0.1718
0.1657
0.1602
0.1552
0.1508
0.1469
0.1436
0.1409
0.1388
0.1372

5th
Percentile
0.2848
0.2726
0.2609
0.2497
0.2391
0.2291
0.2195
0.2106
0.2021
0.1942
0.1869
0.1801
0.1738
0.1681
0.1629
0.1583
0.1542
0.1506
0.1476
0.1451
0.1432

10th
Percentile
0.3235
0.3078
0.2929
0.2787
0.2653
0.2526
0.2407
0.2295
0.2192
0.2095
0.2007
0.1926
0.1852
0.1786
0.1728
0.1677
0.1634
0.1599
0.1571
0.1551
0.1538

25th
Percentile
0.3729
0.3542
0.3365
0.3196
0.3037
0.2886
0.2744
0.2610
0.2486
0.2371
0.2264
0.2166
0.2077
0.1997
0.1926
0.1863
0.1810
0.1765
0.1729
0.1702
0.1684

50th
Percentile
0.4526
0.4276
0.4040
0.3815
0.3603
0.3403
0.3215
0.3040
0.2877
0.2726
0.2587
0.2461
0.2347
0.2246
0.2157
0.2080
0.2015
0.1963
0.1923
0.1895
0.1880

75th
Percentile
0.5495
0.5160
0.4843
0.4544
0.4262
0.3997
0.3749
0.3520
0.3307
0.3112
0.2934
0.2774
0.2632
0.2506
0.2398
0.2308
0.2235
0.2180
0.2142
0.2121
0.2118

90th
Percentile
0.7036
0.6562
0.6114
0.5690
0.5292
0.4919
0.4572
0.4249
0.3952
0.3680
0.3434
0.3212
0.3016
0.2845
0.2699
0.2579
0.2484
0.2413
0.2369
0.2349
0.2355

95th
Percentile
0.7643
0.7136
0.6654
0.6200
0.5771
0.5368
0.4992
0.4642
0.4319
0.4022
0.3750
0.3506
0.3287
0.3095
0.2929
0.2789
0.2676
0.2588
0.2527
0.2493
0.2484

97th
Percentile
0.8835
0.8207
0.7612
0.7050
0.6522
0.6027
0.5566
0.5138
0.4744
0.4383
0.4055
0.3761
0.3501
0.3273
0.3080
0.2919
0.2792
0.2699
0.2638
0.2612
0.2618

117

Figure 4.1: City-Wide Placenta and Birth Weight Percentile Distributions by Gestational
Age
A) Males

B) Females
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Figure 4.2: City-wide Placental Weight Ratio Distributions by Gestational age
A) Males

B) Females
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Figure 4.3: Inclusive of Regional Referrals Placental Weight Ratio Distributions by
Gestational Age
A) Males

B) Females
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Figure 4.4: Inclusive of Regional Referrals SGA, AGA and LGA Median Placental
Weight Ratio Distributions by Gestational Age
A) Males

B) Females
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Figure 4.5: Inclusive of Regional Referrals AGA Placental Weight Ratio Distributions
by Gestational Age
A) Males

B) Females
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CHAPTER 5: DETERMINANTS OF PLACENTAL WEIGHT RATIOS

5.1.

Introduction

The placental weight ratio (PWR) is a measure of the balance between fetal and
placental growth. The PWR is defined as the placental weight divided by the birth
weight, and it decreases across gestation as the placenta matures, concurrent with
increased transport capacity and corresponding increases in fetal weight.4 Recent reports
indicate that placental weight and the PWR are predictive of maternal disease, obstetric
outcome, perinatal morbidity and mortality, and childhood growth and development.1–6

It is postulated that in situations involving complications such as preeclampsia, a
disproportionally large placental indicative of placental hypertrophy occurs and have
been postulated to be an adaptation to maintain placental function, though the adaptation
is insufficient and fetal growth is impacted. If this is true, a pregnancy with impaired fetal
growth, resulting in a small for gestational age (SGA) infant, should have an increased
PWR compared to those infants who are appropriate for gestational age (AGA) or large
for gestational age (LGA).5,6 However, other maternal factors and pregnancy
complications can also alter the PWR, but have been minimally studied in the
epidemiologic literature.

Therefore, the relationship of the PWR to maternal baseline factors and pregnancy
complications needs to be explored. Preeclampsia, intrauterine growth restriction
(IUGR), and placental abruption, conditions that constitute ischemic placental disease
(IPD), have been shown to exert their effects differently in term infants than in preterm
infants, potentially resulting from different pathophysiological mechanisms.7 Therefore,
the purpose of this large-scale population study is to evaluate the various risk factors
associated with atypical PWRs in (a) term infants, (b) infants born between 32 and 37
weeks gestation and (c) infants born between 21 and 33 weeks gestation.

5.2.

Methods
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The study included all singleton births from St. Joseph’s Health Care and Victoria
Hospital in London, Ontario between June 1, 2006 and March 31, 2011. The time
window was selected based on a start date for which all of the covariates of interest were
collected in the database. The perinatal database provides specific information on all
births occurring at the hospitals. The data are prospectively entered from the medical
chart, delivery records, and neonatal records by a committed research assistant. For the
time window examined in the present study, the sample available was after exclusion of
congenital anomalies (n=414), stillbirths (n=193), and multiple gestations (n=1,374), as
well as exclusion of those for whom placental weight was missing (n=4,812). The latter
occurred because placental weight was not collected at both hospitals for the entire
duration of the study window. Gestational ages of births recorded in the database ranged
from 20 to 44 weeks, but only births between 22 and 42 weeks gestation were included in
the analyses.

Placentas and infants were weighed by nursing assistants with an electronic
weight scale immediately after delivery. The placentas were weighed with the
membranes and umbilical cord, including the segment of cord used for cord blood
sampling, and no attempt was made to remove placental blood before weighing.

Descriptive analyses were carried out on all study variables. Implausible values
and potential errors were excluded from the analyses. Birth weights above or below the
mean by three SD’s were removed from the analyses. Placental weights that were ≤100 g
or ≥2500g were also excluded from the analyses. Maternal age, maternal height and prepregnancy weight were all trimmed at the 1st and 99th percentiles to remove any
erroneous values. Any unknown or ambiguous sexes were also excluded. For analysis,
gestational age was truncated to the number of completed weeks based on the
recommendations from World Health Organization and International Classification for
Disease, and was based on ultrasound or last menstrual period. Birth weight was
categorized into SGA, AGA and LGA based on Kramer standards.8
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Univariable and multivariable analyses were stratified by gestational age
categories of ≥ 37 weeks, 32-37 weeks and <32 weeks. This stratification was based on
both conceptual and statistical grounds, since research has identified different risk factors
for placental and fetal growth disturbances at different gestational ages. Thus,
stratification will provide more meaningful information on how various risk factors
influence both placental and fetal growth, as captured in the PWR, at different points in
gestation. Statistically it was anticipated that there would therefore be interaction between
factors influencing PWR and gestational age category. Stratification provides an
opportunity to evaluate this interaction within clinically meaningful gestational age
categories.
Multivariable analysis of the factors associated with a PWR <10th percentile or
>90th percentile was carried out using multinomial logistic regression with chunked entry
of variables entered in order of temporality, based on a hypothesized conceptual model.
During the model building process, variable pruning was conducted using p-to-remove of
<0.20. For the final model, this was adjusted to p<0.05. PWR between the 10th and 90th
percentile was the reference group. The chunks were: baseline variables (parity, smoking
status, maternal asthma, age, BMI, maternal height); mid-pregnancy variables
(gestational diabetes, preeclampsia); placental and cord complication variables (placental
previa and abruption, cord complications); and late pregnancy and postpartum variables
(gestational weight gain, birth weight category, anaemia, placental delivery).

5.3.

Results

The final sample were 10,404 males and 9,812 females (total n=20216). The
mean gestational age for the population studied was 38.8 weeks (SD=2.1 weeks). There
were 17,838(80.44%) infants with PWRs between the 10th and 90th percentile, 2,084
(9.40%) infants with PWRs ≤10th percentile, and 2,253 (10.16%) of infants with PWRs
≥90th percentile. Infants with a PWR between the 10th and the 90th percentile were the
reference category for all of the analyses.
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The mean age for participants was 29 years and the mean height is 64.8 inches.
Approximately 18% of the population smoked, 3.0% had preeclampsia, 3.5% had
anaemia before delivery, 4.1% had gestational diabetes, 30% had an underweight prepregnancy BMI, 13% had an overweight BMI and 9% had an obese pre-pregnancy BMI,
and 31% had some form of an umbilical cord complication. The distributions of these
risk factors by gestational age category are outlined in Table 5.1.

Two of the key covariates that showed an association with an atypical PWR, were
smoking and preeclampsia. These two factors were tested to determine if they had
significant interactions with gestational age category. At a significance level of p<0.05,
both smoking and preeclampsia had significant interactions with gestational age category.
The results of the interactions can be found in Appendix O.

The results of the univariable and multivariable regression are presented in Tables 5.2
and 5.3 respectively by gestational age category. The results outlining each model in the
model building process can be found in Appendix P.
For infants born at ≥37 weeks gestation, factors associated with a reduced risk of
PWR<10th percentile were: multiparity, smoking, abnormal BMI, gestational diabetes, an
umbilical cord around the neck or body, a knot in the cord, or a prolapsed or lacerated
cord, and being LGA. Factors associated with an increased risk of PWR<10th percentile
were: a short, 2-vessel or velamentous umbilical cord insertion, SGA infants, and any
assisted placental delivery methods increased the odds of a PWR <10th percentile.
Conversely, the risk of PWR >90th percentile was higher for: multiparity, smoking,
abnormal BMI, preeclampsia, placental abruption, a cord around the neck or body, a knot
in the cord, or a prolapsed or lacerated cord, both SGA and LGA infants and maternal
anaemia. Findings that were significant in the univariable, but fell out of statistical
significance when controlled for other factors in the multivariable model was increased
effect of a PWR<10th percentile that resulted from increasing maternal height. Finally,
maternal age <21 year of age increased the odds of a PWR >90th percentile in the
univariable, but was no longer significant in the multivariable.
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For infants born between 32 and 37 weeks gestation, multiparity attenuated the
odds of a PWR <10th percentile. Alternatively, factors associated with all increased the
odds of a PWR >90th percentile were: multiparity, smoking, preeclampsia, placental
abruption, a cord around the neck or body, a knot in the cord, or a prolapsed or lacerated
cord, a short, 2-vessel or velamentous umbilical cord insertion, and maternal anaemia.
Turning attention to the infants born at ≤32 weeks gestation, factors associated
with attenuated odds of a PWR<10th percentile were: multiparity, placental abruption,
and manual placental delivery. Conversely, factors associated with increased odds of a
PWR<10th percentiles were: increasing maternal height, short, 2-vessel or velamentous
umbilical cord insertion and retained placental delivery. Multiparity, increasing maternal
height and placental previa all increased the odds of a PWR >90th percentile. A finding
that was significant in the multivariable but fell out of significance in the univariable was
preeclampsia’s effect on increasing the odds of a PWR <10th percentile

5.4

Discussion

5.4.1 Main Findings and Implications

The results will be presented in the context of preplacental, uteroplacental, postplacental,
and carbon monoxide hypoxia, as well as IPD, umbilical cord and placental
complications and key baseline characteristics, for the discussion.

Baseline Factors

The majority of the baseline factors were associated with a hypertrophic growth
response of the placenta in relation to birth weight.

High BMI has been identified as predictor of a higher PWR by some
investigators,9–11 but an elevated ratio has not been previously associated with an
underweight BMI group.12 We found that the PWRs are elevated at BMIs both above and
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below the normal BMI range in term infants. Physiological research shows that maternal
body compositions are associated with changes in the ability of the placenta to transfer
maternal nutrients to the fetoplacental compartment through increases in the placental
System A amino acid transporter. Furthermore, System A activity was found to be higher
in placentas which were large in relation to birth weight.13 Increased awareness on the
importance of health pre-pregnancy weight, and thereby infants at high risk for elevated
PWRs, would have implications for the health care system, the health of the mother and
the health of the child.

The literature shows that a positive association exists both between placental
weight9,14,15 and birth weight with parity. 16 Our results indicate that throughout all
gestational age categories, being multiparous increases the odds of having a PWR≥90th
percentile, and the effect is most pronounced in the infants born at ≤32 weeks. The
physiological role of the placenta in mediating the effects of parity needs further
investigation.

Results are divided on the proposed association between maternal age and
placental weight.14,17 However, SGA is the most common among pregnancies at both
extremes of reproductive bearing age.18,19 Increasing maternal height is associated with
both an increased odds of a PWR ≥90th and a PWR ≤10th percentile in infants born at the
earliest gestational ages. Height is an non-modifiable characteristic due to its genetic
contribution.20 Other studies have looked at the effect of maternal height on both birth
and placental weight, and have found a positive association9,22; yet, no other study to
date, that we are aware of, has examined the relationship between maternal height and the
PWR.

Ischemic Placental Disease
IPD has been shown to exert its effects differently in term and preterm infants7,23.
Ananth et al.23 have shown that among infants with IPD the frequency of SGA is higher
in term than in preterm infants. Interestingly, SGA was only significantly associated with
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atypical PWRs in term infants. Ananth et al.23 have also shown that IPD in preterm birth
is more likely to include the mother and the fetus through not only SGA, but also the
addition of preeclampsia and placental abruption. Preeclampsia and placental abruption
share a significant number of risk factors which supports the proposed common
underlying pathophysiology.24 Our results have shown that preeclampsia and placental
abruption increase the odds of a PWR ≥90th percentile in the highest two gestational age
categories. Moreover, the effect of placental abruption and preeclampsia in infants born
between 32 and 37 weeks on a PWR ≥90th percentile is slightly increased compared to
term infants.

Preplacental Hypoxia

Preplacental hypoxia, a reduction in maternal blood oxygen content, occurs when
the placenta and fetus become hypoxic due to conditions such as maternal asthma and
maternal anaemia.25 Many researchers have noted that placentas tend to be heavy in
pregnancies complicated by both severe and mild maternal anaemia, with the fetus often
being small, and therefore the PWR increased.14,22,26–29 In term infants, maternal anaemia,
were associated with amplified odds of having a PWR≥90th percentile. The increased size
of the placenta has been understood as a compensatory mechanism to overcome the lack
of oxygen in the maternal blood, as well as the increased trophoblastic proliferation and
placental angiogenesis that results from anaemia.30 In response to the lack of oxygen, the
extravillous trophoblast of the placenta bed shows an increased depth of invasion and the
villi appear hypercapillarized.31

Uteroplacental Hypoxia

Uteroplacental hypoxia occurs when normally oxygenated maternal blood has
restricted entry into the uteroplacental tissues due to either occlusion or failed trophoblast
invasion of the uteroplacental arterioles. Uteroplacental hypoxia represents late onset
growth restriction with preserved end diastolic flow volume, and term preeclampsia.25
Both low and high placental weight has been shown to be associated with term
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preeclampsia.32 Our results exhibit that individuals with preeclampsia who deliver an
infant at term have increased odds of a PWR ≥90th percentile. These results are congruent
with current literature which shows that the PWR is often increased in pregnancies that
are complicated with preeclampsia.33,34 This suggests that there is compensatory growth
of placental villi in an attempt to overcome an unfavourable maternal environment.35,36
However, our results do not show increased odds for having a PWR ≤10th percentile,
thereby indicating a potentially smaller placenta. This may be the result of, at least in
part, that we do not have the timing of diagnosis for preeclampsia. Nevertheless, it has
been suggested that the majority of pregnancies with preterm preeclampsia do result in a
preterm delivery.37

It has been found that low placental weight is strongly associated with preterm
preeclampsia.32,38 Interestingly, in the univariable analysis preeclampsia’s effects in terms
infants showed a protective effect on having a PWR≤10th percentile and a strengthened
effect on having a PWR≥90th percentile. On the other hand, infants born between 32 and
37 weeks only had increased odds of having a PWR≥90th but were not significantly
protected against a PWR≤10th. Finally, in infants born at ≤32 weeks both the odds of
having a PWR≥90th and ≤10th were increased, but they were only significantly increased
for having a PWR≤10th. Therefore, the direction of the effect changed as the pregnancy
progressed. This may represent the two different forms of preeclampsia that have been
proposed.39 However, these effects fell out of significance in the multivariable analysis.

Postplacental Hypoxia

Postplacental hypoxia is when oxygenated maternal blood enters the intervillous
space at a normal or reduced rate, but a defect in fetoplacental perfusion prevents the
fetus from receiving sufficient oxygen.25 We had focused the discussion of postplacental
hypoxia on gestational diabetes, as it is the only risk factor with this hypoxia type
available in the database. Placental adaptations in mothers with pre-gestational diabetes
resemble those adaptations seen in other postplacental hypoxia conditions. It has been
noted by several authors that the placentas from women with gestational diabetes often
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weigh more.40–45 However, the literature is inconclusive on the effect of gestational
diabetes on the PWR.41,46 In our highest gestational age categories, gestational diabetes
was associated with increased odds of a PWR ≥90th and protective against a PWR ≤10th
percentile. Increased levels of haemoglobin and erythropoietin provide evidence that
fetuses in mothers with pre-diabetes are hypoxic. The literature proposes that the surface
and exchange areas are enlarged as a result of the hypoproliferation and
hypervascularization in gestational diabetes.47 Therefore, the maternal placental oxygen
supply is reduced, and the fetal oxygen demand is increased.48,49 This phenomenon could
be explained by aerobic metabolism which is stimulated by fetal hypersinsulinemia
which can result in reduced trophoblast proliferation. The low oxygen levels up regulate
transcriptional synthesis of leptin, VEGF and fibroblast growth factor which promotes
placental endothelial cell proliferation. The result is enhanced vascularisation of the
placenta.50,51

Carbon Monoxide Hypoxia

Maternal smoking presents itself as carbon monoxide hypoxia. While this seems
similar to preplacental hypoxia, and the changes in fetal capillaries and peripheral villi do
reflect the effects in preplacental hypoxia, the morphology and oxygen diffusion
conductance’s are not mirrored.52,53 Cigarette smoking is associated with a decreased
fetal weight. The few studies that have looked at maternal smoking and placental weight
have found conflicting results,14,54–58 as are the results on the role of smoking on the
PWR.9,54,56 Our results indicate that in term infants and infants born between 32 and 37
weeks gestation, smoking increases the odds of having a PWR ≥90th percentile and
attenuates the odds of having a PWR ≤10th percentile. When a mother smokes during
pregnancy, the placenta and fetus become hypoxic because of a reduction of oxygen
content within the maternal blood along with an increased vascular resistance on the fetal
side of the placenta. These conditions result in reduced intraplacental oxygen content,
predominately branching angiogenesis and reduced vascular impedance. The increase in
branching angiogenesis and thereby reduced vascular impedance is an adaptive
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mechanism to the hypoxic state. This mechanism is associated with excessive placental
weight.59

The number of women who smoke during pregnancy is high despite current
recommendations for mothers to quit. Targeting women who smoke during pregnancy
and aiding them in quitting may be an effective strategy to reduce decreases in birth
weight accompanied by increases in placental weight.

Placental and Umbilical Cord Complications

Any type of force that compresses umbilical cords may lead to diminished blood
flow in umbilical vessels and subsequent fetal hypoxia or circulatory compromise.
Mechanical cord compression can be caused by cord entanglements and cord prolapse, or
it may occur from an abnormal configuration of the cord such as true knots, hypercoiling,
abnormally short or long cords, abnormal cord insertions, or strictures.60 These
complications are often associated with decreased fetal weight, and both marginal and
velamentous cord insertion are associated with an increased placental weight and reduced
metabolic efficiency.61–63 In addition, a single umbilical artery is also associated with a
reduced placental weight.61 Furthermore, abnormal cord insertion has also been found to
be associated with a high PWR.64 Our results show that a short, 2-vessel or velamentous
cord insertion are associated with increased odds of a PWR ≥90th percentile in infants
born between 32 and 37 weeks, and increased odds of a PWR ≤10th percentile in terms
infants and infants born ≤32 weeks. On the other hand, a cord around the neck or body,
knot in the cord, prolapsed or lacerated cord is also associated with a PWR ≥90th
percentile in all infants born at >32 weeks.

Literature on this topic indicates that some placental factors, such as placenta
abruption, placenta previa and antepartum hemorrhage are not individually associated
with placental weight,61 but as a group are associated with a decreased PWR.12 Our
results partially disagree with these findings. We found no association between placental
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previa and the PWR, but we did note that placental abruption strengthened the odds of
having a PWR ≥90th percentile.

5.4.2

Strengths and Limitations

The perinatal database has a number of attributes, which prompted its use in this
study. A major strength of the study is the available sample size. This study is strong due
to the quality and comprehensive nature of the data. The internal validity of the study is
strong because every birth at St. Joseph’s Hospital and Victoria Hospital was captured.
The results will be important for both obstetricians and neonatologists managing highrisk pregnancies and infants with extreme birth and placental weights.

This research is novel in its ability to combine the proposed physiological
mechanisms along with a theoretic framework to examine the relationships between
various risk factors and their associations with atypical PWRs. The strong theoretical
framework, based on biologically plausible mechanistic literature, combined with
epidemiological literature provides a strong base for this study. This approach also allows
the complexity of the relationships that exist between factors to be conserved and
provides an understanding of how these factors relate within this population.

Like other studies that use administrative databases, this study was unable to
assess a few covariates that may influence the PWR such as residing at high altitude and
ethnicity. Future studies which can incorporate this information may be useful. However,
residing at high altitude is a form of preplacental hypoxia which was evaluated by other
variables, and is not believed to be a variable of great significance for many women
living in the region. Ethnicity has been shown to influence the PWR in previous studies,
but the effect was small.11,14

We were limited by the data available in the database, so the available variables
are categorized into their respective sections in the discussion. However, we did not have
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uterine artery Doppler’s or timing of preeclampsia, so we speculated based on the scope
of our data.

Height and weight data contributing to the calculation for pre-pregnancy came
from variable sources, including self-report, therefore misreporting may have influenced
the accuracy of BMI. We speculate it may have produced an underestimate in BMI. The
situation is similar for smoking because women sometimes fail to report such behaviours.

Although quality control measures are in place, human error was expected. Any
missing data however was expected to be missing completely at random. A more detailed
description of missing data with regards to placental weight can be found in Appendix Q.

5.4.3

Conclusions and Future Directions

Our results propose that adverse obstetric conditions are associated with either
placental growth restriction or placental hypertrophy in relation to birth weight, and even
both, based on gestational age at delivery. The majority of the risk factors assessed
resulted in increased odds of a PWR ≥90th percentile. This suggests that the placenta may
have particular compensatory responses to maternal obstetric conditions, each with a
distinct pathophysiologic mechanism, but similar PWR outcome. Further research is
justified to elucidate the biological mechanisms underlying the associations between
anemia, gestational diabetes, hypertensive disease, maternal pre-pregnancy BMI, and
umbilical cord complications with abnormal placental growth relative to fetal growth.
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Table 5.1: Descriptive Statistics of Risk Factors by Gestational Age Category

0

≥37 Weeks
Gestation
24713
10808(43.74%)

Between 32-37
Weeks Gestation
1370
651(47.52%)

≤32 Weeks
Gestation
987
305(56.80%)

≥1
No

13902(56.26%)
20357(82.38%)

719(52.48%)
1046(76.35%)

232(43.20%)
412(76.72%)

Maternal Asthma

Yes
No

4354(17.62%)
23648(95.69%)

324(23.65%)
1284(93.72%)

125(23.28%)
494(91.99%)

Maternal Age

Yes
<21 years

1065(4.31%)
2166(9.01%)

86(6.28%)
129(9.66%)

43(8.01%)
51(9.85%)

21-34 years

18150(75.51%)

970(72.66%)

384(74.13%)

>34 years
≤18.5 kg/m2

3719(15.47%)
7417(30.01%)

236(17.68%)
385(28.10%)

83(16.02%)
154(28.68%)

18.5-24.9 kg/m2

11724(47.44%)

695(50.73%)

259(48.23%)

25.0-29.9 kg/m2

3331(13.48%)

169(12.34%)

60(11.17%)

>30.0 kg/m2
No

2241(9.07%)
23742(96.07%)

121(8.83%)
1291(94.23%)

64(11.92%)
507(94.41%)

Preeclampsia

Yes
No

971(3.93%)
24180(97.87%)

79(5.77%)
1216(88.95%)

30(5.59%)
427(79.52%)

Placenta Previa

Preeclampsia
No

526(2.13%)
24590(99.50%)

151(11.05%)
1323(96.57%)

110(20.48%)
512(95.34%)

Yes
No

123(0.50%)
24461(98.98%)

47(3.43%)
1280(93.43%)

25(4.66%)
408(75.98%)

Yes
No

252(1.02%)
16979(68.70%)

90(6.57%)
418(30.51%)

129(24.02%)
396(73.74%)

Cord around the neck or
body, knot in the cord,
prolapsed or lacerated
cord

7490(30.31%)

927(67.66%)

129(24.02 %)

244(0.99%)
22409(90.68%)

25(1.82%)
1288(94.01%)

12(2.23%)
521(97.02%)

242(0.98%)

20 (1.46%)

6(1.12%)

Predictor Variables (Binary/Categorical)
TOTAL
Parity

Smoking during
Pregnancy

Pre-Pregnancy
Body Mass Index

Gestational
Diabetes

Placental
Abruption
Umbilical Cord
Complication

Gestational
Weight Gain

Short, 2-vessel or
velamentous cord
Normal
<10lb at 30 weeks’ or <20
lbs at term
>40 lbs at term
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SGA

2062(8.34%)
1960(7.95%)

62(4.53%)
117(8.54%)

10(1.86%)
66(12.29%)

AGA

20128(81.65%)

1092(79.71%)

430(80.07%)

Anaemia

LGA
No

2564(10.40%)
23777(96.75%)

161(11.75%)
1293(94.86%)

41(7.64%)
482(90.09%)

Placenta Delivery

Yes
Spontaneous

798(3.25%)
16640(67.98%)

70(5.14%)
851(62.71%)

53(9.91%)
245(45.79%)

Expressed or assisted

2661(10.87%)

105(7.74%)

12(2.24%)

5053(20.64%)

385(28.37%)

257(48.04%)

125(0.51%)

16(1.18%)

21(3.93%)

64.78(±2.48)

64.49(±2.42)

64.(±2.49)

Birth Weight
Category

Manual
Retained
Predictor Variables (Continuous)
Maternal Height
(inches)
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Table 5.2: Univariable Analyses Stratified by Gestational Age Categories: Factors Associated with Low and High PWR’s
Predictors

Parity

0
≥1

Smoking
During
Pregnancy

No (ref)

Maternal
Asthma

No (ref)

Yes

Yes
Maternal
Height
Maternal Age

For every 10cm
increase
<21 years
21-34 years
>34 years

Prepregnancy
BMI

≤18.5 kg/m2
18.5-24.9
kg/m2 (ref)
25.0-29.9
kg/m2

Gestational
Diabetes

>30.0 kg/m2
No (ref)
Yes

Gestational Age ≥37 Weeks’

Gestational Age ≤32 Weeks’

Gestational Age between 32-37
Weeks’
Odds Ratio for
Odds Ratio for
PWR <10th
PWR >90th
Percentile
Percentile
(95%
(95%
Confidence
Confidence
Interval)
Interval)
-

Odds Ratio for
PWR <10th
Percentile
(95%
Confidence
Interval)
-

Odds Ratio for
PWR >90th
Percentile
(95%
Confidence
Interval)
-

Odds Ratio for
PWR <10th
Percentile
(95%
Confidence
Interval)
-

Odds Ratio for
PWR >90th
Percentile
(95%
Confidence
Interval)
-

0.915
(0.832, 1.006)
-

1.073
(0.979, 1.176)
-

0.687
(0.435, 1.084)*
-

1.686
(1.094, 2.598)*
-

0.604
(0.339, 1.077)*
-

2.170
(1.128, 4.174)*
-

0.647
(0.559, 0.749)*
-

1.795
(1.616, 1.994)*
-

0.493
(0.256, 0.947)*
-

1.518
(0.970, 2.378)
-

0.938
(0.494, 1.779)
-

0.630
(0.271, 1.465)
-

0.809
(0.642, 1.020)
1.013
(0.993, 1.033)
0.881
(0.736, 1.055)
-

1.085
(0.890, 1.322)
1.001
(0.982, 1.020)
1.217
(1.042, 1.421)*
-

0.965
(0.405, 2.298)
1.027
(0.933, 1.130)
0.265
(0.064, 1.104)
-

1.075
(0.500, 2.308)
1.034
(0.946, 1.131)
1.206
(0.596, 2.439)
-

0.878
(0.331, 2.332)
1.123
(1.004, 1.255)*
0.679
(0.231, 2.000)
-

0.492
(0.114, 2.119)
1.139
(0.993, 1.306)
1.148
(0.381, 3.464)
-

1.079
(0.949, 1.226)
0.923
(0.829, 1.027)
-

0.998
(0.877, 1.136)
1.296
(1.161, 1.446)*
-

1.283
(0.744, 2.211)
1.018
(0.610, 1.698)
-

1.291
(0.767, 2.173)*
1.494
(0.891, 2.505)
-

0.578
(0.237, 1.410)*
0.569
(0.314, 1.030)
-

1.139
(0.476, 2.721)
0.898
(0.427, 1.891)
-

0.827
(0.709, 0.965)*

1.218
(1.050, 1.413)*

0.807
(0.379, 1.718)

1.137
(0.549, 2.357)

0.416
(0.151, 1.144)

0.863
(0.292, 2.555)

0.805
(0.670, 0.967)*
-

1.522
(1.296, 1.787)*
-

0.708
(0.263, 1.902)
-

2.326
(1.141, 4.744)
-

0.313
(0.104, 0.942)*
-

0.814
(0.276, 2.403)
-

0.707

1.513

0.194

1.014

0.475

0.342
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Preeclampsia

No (ref)
Preeclampsia

Placental
Previa

No (ref)
Yes

Placental
Abruption

No (ref)
Yes

Umbilical
Cord
Complications

Gestational
Weight Gain

None (ref)
Cord around
the neck or
body, knot in
the cord,
prolapsed or
lacerated cord
Short, 2-vessel
or velamentous
cord
<10lb at 30
weeks’ or <20
lbs at term
Normal (ref)
>40 lbs at term

Birth Weight
Category

SGA
AGA (ref)
LGA

Anaemia

(0.533, 0.937)*
-

(1.240, 1.846)*
-

(0.026, 1.422)
-

(0.424, 2.423)
-

(0.110, 2.052)
-

(0.045, 2.583)
-

0.979
(0.691, 1.387)
-

1.775
(1.364, 2.309)*
-

1.028
(0.479, 2.206
-

1.834
(1.026, 3.276)*
-

1.173
(0.615, 2.237)*
-

1.397
(0.673, 2.902)
-

0.747
(0.344, 1.619)
-

0.980
(0.507, 1.895)
-

0.341
(0.046, 2.527)
-

0.282
(0.038, 2.085)
-

1.500
(0.415, 5.424)
-

3.919
(1.324, 11.601)*
-

1.223
(0.795, 1.881)
-

2.077
(1.485, 2.903)*
-

0.523
(0.160, 1.705)
-

2.268
(1.216, 4.229)*
-

0.592
(0.290, 1.212)*
-

1.678
(0.857, 3.285)*
-

0.810
(0.728, 0.901)*

1.189
(1.080, 1.309)*

0.973
(0.594, 1.592)

1.545
(1.001, 2.386)

0.850
(0.439, 1.646)

0.816
(0.376, 1.774)

1.990
(1.390, 2.850)*

1.180
(0.753, 1.851)

0.771
(0.092, 5.482)

3.622
(1.269, 10.338)*

6.603
(1.835, 23.755)*

3.661
(0.681, 19.674)

0.713
(0.427, 1.190)

1.002
(0.654, 1.537)

0.579
(0.076, 4.398)

∞
(0, ∞)

1.278
(0.147, 11.131)

∞
(0, ∞)

-

-

-

-

-

-

0.821
(0.690, 0.977)
1.130
(0.952, 1.342)
-

1.014
(0.868, 1.184)
1.242
(1.057, 1.461)*
-

0.474
(0.113, 1.993)
1.444
(0.689, 3.026)
-

1.646
(0.752, 3.605)
1.322
(0.654, 2.669)
-

0.799
(0.098, 6.502)
0.691
(0.262, 1.822)
-

1.149
(0.140, 9.421)
1.708
(0.742, 3.929)
-

0.829
(0.701, 0.981)*
-

1.096
(0.946, 1.270)
-

1.419
(0.738, 2.728)
-

1.462
(0.808, 2.647)
-

1.110
(0.410, 3.006)
-

0.343
(0.045, 2.603)
-
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No (ref)

Placental
Delivery

0.767
(0.560, 1.052)
-

1.898
(1.538, 2.342 )*
-

0.799
(0.242, 2.643)
-

2.420
(1.170, 5.008)*
-

0.849
(0.320, 2.253)
-

2.677
(1.187, 6.037)*
-

Expressed or
assisted

1.186
(1.006, 1.397)*

0.915
(0.771, 1.086)

1.131
(0.432, 2.963)

1.393
(0.604, 3.212)

1.144
(0.129, 10.114)

0
(0, ∞)

Manual

1.108
(0.987, 1.244)*
3.832
(2.344, 6.264)*

1.010
(0.903, 1.130)
1.450
(0.737, 2.854)*

1.054
(0.630, 1.762)
5.657
(1.374, 23.290)*

1.329
(0.845, 2.090)
1.658
(0.196, 14.010)

0.659
(0.369, 1.176)
3.119
(1.077, 9.033)*

2.156
(1.060, 4.383)*
4.159
(1.022, 16.931)*

Yes
Spontaneous
(ref)

Retained

*-Covariates with a significance level of p<0.05
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Table 5.3: Final Multivariable Logistic Regression model of Baseline Pregnancy Factors Hypothesized to Influence a
Placental Weight Ratio either ≤10th or ≥90th percentile by Gestational Age Category

Gestational Age ≥37 Weeks’
Predictors

Parity
0
≥1
Smoking During
Pregnancy
No (ref)
Yes

Odds Ratio (95% Confidence Interval)
Gestational Age between 32 and 37
Weeks’
PWR <10th
PWR >90th
Percentile
Percentile

PWR <10th
Percentile

PWR >90th
Percentile

-

-

-

0.928
(0.841, 1.024)*

1.067
(0.969, 1.176)*

-

Gestational Age ≤32 Weeks’
PWR <10th
Percentile

PWR >90th
Percentile

-

-

-

0.661
(0.412, 1.059)*

1.612
(1.011, 2.570)**

0.576
(0.306, 1.084)*

2.224
(1.060, 4.664)**

-

-

-

X

0.609
(0.522, 0.711)**

1.808
(1.618, 2.019)**

0.542
(0.278, 1.055)*

1.583
(0.987, 2.540)**

X

X

X

X

X

X

X

0.907
(0.811, 1.014)*
-

1.263
(1.126, 1.417)**
X

0.813
(0.694, 0.953)**
0.806
(0.666, 0.975)**

1.223
(1.050, 1.426)**
1.402
(1.184, 1.661)**

-

-

X

Maternal Age
<21 years
21-34 years
>34 years
Maternal Height
For every 10cm increase
Pre-pregnancy BMI
≤18.5 kg/m2
18.5-24.9 kg/m2 (ref)
25.0-29.9 kg/m2
>30.0 kg/m2
Gestational Diabetes
No (ref)

X

X

X

X

1.131
(1.005, 1.272)**

1.139
(0.984, 1.318)*

X

X

X

X

X

X
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Gestational Diabetes

0.734
(0.551, 0.979)**

Preeclampsia
No (ref)

1.442
(1.176, 1.770)**
-

X
Preeclampsia

X

1.684
(1.281, 2.213)**

X

Placental Previa
No (ref)

X

X

X

X

Yes
Placental Abruption
No (ref)

X

Yes

X

X
1.991
(1.027, 3.861)**

-

-

-

-

Cord around the neck or
body, knot in the cord,
prolapsed or lacerated
cord

0.821
(0.735, 0.916)**

1.183
(1.071, 1.308)**

1.453
(0.918, 2.298)*

X

Short, 2-vessel or
velamentous cord
Birth Weight Category
SGA

1.932
(1.338, 2.790)**

X

3.745
(1.240, 11.307)**

5.298
(1.395, 20.128)*

1.153
(0.963, 1.381)*
-

1.109
(0.934, 1.317)*
-

X

X

0.824
(0.693, 0.980)**

1.114
(0.955, 1.298)*

AGA (ref)
LGA
Anaemia
No (ref)

X

Yes

1.876

3.333
(0.904, 12.285)**

X

2.084
(1.481, 2.931)**

Umbilical Cord
Complications
None (ref)

X

1.938
(1.040, 3.610)**

X

X

X

2.068

X

X

X

X

X
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(1.507, 2.336)**
Placental Delivery
Spontaneous (ref)
Expressed or assisted
Manual
Retained

(0.961, 4.448)*

1.163
(0.976, 1.387)*
1.104
(0.981, 1.243)*
4.053
(2.461, 6.675)**

X
X

X

X

X
0.616
(0.324, 1.174)*
3.452
(1.095, 10.881)**

*-Covariates with a significance level of p<0.20; **-Covariates with a significance level of p<0.05; Factors considered but not significant
in any of the models were maternal asthma and gestational weight gain
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CHAPTER 6: INTEGRATED DISCUSSION

This chapter summarizes the thesis results and implications, provides a detailed
discussion where appropriate, identifies limitations and strength and provides
recommendations for future research. While multiple objectives were addressed, the main
purpose of this thesis was twofold: to established norms for the placental weight ratio
(PWR) across gestational age, and compare these norms between small, average and
large for gestational age infants (SGA, AGA and LGA) and to use the PWR norms we
established to identify risk factors associated with atypical PWRs in different gestational
age categories.

6.1 Brief Summary of Results
6.1.1

Population-Based Placental Weight Ratio Distributions
The placental and birth weight distributions show that placental growth has to

some degree levelled off while fetal growth continues at an accelerated pace. This pattern
is reflective of the second half of gestation. Comparing the city-wide population to the
total sample PWR distributions revealed them to be similar, with small differences
presenting themselves at the extreme percentiles at the earlier gestational ages. In general,
the females have higher PWR’s than males. These PWR distribution curves make a
substantial contribution to the literature. They show how the PWR changes across
gestation by percentile.
The curves that are stratified by fetal growth adequacy are the first of their kind.
Distinctly, they show that SGA infants had much higher PWR’s in early gestation than
both LGA and AGA infants at the early gestations. On the other hand, LGA infants have
lower PWR’s at the lower gestational ages when compared to AGA infants. However, the
PWR’s at term gestations are nearly identical in both SGA and LGA infants. In fact,
LGA infants have slightly higher median ratios at term than both SGA and AGA infants.
6.1.2

Determinants of Atypical Placental Weight Ratios
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The results presented in Chapter 5 suggest that adverse obstetric conditions are
associated with either placental growth restriction or placental hypertrophy, or both,
based on gestational age at birth. Inferences are sharpened by the use of PWR, rather than
merely placental weight, since PWR presents an opportunity to look at placental growth
in relation to birth weight.
For infants born at ≥37 weeks gestation, factors associated with an increased risk
of PWR<10th percentile were: a short, 2-vessel or velamentous umbilical cord insertion,
SGA infants, and any assisted placental delivery methods. On the other hand, multiparity,
smoking, abnormal BMI, preeclampsia, placental abruption, a cord around the neck or
body, a knot in the cord, or a prolapsed or lacerated cord, both SGA and LGA infants and
maternal anaemia increased the odds of a PWR>90th percentile.
For infants born between 32 and 37 weeks gestation, multiparity and smoking
attenuated the odds of a PWR<10th percentile. Alternatively, multiparity, preeclampsia,
placental abruption, a cord around the neck or body, a knot in the cord, or a prolapsed or
lacerated cord, a short, 2-vessel or velamentous umbilical cord insertion, and maternal
anaemia all increased the odds of a PWR >90th percentile.
For infants born ≤32 weeks gestation, increasing maternal height and a short, 2vessel or velamentous umbilical cord insertion increased the odds of a PWR <10th
percentile. Multiparity, increasing maternal height and placental previa all increased the
odds of a PWR >90th percentile.
The majority of the risk factors considered resulted in increased odds of a PWR
≥90th percentile. This proposes that the placenta may have compensatory responses to
maternal obstetric conditions, potentially each with a distinct pathophysiologic
mechanism, but similar PWR outcome.
6.1.3

Integration of Findings

Collectively, the results from this thesis supplement the literature on the PWR by
first creating population standards and comparing the standards between SGA, AGA and
LGA infants. Subsequently, we examined various risk factors proposed to be associated
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with atypical placental and fetal growth using the standards we created. The results of the
distributions allowed us to use gestational age and sex specific population-based
standards to identify infants as having a PWR<10th percentile or >90th percentile.
Furthermore, it afforded us the opportunity to examine multiple maternal obstetric
conditions and baseline factors that might influence the PWR using large scale population
standards.

6.2 Detailed Discussion of Determinants of Placental Weight Ratios

The framing of the findings in the context of hypoxia of various mechanisms is a useful
framework in which to interpret the findings of Chapter 5. The following section presents
a more detailed discussion which expands on points introduced in Chapter 5.

Ischemic Placental Disease
Ischemic placenta disease (IPD), which describes fetal growth restriction,
placental abruption and preeclampsia have been shown to apply its effects differently in
term and preterm infants.1,2 Among infants with IPD, the frequency of SGA is higher in
term, than preterm, infants.1 Interestingly, SGA was only significantly associated with
atypical PWRs in term infants after controlling for other factors in our analyses.
Furthermore, when PWRs have been compared between AGA and SGA infants based on
gestational age, SGA infants are found to have higher ratios than AGA infants.3 Our
results agree with both of these separate, yet dependant observations, and provide further
evidence that the role of the placenta in relation to fetal weight differs between
complications and timing during pregnancy.
Ananth et al.1 have shown that IPD in preterm infants is more likely to include the
mother and the fetus through SGA, preeclampsia and placental abruption, than in term
infants. A common pathophysiology between preeclampsia and placental abruption is
indicated by the sharing of a large proportion of risk factors.4 Our results have shown that
preeclampsia and placental abruption increase the odds of a PWR ≥90th percentile in the
highest two gestational age categories. Furthermore, the effect of placental abruption and
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preeclampsia in infants born between 32 and 37 weeks on a PWR ≥90th percentile is
slightly increased compared to term infants.

Preplacental Hypoxia
Preplacental hypoxia, a reduction in maternal blood oxygen content, occurs when
the placenta and fetus become hypoxic due to conditions such as maternal asthma and
maternal anaemia.5 Correlations between mild to severe anaemia and heavier than
average placentas have been noted in numerous studies.6–11 These studies have also
shown that hypoxia resulted in a smaller fetus, and therefore the PWR increased.6–11 For
term infants, maternal anaemia was associated with amplified odds of having a
PWR≥90th percentile. Our results are in agreement with the proposed physiological
mechanism. The increased size of the placenta has been understood as a compensatory
mechanism to overcome the lack of oxygen in the maternal blood, as well as the
increased trophoblastic proliferation and placental angiogenesis that result from
anaemia.12 In response to a lack of oxygen, the extravillous trophoblast of the placenta
bed shows an increased depth of invasion and the villi appear hypercapillarized.13

Uteroplacental Hypoxia

Uteroplacental hypoxia occurs when normally oxygenated maternal blood has
restricted entry into the uteroplacental tissues due to either occlusion or failed trophoblast
invasion of the uteroplacental arterioles. This situation represents late onset growth
restriction with preserved end diastolic flow volume, and term preeclampsia.5 Both low
and high placental weight has been shown in the literature to be associated with term
preeclampsia.14 Our results indicate that individuals with preeclampsia who deliver an
infant at term have increased odds of a PWR ≥90th percentile. These results are congruent
with current literature which shows that the PWR is often increased in pregnancies that
are complicated by preeclampsia.15,16 This suggests that there is compensatory growth of
placental villi in an attempt to overcome an unfavourable maternal environment.17,18
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Our results do not show increased odds for having a PWR ≤10th percentile,
thereby indicating a potentially smaller placenta. However, since we do not have the
timing of diagnosis for preeclampsia, we were only looking at infants born at term whose
mothers had preeclampsia. Nevertheless, the majority of pregnancies with preterm
preeclampsia do result in a preterm delivery.19
Postplacental Hypoxia

Postplacental hypoxia is when oxygenated maternal blood enters the intervillous
space at a normal or reduced rate, but a defect in fetoplacental perfusion prevents the
fetus from receiving sufficient oxygen.5 Placental adaptations in mothers with pregestational diabetes resemble those adaptations seen in other postplacental hypoxia
conditions. Placentas from women with gestational diabetes are often increased in weight
when compared to women who had only one abnormal oral glucose tolerance test.20–25
However, the literature is inconclusive on the effect of gestational diabetes on the
PWR.21,26

In our highest gestational age categories, gestational diabetes was associated with
increased odds of a PWR ≥90th and was protective against a PWR ≤10th percentile.
Levels of haemoglobin and erythropoietin provide evidence that fetuses in mothers with
pre-diabetes are hypoxic. The literature suggests that the surface and exchange areas are
enlarged as a result of the hypoproliferation and hypervascularization in gestational
diabetes. Therefore, the maternal placental oxygen supply is reduced, and the fetal
oxygen demand is increased.27,28 This phenomenon could be explained by aerobic
metabolism which is stimulated by fetal hypersinsulinemia which can result in reduced
trophoblast proliferation. The low oxygen levels up regulate transcriptional synthesis of
leptin, VEGF and fibroblast growth factor which promotes placental endothelial cell
proliferation. The result is enhanced vascularisation of the placenta.29,30

Carbon Monoxide Hypoxia

153
Maternal smoking is associated with carbon monoxide hypoxia which reduces
oxygen content in maternal blood. While this seems similar to preplacental hypoxia, and
the changes in fetal capillaries and peripheral villi do mirror the effects in cases such as
anaemia, the morphology and oxygen diffusion conductances are not consistent with
other cases of preplacental hypoxia.31,32 However, these differences may be confounded
by some of the other toxins in cigarettes.33
Cigarette smoking is associated with a decreased fetal weight, but of the few studies
that have examined the association between maternal smoking and placental weight, there
has been no significant effect found.9,34–38 Some studies that investigated the PWR found
significantly higher ratios in smokers versus non-smokers.36,39 On the other hand, another
study found a significantly lower PWR for smokers than non-smokers.34 Our results
account for such discrepancies as we found that smoking increases the odds of having a
PWR ≥90th percentile and attenuates the odds of having a PWR ≤10th percentile. When a
mother smokes during pregnancy, the placenta and fetus become hypoxic because of a
reduction of oxygen content within the maternal blood along with an increased vascular
resistance on the fetal side of the placenta. These conditions result in reduced
intraplacental oxygen content, predominately branching angiogenesis and reduced
vascular impedance. The increase in branching angiogenesis, and thereby reduced
vascular impedance, is an adaptive mechanism to the hypoxic state. This mechanism is
associated with excessive placental weight.40

Placental and Umbilical Cord Complications
Placentas with a non-centrally inserted umbilical cord, such as a velamentous
insertion, tend to be heavier.41 Any force that compresses umbilical cords may lead to
diminished blood flow in umbilical vessels and subsequent fetal hypoxia or circulatory
compromise. Mechanical cord compression can be caused by cord entanglements
(nuchal/body cords) and cord prolapse; or it may take place as a result of an abnormal
configuration of the cord such as true knots, hypercoiling, abnormally short or long cords,
abnormal cord insertions, or strictures.42 These complications are often associated with
decreased fetal weight, and both marginal and velamentous cord insertion are associated
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with an decreased placental weight, an increased PWR and a reduced metabolic
efficiency.3,41,43 On the contrary, a single umbilical artery is also associated with a
reduced placental weight.43 Abnormal cord insertion has also been found to be associated
with a high PWR.44 Our results show that a short, 2-vessel or velamentous cord insertion
are associated with increased odds of a PWR ≥90th percentile in infants born between 32
and 37 weeks, and increased odds of a PWR ≤10th percentile in terms infants and infants
born ≤32 weeks. However, a cord around the neck or body, knot in the cord, prolapsed or
lacerated cord is also associated with a PWR ≥90th percentile in all infants born at >32
weeks.
As indicated within the literature, some placental factors, such as placenta
abruption, placenta previa and antepartum hemorrhage are not individually associated
with placental weight,43 but as a group are associated with a decreased PWR.45 Our
results partially disagree with these findings. We found that placenta previa has no
significant association, but that placental abruption strengthened the odds of having a
PWR ≥90th percentile.

6.3 Study Implications

Findings from this thesis have potentially important implications for implementing the
population based PWR standards in research.

6.3.1

Applications of the Placental Weight Ratio Distributions in Research

Future research directions can make use of the PWR distributions for identifying
infants with atypical PWRs. Previous studies that have looked at atypical PWRs have not
used a population standard to identify abnormal PWRs.15–17 Furthermore, the SGA, AGA
and LGA distribution curves can provide new dimension in future similar studies.

6.4 Strengths and Limitations
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A major strength of the study is the available sample size. The perinatal database
provided a large number of observations with a placental weight, birth weight and
gestational age. This allowed for the creation of accurate standards. It also allowed for the
percentile curves to be stratified by fetal growth adequacy which required large enough
sample sizes in each of the fetal growth adequacy categories. This study is strong due to
the quality and comprehensive nature of the data. The internal validity of the study is
strong because every birth at St. Joseph’s Hospital and Victoria Hospital was captured;
this is a population-based, representative sample. The results will be important for both
obstetricians and neonatologists managing high risk pregnancies and infants with extreme
birth and placental weights.

This research is novel in the approach of considering a modern framework of
proposed physiological mechanisms along with a theoretic framework to examine the
relationships between various risk factors and their associations with atypical PWRs. The
strong theoretical framework, based on biologically plausible mechanistic literature,
combined with epidemiological literature provides a strong base for this study. This
approach also allows the complexity of the relationships that exist between factors to be
conserved and provides an understanding of how these factors relate within this
population.

The appropriate use of quantile regression (QR) is a principle strength of the
study since it does not make any distributional assumption beforehand. It is able to model
data with heterogeneous conditional distributions, and it is robust to extreme values of the
outcome. Furthermore, compared to other statistical methods QR is more stable and is
able to reveal departures from underlying assumption of parametric models.50

Like other studies that use administrative databases, this study was unable to
assess a few covariates that may influence the PWR. Examples include residing at high
altitude and ethnicity. However, residing at high altitude, a form of preplacental hypoxia,
is not a variable of great significance for many women living in the region. Preplacental
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hypoxia was represented by other variables in the study. Ethnicity has been shown to
influence the PWR in previous studies, but the effect was small.9,53

Height and weight data contributing to the calculation for pre-pregnancy came
from variable sources, including self-report, therefore misreporting may have influenced
the accuracy of BMI. We speculate it may have produced an underestimate in BMI. The
situation is similar for smoking because women sometimes fail to report such behaviours.
Generally, because these are secondary data from an administrative data source, we
cannot be certain as to how error-free the data are. We have excluded implausible values
as an effort to control the data quality.

6.5 Future Directions

Further studies are warranted to provide comparisons in other populations. Birth
weights are known to vary from country to country.52,54 Therefore, the creation of PWR
distribution curves in other populations is recommended, as percentiles can best be used
as a standard in research studies if they can be argued to be comparable to the population
in which the studies are conducted.

Our data are cross-sectional. This is typical of studies which establish growth
standards based on birth outcomes.52 However, neonates at early gestations are likely not
representative of their same-gestation peers who remain in utero. It would be of interest
to conduct longitudinal studies looking at serial estimates of placental and fetal growth in
order to further understand the timelines attached to growth deviations. Longitudinal
studies following a cohort of placentas throughout the pregnancy would require serial
ultrasound estimation; however, ultrasound weight estimations have their inaccuracies.51

Further research is justified to elucidate the biological mechanisms underlying the
associations between anemia, gestational diabetes, hypertensive disease, maternal prepregnancy BMI, and umbilical cord complications with abnormal placental growth
relative to fetal growth. Additionally, understanding the biological mechanisms in infants
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at different gestational ages is vindicated based on the differing results seen in the three
gestational age categories we examined for risk factors such as preeclampsia and
placental previa.

Additionally, future cohort studies should examine these associations to determine
if children with either low or high PWRs are at a greater risk for certain medical
conditions. Limited literature exists that examines later child health outcomes in infants
with atypical PWRs.

All of the aforementioned prospective directions can make use of the PWR
standards we created, as they provide a large population-based standard to define atypical
PWRs in across the second half of pregnancy. Furthermore, the stratified curves may
provide a new dimension in future studies.

6.6 Conclusions
The PWR distribution curves make a substantial contribution to the literature.
They show how the PWR changes across gestation by percentile. Further, the PWR
distribution curves provide a standard that clinicians and researchers can apply as a
reference standard to identify infants who have abnormal PWRs. Identifying infants with
high PWRs is important for patient care in both the short and long term. Previous
literature has shown that neonates with a high PWR had increased incidence of shortterm complications.55 Furthermore, in recent years, birthweight, sometimes in
conjunction with placental weight, has been associated with the development of a series
of diseases later in life.56 However, the relative magnitude of the PWR, in terms of
standards, is not available for all gestational ages in a Canadian population. As well,
PWR has not been documented for SGA, AGA and LGA infants. Thus, the distributions
estimated in this study may provide a useful tool for adding this dimension in future
similar studies.
Using the population-based standards we created to define the PWR we found that
both maternal obstetric conditions and maternal baseline factors are either associated with
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placental growth restriction or placental hypertrophy in relation to birth weight, and even
both, based on gestational age at delivery. The majority of the risk factors assessed
resulted in increased odds of a PWR ≥90th percentile. This suggests that the placenta may
have particular compensatory responses to maternal obstetric conditions, each with a
different pathophysiologic mechanism, but comparable PWR outcome.
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Appendix A: Definitions
Asymmetrical Small for Gestational Age- an infant with a ponderal index less than the
10th percentile, based on population standards for each sex by gestational age.
Average for Gestational Age- an infant with a birth weight between the 10th and 90th
percentile after controlling for gestational age and sex, as defined by the World Health
Organization in the International Classification of Diseases Version 10, as per code
P05.1.
Blastocyst- a structure formed in the early embryogenesis of mammals, after the
formation of the morula. It contains an inner cell mass which eventually forms the fetus,
and the outer cell mass containing trophoblasts which later forms the placenta.
Body Mass Index- the individuals weight in kilograms divided by their height in meters
squared.
Decidua- is the uterine lining which forms the maternal part of the placenta.
Extravillous Trophoblasts- cells which originate from the trophoblasts. Extravillous
trophoblast grow out from the placenta and penetrate into the decidualised uterus. This
process attaches the placenta to the mother, and alters the vasculature in the uterus to
allow it to provide an adequate blood supply to the growing fetus as pregnancy
progresses.
Fetal Growth Restriction- a fetus that has not reached its growth potential because of
genetic or environmental factors.
Lacunae- one of the blood spaces of the placenta in which the fetal villi are found.
Large for Gestational Age- an infant who exceed the 90th percentile for birth weight
after controlling for gestational age and sex, as defined by the World Health Organization
in the International Classification of Diseases Version 10, as per code P05.1.
Morula- an embryo at an early stage of embryonic development, consisting of a ball of
about 16 undifferentiated cells contained inside the zona pellucida.

167
Placental Weight Ratio- the ratio of the placental weight in grams to the fetal weight in
grams.
Ponderal Index- the birth weight in kilograms divided by the length in meters cubed,
according to Rohrer(1908).
Preeclampsia- is a conditional that occurs when a pregnant woman develops high blood
pressure (>140/90mmHg) and protein in the urine after the 20th week of pregnancy.
Small for Gestational Age- an infant that weighs less than the 10th percentile for their
gestational age and sex, as defined by the World Health Organization in the International
Classification of Diseases Version 10, as per code P05.1
Symmetrical Small for Gestational Age- an infant with a ponderal index greater than
the 10th percentile, based on population standards for each sex by gestational age.
Syncytiotrophoblast- the thick layer of cell boundary that forms the endometrial stroma.
It secretes human chorionic growth hormone in order to maintain progesterone secretion
and sustain pregnancy. It is a specialized epithelium covering the villous tree and has
several functions, such as transport of gases, nutrients, and waste products and synthesis
of peptide and steroid hormones that regulate placental, fetal, and maternal systems
Trophoblasts- cells forming the outer layer of the blastocyst.
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Appendix C: Conceptual Model of Risk Factors Associated with Reduced Placental
Weight and SGA
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Appendix D: Conceptual Model of Risk Factors Associated with Increased Placental
Weight and LGA

171
Appendix E: Conceptual Model of the Risk Factors Association with an Atypical PWR
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Appendix F: Tables of References for Risk Factors Associated with SGA, LGA and both Reduced and Increased Placental
Weights
Risk Factors
Short Maternal Height

Low Maternal Weight

Low Pregnancy Weight
Gain

Low Parity

High levels of
Psychosocial Stress

Smoking

References for SGA
(Xun et al., 2007)(M. S.
Kramer, 1987)(Voigt et al.,
2010)
(Reader, 2007)(Voigt et al.,
2010)(Hibbert et al., 1999)

(Reader, 2007)(Berghella,
2007)(Mamun et al.,
2011)(Hellerstedt et al.,
1997)
(Siega-Riz et al.,
2009)(Crane et al.,
2009)(Margerison Zilko et
al., 2010)
(X. Zhang et al., 2007)

(Wadhwa et al.,
2004)(Goland et al.,
1993)(GrackaTomaszewska, 2010)
(Rondó et al., 2003)
(Adams, Eberhard-Gran,
Hofoss, & Eskild, 2011)
(Chrousos & Gold, 1992)
(M. S. Kramer,
1987)(Romo et al.,
2009)(Figueras et al.,
2008)(Rasmussen & Irgens,
2006) (Hellerstedt et al.,

References for Reduced
Placental Weight
(L. A. Williams et al.,
1997)

References for LGA

References for Increased
Placental Weight

(Thame et al., 2001)(Junichi
Hasegawa et
al.,2011)(Hibbert et al.,
1999)(Naeye, 1987)
(L. A. Williams et al.,
1997)(Baptiste-Roberts et
al., 2008)
(L. A. Williams et al.,
1997)(Naeye, 1987)

(L. A. Williams et al.,
1997)(Baptiste-Roberts et
al., 2008)
(Tegethoff, Greene, Olsen,
Meyer, & Meinlschmidt,
2010).

(R. E. Christianson, 1979;
H. C. Miller, Hassanein, &
Hensleigh, 1976;
Mochizuki, Maruo,
Masuko, & Ohtsu, 1984;

(Pfarrer et al., 1999) (R. E.
Christianson, 1979; H. C.
Miller, Hassanein, &
Hensleigh, 1976;
Mochizuki, Maruo,
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Alcohol Consumption
during Pregnancy
Excessive Aerobic
Exercise during
Pregnancy

Chronic Hypertension
Gestational Hypertension

1997)(Aagaard-Tillery et
al., 2008)
(Lieberman et al.,
1994)(Spinillo et al.,
1994)(Aliyu et al.,
2010)(Martin & Bracken,
1986) (C. Ward, Lewis, &
Coleman, 2007a)(C. Ward,
Lewis, & Coleman, 2007b)
(Ira M Bernstein et al.,
2005)(Berghella,
2007)(Lesley M E
McCowan et al., 2009)
(Polakowski, Akinbami, &
Mendola, 2009)
(Lieberman et al.,
1994)(Prabhu et al., 2010)
(Patra et al., 2011)
(Romo et al., 2009)
(C. M. O’Leary et al., 2009)
(M. K. Campbell &
Mottola, 2001)
(Hopkins et al., 2010)
(Lesley M E McCowan et
al., 2009)
(Erkkola et al., 1992)
(Lawrence, 2006)
(Catov et al., 2008)
(Buchbinder, Sibai, Caritis,
Macpherson, Hauth,
Lindheimer, Klebanoff,
Vandorsten, Landon, Paul,
Miodovnik, Meis, &
Thurnau, 2002b)(J. C.
Hauth et al., 2000)(José
Villar et al., 2006)
(Buchbinder, Sibai, Caritis,
Macpherson, Hauth,
Lindheimer, Klebanoff,
Vandorsten, Landon, Paul,

Carolyn M. Salafia,
Vintzileos, Lerer, &
Silberman, 1992; Wingerd,
Christianson, Lovitt, &
Schoen, 1976)(BaptisteRoberts et al., 2008)

Masuko, & Ohtsu, 1984;
Carolyn M. Salafia,
Vintzileos, Lerer, &
Silberman, 1992; Wingerd,
Christianson, Lovitt, &
Schoen, 1976)(BaptisteRoberts et al., 2008)
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Preeclampsia

Nutritional Deprivation

Low and High Maternal
Age
Short Interpregnancy
Interval
Toxins

Residing at High Altitude

Abnormal umbilical cord
insertion

Miodovnik, Meis, &
Thurnau, 2002a)(Baha M
Sibai, 2003)
(Eskenazi et al.,
1993)(Saftlas, Beydoun, &
Triche, 2005)(Rasmussen &
Irgens, 2003)(Long et al.,
1980)(M. P. Moore &
Redman, 1983)
(MacKay, Berg, & Atrash,
2001)(X Xiong & Fraser,
2004) (Lars J Vatten &
Skjaerven, 2004)
(Odegard et al., 2000)
(Xu Xiong et al., 2002)
(PW Nathanielsz,
2000)(Nørgård et al., 1999)
(R. L. Bergmann et al.,
2008)

(Aldous & Edmonson,
1993)
(Strobino et al., 1995)
(van Eijsden et al., 2008).
(Conde-Agudelo et al.,
2006)
(P. S. Bernstein & Divon,
1997)(Shi Wu Wen et al.,
2008)
(H L Galan et al., 2001)(L.
G. Moore et al., 2001)
(Mortola et al., 2000)
(Kametas et al., 2004)

(J Hasegawa et al., 2010)(A
Eskild et al., 2009)
(A Eskild & Vatten,
2010)(Baptiste-Roberts et
al., 2008)(Leung et al.,
2001)

(Thomson et al., 1969)
(Soma et al., 1982)(P. A.
Boyd et al., 1986)(P. M.
Coan et al.,
2010)(Dahlstrøm et al.,
2008)

(Lumey, 1998)(J. M.
Wallace, Aitken, Milne, &
Hay, 2004a) Heasman,
Clarke, Stephenson, &
Symonds, 1999)
(L. J. Edwards &
McMillen, 2001)
(Dandrea et al., 2001)(C.
Steyn et al., 2001)
(Haavaldsen et al., 2011)

(J. Kingdom, Huppertz,
Seaward, & Kaufmann,
2000a)
(Junichi Hasegawa et al.,
2011)
(S Heinonen et al., 2001)
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Abnormal cord length
Abnormal or Absent
Umbilical artery
Placental Conditions
(Previa, Abruption,
Hemorrhage)
Infant Sex (Female)
Anemia

Ethnicity (African
American and Asian)
Gestational Diabetes

(Junichi Hasegawa et al.,
2011)
(Junichi Hasegawa et al.,
2011)
(Little et al., 2003)

(S Heinonen et al., 2001)
(Naeye, 1987)
(Steer, 1992)
(Godfrey et al., 1991)

(Agboola, 1975)
(Akhter et al., 2010)
(Baptiste-Roberts et al.,
2008)(Lao & Wong,
1997)(Lao & Tam, 2000)
(Levario-Carrillo et al.,
2003)

(Baptiste-Roberts et al.,
2008)
(Perry et al., 1995)
(Langer et al., 2005)
(Rodrigues et al., 2000)
(Casey et al., 1997)
(Hardy, 1999)(Di Cianni et
al., 2003)
(Stephens et al., 2001)
(P. Thureen et al., 2006)
(Rosenn, 2008)

Diabetes Mellitus

High Maternal Weight
(Obesity)

Increased Maternal
Weight Gain

(Baeten et al., 2001)
(Rosenberg et al.,
2003)(Cnattingius et al.,
1998)(Langer et al., 2005)
(Kahn & Flier, 2000)
(Rodriguez et al.,

(Makhseed et al., 2004)
(Kucuk & Doymaz,
2009)(Taricco, Radaelli,
Nobile de Santis, & Cetin,
2003b) (Desoye &
Hauguel-de Mouzon,
2007)(Johnston,
1995)(Ericsson et al.,
2007)(Makhseed et al.,
2004)(Kucuk & Doymaz,
2009).
(Thomson et al., 1969)
(Nummi, 1972)(Clarson et
al., 1989)
(L. A. Williams et al.,
1997)(Baptiste-Roberts et
al., 2008)
(Baptiste-Roberts et al.,
2008)(L. A. Williams et al.,
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Multiparity

Infant Sex (Male)

Pregnancy Nutrition

High Maternal Age
Decompensated Cardiac
Disease
High Levels of
Psychosocial Stress

(L. J. Edwards &
McMillen, 2001) (Dandrea
et al., 2001)(C. Steyn et al.,
2001)

1999)(Okun et al.,
1997)(Reader, 2007)
(Brunskill et al., 1991).
(J. A. O’Leary & Leonetti,
1990)
(Brunskill et al., 1991)
(Lackman, Capewell,
Richardson, et al., 2001)
(Denguezli et al.,
2009)(Lumey, 1998)

1997)
(L. A. Williams et al.,
1997)(Baptiste-Roberts et
al., 2008)
(S Heinonen et al.,
2001)(Naeye, 1987)
(L. J. Edwards & McMillen,
2001) (Dandrea et al.,
2001)(C. Steyn et al.,
2001)(Woodall et al., 1996)
(Lumey, 1998)
(Haavaldsen et al., 2011)
(Clavero & Botellallusia,
1963)
(Tegethoff et al., 2010)
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Appendix G: Preplacental Hypoxia Pathways
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Appendix H: Uteroplacental Hypoxia Pathways
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Appendix I: Postplacental Hypoxia Pathways
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Appendix J: Calculations for the Removal of Birth Weights Three Standard Deviations
from the Mean
J.1.Males Calculations
Gestational
Week

Mean

Standard
Deviation

3 SD’s
Below the
Mean

3 SD’s
Above the
Mean

22

507.07

48.56

361.40

652.74

23

622.72

82.59

374.96

870.49

24

651.85

81.45

407.50

896.19

25

747.82

143.02

318.75

1176.89

26

910.21

143.17

480.70

1339.72

27

1066.63

312.56

128.96

2004.31

28

1124.75

323.15

155.29

2094.21

29

1344.45

250.12

594.10

2094.80

30

1616.97

464.91

222.24

3011.71

31

1682.85

320.60

721.04

2644.66

32

1861.19

357.40

789.01

2933.38

33

2184.94

430.18

894.40

3475.48

34

2426.94

481.33

982.94

3870.93

35

2637.10

444.17

1304.60

3969.60

36

2903.94

461.97

1518.04

4289.84

37

3137.07

479.18

1699.52

4574.63

38

3376.84

461.46

1992.46

4761.23

39

3527.79

446.39

2188.63

4866.95

40

3686.96

442.43

2359.66

5014.26

41

3806.74

449.57

2458.02

5155.46

42

3948.84

532.46

2351.47

5546.20
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J.2.Females Calculations

68.95

3 SD’s
Below the
Mean
226.04

3 SD’s
Above the
Mean
639.74

542.62

81.20

299.01

786.22

24

594.46

77.89

360.79

828.12

25

795.53

205.16

180.05

1411.01

26

878.03

179.77

338.71

1417.34

27

958.51

218.68

302.49

1614.54

28

1118.46

198.04

524.35

1712.57

29

1220.42

265.88

422.78

2018.07

30

1388.42

320.18

427.88

2348.96

31

1626.87

270.82

814.42

2439.31

32

1777.17

335.55

770.52

2783.83

33

2069.75

383.85

918.19

3221.30

34

2278.60

455.73

911.41

3645.79

35

2581.60

458.61

1205.76

3957.44

36

2805.16

495.61

1318.34

4291.99

37

3044.04

474.75

1619.80

4468.28

38

3259.82

448.94

1912.99

4606.66

39

3404.52

426.01

2126.48

4682.57

40

3548.62

431.27

2254.80

4842.44

41

3643.93

437.09

2332.67

4955.20

42

3732.27

433.71

2431.14

5033.40

Gestational
Week

Mean

Standard
Deviation

22

432.89

23
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Appendix K: Macro for Quantile Regression
ods graphics on;
ods html;
%macro quantiles(NQuant, Quantiles);
%do i=1 %to &NQuant;
proc quantreg data=x4 algorithm=INTERIOR(TOLERANCE=1E-4
KAPPA=0.25)PLOT=FITPLOT(NODATA);
model fpratio = GESTWK GESTWK*GESTWK/ quantile=%scan(&quantiles,&i,'','');
output out=outp&i pred=p&i;
run;
%end;
%mend;
%let quantiles = %str(.03,.05,.10,.25,.5,.75,.90,.95,.97);
%quantiles(10,&quantiles);
ods graphics off;
ods html close;
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Appendix L: Descriptive Statistics for Sample: Binary, Categorical and Continuous
Variables

Parity

Predictor Variables (Binary/Categorical)
0

Smoking during Pregnancy

Gestational
Hypertension/Preeclampsia

n
53954

Frequency (%)
23968(44.42)

Missing
3

≥1
No

53954

29985(55.58)
44986(83.38)

2

Yes
No

53943

8968(16.62)
49169(91.15)

13

Preeclampsia

Body Mass Index

Gestational Hypertension
≤18.5 kg/m2

1827(3.39)

53956

2947(5.46)
19696 (36.50)

18.5-24.9 kg/m2

19856(36.80)

25.0-29.9 kg/m2

8675(16.08)

0

Anaemia

>30.0 kg/m2
No

26674

5729(10.62)
25710(96.51)

27316

Sex

Yes
Male

53956

930(3.49)
27636(51.22)

0

Maternal Asthma

Female
No

53956

26320 (48.78)
52748(97.76)

0

Placenta Delivery

Yes
Spontaneous

53411

1208(2.24)
40246(75.34)

547

Expressed or assisted

280(5.24)

Manual

10095(18.90)

Placenta Previa

Retained
No

53956

270(0.52)
53579(99.30)

0

Placental Abruption

Yes
No

53956

377(0.70)
52776(97.80)

0

Gestational Diabetes

Yes
No

53952

1180(2.20)
50834(94.22)

4

Cord Complication

Yes
No

53956

3118(5.78)
37220(68.98)

0

Cord around the neck or
body, knot in the cord,
prolapsed or lacerated
cord

16259(30.13)
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Gestational Weight Gain

Birth Weight Category

Short, 2-vessel or
velamentous cord
Normal

477(0.88)
53956

46802(86.74)

<10lb at 30 weeks or <20
lbs at term

1514(2.81)

>40 lbs at term
SGA

5640(10.45)
4259(7.91)

53834

43697(81.17)

AGA
LGA
Predictor Variables (Continuous)

122

n

5878(10.92)
Mean (±S.D.)

Missing

Maternal Age (years)

52227

29.14(±5.11)

1729

Maternal Height (inches)

50534

64.80(±2.47)

3422
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Appendix M: Distributions of Key Variables
M.1. Gestational Age Distribution
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M.2. Birth Weight Distribution

187
M.3. Placenta Weight Distribution
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Appendix N: Detailed Description of SGA and LGA Placental Weight Ratios
N.1. Description of SGA PWR Curves
Infants were defined as SGA based on Kramer’s gestational age and sex specific
standards. There are 1677 males and 1533 females who are included in the analysis after
the exclusion criteria were applied and missing data were removed. The 3rd percentile
reached statistical significance at p<0.05, the 5th at p<0.01 and the remaining percentiles
at p<0.001. The median gestational age was 39 weeks for both males and females which
was the same as for the overall population. The mean gestational ages for males and
females are 38.5 (SD=2.49) and 37.5(2.34) respectively. While the mean gestational ages
are similar to that of the overall population, the standard deviations were larger for the
SGA group.
Males have a mean PWR of 0.2036 (SD=0.0537) and a median PWR of 0.1955.
The means at the 3rd, 5th, 10th, 25th, 50th, 75th, 90th, 95th, 97th are 0.1391, 0.14500.1562,
0.1756, 0.1986. 0.2242, 0.2559, 0.2794 and 0.2950. Females have a mean PWR of
0.2059 (SD=0.0516) and a median PWR of 0.1990. The means at the 3rd, 5th, 10th, 25th,
50th, 75th, 90th, 95th, 97th are 0.1434, 0.1503, 0.1623, 0.1792, 0.2011, 0.2260, 0.2575,
0.2803 and 0.2979. Again the PWR decreases as gestational age increases and there was
more dispersion in the lower gestational ages than at the higher gestational ages for both
males and females.
Through examination of Table 4.5 and 4.6, which show the exact PWR at each
gestational age by percentile, it was evident that the SGA infants have higher PWR’s than
the overall population. Similar to the overall population, the females have higher PWR’s
than males, yet not significantly different from each other. Again, there was more
dwaspersion at the lower gestational ages for both males and females. There was a
greater range of PWR values at the 50th percentile for males than females. The range for
the PWR between 22 and 42 weeks at the 50th percentile was 0.3171 and 0.3021 for
males and females respectively. The same pattern of a higher range of PWR’s at
particular percentile for males than females also holds true for extremes, as shown in the
10th and 90th percentile.
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N.2. Description of LGA PWR Curves
Infants were defined as LGA based on Kramer’s gestational age and sex specific
standards. There are 2566 males and 1813 females who are included in the analysis after
the exclusion criteria were applied and the missing data were removed. The median
gestational age for males was 39 weeks and for females it was 40 weeks. The mean
gestational age for males was 38.8 weeks (SD=2.06) and 38.9 weeks (SD=2.05) for
females. The range of gestational ages for females was between 25 and 42 weeks, and for
males it was between 23 and 42 weeks. Statistically significance was not achieved at a
level of p<0.05 for the 3rd and 5th percentiles for both males and females, therefore, they
were not included.
Males have a median PWR of 0.1956 and a mean PWR of 0.1998 (SD=0.0374).
The means at the 10th, 25th, 50th, 75th, 90th, 95th, 97th are 0.1602, 0.1776, 0.1947, 0.2188,
0.2403, 0.2576 and 0.2685 respectively. Females have a median PWR of 0.2020 and a
mean PWR of 0.2072 (SD=0.0422). The means at the 10th, 25th, 50th, 75th, 90th, 95th, 97th
are 0.1649, 0.1816, 0.2043, 0.2293, 0.2523, 0.2700 and 0.2868 respectively.
Again, females had higher PWR’s than males across percentiles, but the
difference was not significant. There was a greater range in PWR’s at the 50th percentile
across gestations for females than for males. Furthermore, this pattern holds true at the
extreme percentiles. There was a greater range in PWR’s between the 25th and 42nd week
of gestation at the 10th and 90th percentile in females than in males. The graphical
representation for these distributions can be found in Figure 4.10 and 4.11, and the exact
values for each percentile by gestational age can be found in Table 4.9 and 4.10.
N.3. Differences between SGA, AGA and LGA Curves
The figures below show graphically how the PWR changes across gestation
between SGA, AGA and LGA infants at the median. Specifically, they show that there
was a greater dispersion in the PWR in SGA infants than in AGA and LGA infants,
especially in the lower gestational ages. The range of PWR’s between the 3rd and 97th
percentiles at 22 and 23 weeks for male SGA infants was 0.7295 and 0.6640 respectively.
The range of PWR’s between the 3rd and 97th percentiles at 22 and 23 weeks for female
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SGA infants was 0.8513 and 0.7758 respectively. However, the range of PWR’s between
the 3rd and 97th percentiles at 22 and 23 weeks for male AGA infants was 0.4776 and
0.440 respectively. Also, the range of PWR’s between the 3rd and 97th percentiles at 22
and 23 weeks for female AGA infants was 0.6073 and 0.5567 respectively. Therefore, it
was evident that there was more dispersion in the PWR’s at the earlier gestations in SGA
infants than in AGA infants. To provide a similar comparison, the range of values
between the 10th and 97th percentile for LGA male infants at 22 and 23 weeks gestation
are 0.2196 and 0.1782. The ranges for female LGA infants between the 10th and 97th
percentiles at 22 and 23 weeks are 0.4778 and 0.4315 respectively. Comparing these
results to the male and female AGA ranges for between the 10th and 97th percentile, the
dispersion in LGA infants was less than in AGA infants. It can then be concluded that the
dispersion at the lower gestational ages was greatest in SGA infants than in both LGA
and AGA infants. When comparison was made between LGA and AGA infants the AGA
infants show more dispersion at the lower gestational ages than do the LGA infants.
Furthermore, at the earlier gestational ages both male and female SGA infants
have higher PWR’s than male and female AGA and LGA infants. The differences in
PWR’s were the most pronounced at the higher percentiles and at the earlier gestational
ages. SGA infants had much higher PWR’s in early gestation than both SGA and AGA
infants at the early gestation. At the 90th, 95th and 97th percentile SGA infants have
PWR’s that were a lot higher than the AGA and LGA infants. On the other hand, LGA
infants have lower PWR’s at the lower gestational ages when compared to AGA infants.
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N.4. SGA Male Placental Weight Ratios by Gestational Age for the 3rd through the 97th Percentile
Gestational
Age
22
23
24
25
26
28
29
30
31
32
32
33
34
35
36
37
38
39
40
41
42

3rd
Percentile
0.2987
0.2827
0.2675
0.2531
0.2394
0.2146
0.2034
0.1930
0.1834
0.1745
0.1745
0.1665
0.1593
0.1529
0.1473
0.1425
0.1384
0.1352
0.1328
0.1312
0.1304

5th
Percentile
0.2954
0.2805
0.2664
0.2531
0.2404
0.2172
0.2067
0.1970
0.1879
0.1796
0.1796
0.1719
0.1650
0.1589
0.1534
0.1487
0.1446
0.1413
0.1387
0.1369
0.1357

10th
Percentile
0.3157
0.2995
0.2842
0.2696
0.2559
0.2310
0.2197
0.2093
0.1997
0.1909
0.1909
0.1829
0.1758
0.1694
0.1639
0.1592
0.1553
0.1522
0.1500
0.1486
0.1480

25th
Percentile
0.3971
0.3736
0.3515
0.3306
0.3109
0.2754
0.2596
0.2450
0.2316
0.2196
0.2196
0.2087
0.1992
0.1909
0.1838
0.1780
0.1735
0.1702
0.1682
0.1675
0.1680

50th
Percentile
0.5085
0.4749
0.4431
0.4132
0.3852
0.3348
0.3124
0.2919
0.2732
0.2564
0.2564
0.2415
0.2285
0.2173
0.2080
0.2005
0.1950
0.1913
0.1895
0.1895
0.1914

75th
Percentile
0.5673
0.5320
0.4986
0.4670
0.4372
0.3831
0.3588
0.3363
0.3156
0.2968
0.2968
0.2798
0.2646
0.2512
0.2396
0.2299
0.2220
0.2159
0.2116
0.2092
0.2085

90th
Percentile
0.7931
0.7346
0.6794
0.6275
0.5788
0.4912
0.4523
0.4167
0.3843
0.3552
0.3552
0.3294
0.3069
0.2876
0.2716
0.2588
0.2494
0.2432
0.2402
0.2405
0.2441

95th
Percentile
0.9229
0.8533
0.7877
0.7258
0.6679
0.5634
0.5170
0.4744
0.4357
0.4007
0.4007
0.3697
0.3425
0.3191
0.2996
0.2839
0.2721
0.2641
0.2600
0.2597
0.2633

97th
Percentile
1.0282
0.9467
0.8699
0.7978
0.7303
0.6093
0.5558
0.5070
0.4629
0.4234
0.4234
0.3886
0.3585
0.3330
0.3122
0.2961
0.2847
0.2779
0.2758
0.2783
0.2856
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N.5. SGA Female Placental Weight Ratios by Gestational Age for the 3rd through the 97th Percentile
Gestational
Age
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

3rd
Percentile
0.3107
0.2923
0.2749
0.2586
0.2433
0.2291
0.2159
0.2038
0.1927
0.1827
0.1737
0.1657
0.1588
0.1530
0.1482
0.1445
0.1418
0.1401
0.1395
0.1399
0.1414

5th
Percentile
0.3079
0.2909
0.2749
0.2598
0.2457
0.2324
0.2202
0.2088
0.1984
0.1890
0.1805
0.1729
0.1663
0.1606
0.1558
0.1520
0.1491
0.1472
0.1462
0.1461
0.1470

10th
Percentile
0.3692
0.3479
0.3278
0.3087
0.2908
0.2739
0.2582
0.2436
0.2301
0.2177
0.2064
0.1962
0.1871
0.1791
0.1722
0.1664
0.1618
0.1582
0.1557
0.1544
0.1542

25th
Percentile
0.4060
0.3825
0.3603
0.3393
0.3196
0.3011
0.2838
0.2677
0.2529
0.2393
0.2269
0.2158
0.2058
0.1971
0.1897
0.1834
0.1784
0.1747
0.1721
0.1708
0.1707

50th
Percentile
0.4924
0.4623
0.4338
0.4068
0.3814
0.3577
0.3354
0.3148
0.2958
0.2783
0.2624
0.2481
0.2353
0.2242
0.2146
0.2066
0.2002
0.1953
0.1921
0.1904
0.1903

75th
Percentile
0.5633
0.5280
0.4946
0.4631
0.4334
0.4057
0.3798
0.3558
0.3337
0.3134
0.2951
0.2786
0.2640
0.2513
0.2405
0.2316
0.2245
0.2193
0.2161
0.2146
0.2151

90th
Percentile
0.7303
0.6817
0.6355
0.5919
0.5509
0.5124
0.4764
0.4430
0.4121
0.3837
0.3579
0.3346
0.3138
0.2956
0.2799
0.2668
0.2562
0.2481
0.2426
0.2396
0.2392

95th
Percentile
1.1694
1.0716
0.9794
0.8927
0.8116
0.7360
0.6660
0.6016
0.5427
0.4894
0.4416
0.3994
0.3627
0.3316
0.3060
0.2860
0.2716
0.2627
0.2593
0.2616
0.2693

97th
Percentile
1.1620
1.0681
0.9794
0.8960
0.8178
0.7450
0.6773
0.6150
0.5579
0.5060
0.4595
0.4182
0.3821
0.3513
0.3258
0.3055
0.2905
0.2808
0.2763
0.2771
0.2832
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N.6. LGA Male Placental Weight Ratios Gestational Age for the 3rd through the 97th Percentile
Gestational Age

10th Percentile

25th Percentile

50th Percentile

75th Percentile

90th Percentile

95th Percentile

97th Percentile

23
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

0.2513
0.2352
0.2276
0.2203
0.2134
0.2068
0.2005
0.1946
0.1890
0.1837
0.1787
0.1741
0.1698
0.1658
0.1622
0.1588
0.1559
0.1532
0.1509

0.3199
0.2928
0.2802
0.2682
0.2569
0.2463
0.2363
0.2269
0.2182
0.2101
0.2027
0.1960
0.1899
0.1844
0.1796
0.1755
0.1720
0.1691
0.1669

0.3673
0.3360
0.3214
0.3075
0.2942
0.2817
0.2699
0.2588
0.2483
0.2386
0.2296
0.2212
0.2136
0.2067
0.2004
0.1949
0.1900
0.1859
0.1824

0.4110
0.3745
0.3576
0.3415
0.3263
0.3119
0.2984
0.2858
0.2741
0.2632
0.2531
0.2440
0.2356
0.2282
0.2216
0.2159
0.2110
0.2070
0.2039

0.4568
0.4170
0.3984
0.3808
0.3639
0.3480
0.3330
0.3188
0.3055
0.2931
0.2816
0.2709
0.2611
0.2523
0.2442
0.2371
0.2309
0.2255
0.2210

0.4690
0.4295
0.4111
0.3936
0.3770
0.3614
0.3466
0.3327
0.3198
0.3077
0.2966
0.2863
0.2770
0.2686
0.2610
0.2544
0.2487
0.2439
0.2400

0.4710
0.4295
0.4104
0.3925
0.3757
0.3600
0.3455
0.3321
0.3198
0.3086
0.2986
0.2897
0.2819
0.2752
0.2697
0.2653
0.2620
0.2599
0.2589
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N.7. LGA Female Placental Weight Ratios by Gestational Age for the 3rd through the 97th Percentile
Gestational Age

10th Percentile

25th Percentile

50th Percentile

75th Percentile

90th Percentile

95th Percentile

97th Percentile

25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

0.2835
0.2711
0.2593
0.2480
0.2374
0.2273
0.2178
0.2089
0.2006
0.1929
0.1857
0.1792
0.1732
0.1679
0.1631
0.1589
0.1553
0.1523

0.3131
0.2988
0.2853
0.2725
0.2604
0.2490
0.2384
0.2285
0.2193
0.2109
0.2031
0.1961
0.1899
0.1844
0.1796
0.1755
0.1721
0.1695

0.3782
0.3581
0.3391
0.3212
0.3045
0.2890
0.2746
0.2614
0.2494
0.2385
0.2287
0.2201
0.2127
0.2064
0.2013
0.1973
0.1945
0.1929

0.4769
0.4475
0.4199
0.3940
0.3699
0.3476
0.3270
0.3081
0.2910
0.2756
0.2620
0.2501
0.2399
0.2316
0.2249
0.2200
0.2169
0.2155

0.5365
0.5020
0.4697
0.4395
0.4114
0.3854
0.3616
0.3398
0.3202
0.3027
0.2874
0.2741
0.2630
0.2540
0.2471
0.2423
0.2396
0.2391

0.6261
0.5836
0.5435
0.5061
0.4712
0.4389
0.4091
0.3819
0.3573
0.3353
0.3158
0.2989
0.2846
0.2728
0.2636
0.2570
0.2529
0.2514

0.7623
0.7026
0.6467
0.5947
0.5465
0.5022
0.4618
0.4253
0.3926
0.3638
0.3388
0.3177
0.3005
0.2872
0.2777
0.2721
0.2703
0.2724
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N.8. SGA Male Placental Weight Ratio Distributions by Gestational Age

196
N.9. SGA Female Placental Weight Ratio Distributions by Gestational Age
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N.10. LGA Male Placental Weight Ratio Distributions by Gestational Age
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N.11. LGA Female Placental Weight Ratio Distributions by Gestational Age
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Appendix O: Results of Interaction Terms between Smoking and Preeclampsia with
Gestational Age Category
O.1. Interaction Terms and Significance Levels
Effect
Degrees of
Wald Chi-Square
Freedom
Gestational Age
4
1.95
Category
2
38.51
Preeclampsia
2
250.98
Smoking
Gestational Age
4
9.90
Category x
Preeclampsia
Gestational Age
4
9.52
Category x
Smoking

P-value
0.7446
0.0001
0.0001
0.0420

0.0494
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Appendix P: Full Blocked Logistic Regression Models of Baseline and Pregnancy Factors Hypothesized to Influence a PWR
P.1. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight
Ratio ≤10th Percentile for Infants Born at ≥37 Weeks

Predictors
Parity
0

Odds Ratio (95% Confidence Interval)
Blockwise Model Building at p<.20
Model 22
Model 33

Restricted to p<.05
Model 44
Final Model5

Univariable

Model 11

-

-

-

-

-

0.915
(0.832, 1.006)*

0.886
(0.800, 0.980)**

0.909
(0.826, 1.001)*

0.913
(0.829, 1.005)*

0.928
(0.841, 1.024)*

-

-

-

-

-

-

0.647
(0.559, 0.749)*

0.664
(0.568, 0.776)**

0.631
(0.543, 0.733)**

0.630
(0.542, 0.732)**

0.609
(0.522, 0.711)**

0.612
(0.527, 0.711)**

X

X

X

X

X

X

X

X

X

X

X

X

X

X

0.923
(0.829, 1.027)
-

0.901
(0.806, 1.008)*
-

0.934
(0.838, 1.041)*
-

0.933
(0.837, 1.039)*
-

0.907
(0.811, 1.014)*
-

0.925
(0.829, 1.032)*
-

0.827
(0.709, 0.965)*
0.805
(0.670, 0.967)*

0.820
(0.702, 0.957)**
0.798
(0.662, 0.961)**

0.826
(0.707, 0.966)**
0.811
(0.673, 0.978)**

0.826
(0.707, 0.965)**
0.813
(0.674, 0.980)**

0.813
(0.694, 0.953)**
0.806
(0.666, 0.975)**

0.817
(0.698, 0.956)**
0.826
(0.685, 0.996)**

X
≥1
Smoking During Pregnancy
No (ref)
Yes
Maternal Asthma
No (ref)
Yes
Maternal Age
<21 years
21-34 years(ref)
>34 years
Maternal Height
For every 10cm increase
Pre-pregnancy BMI
≤18.5 kg/m2
18.5-24.9 kg/m2 (ref)
25.0-29.9 kg/m2
>30.0 kg/m2

0.809
(0.642, 1.020)
0.881
(0.736, 1.055)
1.079
(0.949, 1.226)
1.013
(0.993, 1.033)

X
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Preeclampsia
No (ref)

-

-

-

-

-

0.707
(0.533, 0.937)*

0.985
(0.695, 1.398)6

0.990
(0.697, 1.405)6

0.999
(0.703, 1.420)6

0.998
(0.703, 1.417)6

-

-

-

-

-

0.979
(0.691, 1.387)

0.737
(0.555, 0.979)**

0.735
(0.553, 0.976)**

0.734
(0.551, 0.979)**

0.729
(0.547, 0.971)**

X

X

X

-

-

-

-

1.223
(0.795, 1.881)

1.229
(0.791, 1.909)6

1.231
(0.792, 1.914)6

1.273
(0.826, 1.963)6

-

-

-

-

Cord around the neck or body,
knot in the cord, prolapsed or
lacerated cord

0.810
(0.728, 0.901)*

0.815
(0.731, 0.908)**

0.821
(0.735, 0.916)**

0.816
(0.730, 0.912)**

Short, 2-vessel or velamentous
cord
Gestational Weight
Gain
<10lb at 30 weeks or <20 lbs at
term

1.990
(1.390, 2.850)*

1.989
(1.381, 2.864)*

1.932
(1.338, 2.790)**

1.969
(1.369, 2.831)**

Preeclampsia
Gestational Diabetes
No (ref)
Yes
Placental Previa
No (ref)
Yes
Placental Abruption
No (ref)
Yes
Cord Complications
None (ref)

Normal (ref)
>40 lbs at term
Birth Weight Category
SGA

0.747
(0.344, 1.619)

0.713
(0.427, 1.190)
-

X

X

0.821
(0.690, 0.977)
1.130

1.153

1.180
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AGA (ref)
LGA
Anaemia
No (ref)
Yes
Placental Delivery
Spontaneous (ref)
Expressed or assisted
Manual
Retained

1

(0.952, 1.342)
-

(0.963, 1.381)*
-

(0.990, 1.408)*
-

0.829
(0.701, 0.981)*

0.824
(0.693, 0.980)**

0.811
(0.683, 0.962)**

-

-

-

0.767
(0.560, 1.052)

0.787
(0.569, 1.089)6

0.768
(0.557, 1.057)*

-

-

-

1.186
(1.006, 1.397)*
1.108
(0.987, 1.244)*
3.832
(2.344, 6.264)*

1.163
(0.982, 1.376)*
1.104
(0.981, 1.243)*
4.053
(2.461, 6.675)**

1.183
(1.001, 1.398)**
1.119
(0.995, 1.258)
4.022
(2.446, 6.612)**

-Baseline Factors; 2-Baseline +Mid-Pregnancy Factors; 3-Cord and Placental Complications; 4-Late and Post-Pregnancy Factors; 5-Only
Factors with a significance level of p<0.05;6-Variable remains in model despite not reaching statistical significance for the specified level
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of
p<0.20; **-Covariates with a significance level of p<0.05
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P.2. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight
Ratio ≥90th Percentile for Infants Born at ≥37 Weeks

Predictors
Parity
0

Odds Ratio (95% Confidence Interval)
Blockwise Model Building at p<.20
Model 22
Model 33

Model 44

Restricted to p<.05
Final Model5

Univariable

Model 11

-

-

-

-

-

1.073
(0.979, 1.176)

1.074
(0.972, 1.187)*

1.087
(0.989, 1.195)*

1.087
(0.989, 1.195)*

1.067
(0.969, 1.176)*

-

-

-

-

-

-

1.795
(1.616, 1.994)*

1.767
(1.576, 1.981)**

1.805
(1.619, 2.011)**

1.794
(1.609, 1.999)**

1.808
(1.618, 2.019)**

1.798
(1.615, 2.001)**

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

1.296
(1.161, 1.446)**
-

1.272
(1.134, 1.426)**
-

1.260
(1.127, 1.410)**
-

1.268
(1.133, 1.418)**
-

1.263
(1.126, 1.417)**
-

1.265
(1.132, 1.414)**
-

1.218
(1.050, 1.413)**
1.522
(1.296, 1.787)**

1.250
(1.075, 1.453)**
1.477
(1.252, 1.742)**

1.221
(1.050, 1.421)**
1.409
(1.193, 1.664)**

1.219
(1.047, 1.418)**
1.409
(1.193, 1.664)**

1.223
(1.050, 1.426)**
1.402
(1.184, 1.661)**

1.217
(1.046, 1.414)**
1.448
(1.229, 1.708)**

X
≥1
Smoking During
Pregnancy
No (ref)
Yes
Maternal Asthma
No (ref)
Yes
Maternal Age
<21 years
21-34 years(ref)
>34 years
Maternal Height
For every 10cm increase
Pre-pregnancy BMI
≤18.5 kg/m2
18.5-24.9 kg/m2 (ref)
25.0-29.9 kg/m2
>30.0 kg/m2

1.085
(0.890, 1.322)
1.217
(1.042, 1.421)*
0.998
(0.877, 1.136)
1.001
(0.982, 1.020)
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Preeclampsia
No (ref)

-

-

-

-

-

1.513
(1.240, 1.846)*

1.757
(1.342, 2.301)**

1.743
(1.330, 2.283)**

1.684
(1.281, 2.213)**

1.661
(1.269, 2.174)**

-

-

-

-

-

1.775
(1.364, 2.309)*

1.441
(1.176, 1.765)**

1.434
(1.170, 1.757)**

1.442
(1.176, 1.770)**

1.433
(1.169, 1.756)**

X

X

X

-

-

-

-

2.077
(1.485, 2.903)*

2.062
(1.468, 2.896)**

2.084
(1.481, 2.931)**

2.034
(1.446, 2.858)**

-

-

-

-

Cord around the neck or
body, knot in the cord,
prolapsed or lacerated
cord

1.189
(1.080, 1.309)*

1.182
(1.071, 1.304)**

1.183
(1.071, 1.308)**

1.180
(1.070, 1.301)**

Short, 2-vessel or
velamentous cord
Gestational Weight
Gain
<10lb at 30 weeks or <20
lbs at term

1.180
(0.753, 1.851)

1.106
(0.697, 1.757)

1.137
(0.715, 1.807)

1.172
(0.744, 1.845)

Preeclampsia
Gestational Diabetes
No (ref)
Yes
Placental Previa
No (ref)
Yes
Placental Abruption
No (ref)
Yes
Cord Complications
None (ref)

0.980
(0.507, 1.895)

1.002
(0.654, 1.537)
X

Normal (ref)
>40 lbs at term
Birth Weight Category

1.014
(0.868, 1.184)

X
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SGA
AGA (ref)
LGA
Anaemia
No (ref)
Yes
Placental Delivery
Spontaneous (ref)
Expressed or assisted
Manual
Retained
1

1.242
(1.057, 1.461)*
-

1.109
(0.934, 1.317)*
-

1.126
(0.954, 1.328)*
-

1.096
(0.946, 1.270)

1.114
(0.955, 1.298)*

1.111
(0.955, 1.291)

-

-

-

1.898
(1.538, 2.342 )*

1.876
(1.507, 2.336)**

1.862
(1.503, 2.305)**

-

-

-

0.915
(0.771, 1.086)
1.010
(0.903, 1.130)
1.450
(0.737, 2.854)*

0.903
(0.755, 1.080)6
0.979
(0.872, 1.100)6
1.400
(0.706, 2.776)6

0.907
(0.761, 1.081)6
0.972
(0.867, 1.090)6
1.337
(0.675, 2.649)6

-Baseline Factors; 2-Baseline +Mid-Pregnancy Factors; 3-Cord and Placental Complications; 4-Late and Post-Pregnancy Factors; 5-Only
Factors with a significance level of p<0.05;6-Variable remains in model despite not reaching statistical significance for the specified level
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of
p<0.20; **-Covariates with a significance level of p<0.05
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P.3. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight
Ratio ≤10th Percentile in Infants born between 32 and 37 Weeks

Predictors
Parity
0
≥1
Smoking During
Pregnancy
No (ref)
Yes
Maternal Asthma
No (ref)
Yes
Maternal Age
<21 years
21-34 years(ref)
>34 years
Maternal Height
For every 10cm increase
Pre-pregnancy BMI
≤18.5 kg/m2
18.5-24.9 kg/m2 (ref)
25.0-29.9 kg/m2
>30.0 kg/m2

Odds Ratio (95% Confidence Interval)
Blockwise Model Building at p<.20
Model 22
Model 33

Model 44

Restricted to p<.05
Final Model5

-

-

-

0.686
(0.432, 1.089)*

0.710
(0.446, 1.130)*

0.661
(0.412, 1.059)*

0.695
(0.440, 1.099)*

-

-

-

-

-

0.629
(0.322, 1.232)6

0.513
(0.266, 0.989)**

0.525
(0.272, 1.013)*

0.542
(0.278, 1.055)*

0.494
(0.257, 0.950)*

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Univariable

Model 11

-

-

-

0.687
(0.435, 1.084)*

0.631
(0.388, 1.025)*

0.493
(0.256, 0.947)*
0.965
(0.405, 2.298)
0.265
(0.064, 1.104)
1.283
(0.744, 2.211)
1.027
(0.933, 1.130)
1.018
(0.610, 1.698)
0.807
(0.379, 1.718)
0.708
(0.263, 1.902)
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Preeclampsia
No (ref)

-

-

-

-

0.194
(0.026, 1.422)

1.028
(0.473, 2.235)

0.927
(0.429, 2.006)*

0.835
(0.372, 1.878)6

X

X

X

X

X

X

-

-

-

-

0.523
(0.160, 1.705)

0.575
(0.175, 1.893)6

0.593
(0.179, 1.965)6

0.615
(0.295, 1.282)*

-

-

-

Cord around the neck or
body, knot in the cord,
prolapsed or lacerated
cord

0.973
(0.594, 1.592)

0.966
(0.588, 1.587)6

0.919
(0.554, 1.525)6

Short, 2-vessel or
velamentous cord
Gestational Weight
Gain
<10lb at 30 weeks or <20
lbs at term

0.771
(0.092, 5.482)

0.716
(0.092, 5.564)6

0.637
(0.080, 5.078)6

Preeclampsia
Gestational Diabetes
No (ref)
Yes
Placental Previa
No (ref)
Yes
Placental Abruption
No (ref)
Yes
Cord Complications
None (ref)

Normal (ref)
>40 lbs at term
Birth Weight Category

X

1.028
(0.479, 2.206

X

0.341
(0.046, 2.527)

X

0.579
(0.076, 4.398)

-

X

X

0.474
(0.113, 1.993)
X
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SGA
AGA (ref)
LGA
Anaemia
No (ref)

1.444
(0.689, 3.026)
-

X

1.419
(0.738, 2.728)
-

-

0.799
(0.242, 2.643)

0.884
(0.263, 2.967)6

X
Yes
Placental Delivery
Spontaneous (ref)
Expressed or assisted
Manual
Retained
1

1.131
(0.432, 2.963)
1.054
(0.630, 1.762)
5.657
(1.374, 23.290)*

X

-Baseline Factors; 2-Baseline +Mid-Pregnancy Factors; 3-Cord and Placental Complications; 4-Late and Post-Pregnancy Factors; 5-Only
Factors with a significance level of p<0.05;6-Variable remains in model despite not reaching statistical significance for the specified level
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of
p<0.20; **-Covariates with a significance level of p<0.05

X
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P.4. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight
Ratio ≥90th Percentile for Infants Born between 32 and 37 Weeks

Predictors
Parity
0
≥1
Smoking During
Pregnancy
No (ref)
Yes
Maternal Asthma
No (ref)
Yes

21-34 years(ref)
>34 years
Maternal Height
For every 10cm increase
Pre-pregnancy BMI
≤18.5 kg/m2
18.5-24.9 kg/m2 (ref)

Model 44

Restricted to p<.05
Final Model5

-

-

-

1.774
(1.138, 2.764)**

1.644
(1.049, 2.575)**

1.612
(1.011, 2.570)**

1.674
(1.085, 2.583)**

-

-

-

-

-

1.388
(0.852, 2.261)

1.586
(1.007, 2.498)

1.509
(0.952, 2.393)*

1.583
(0.987, 2.540)*

1.488
(0.949, 2.334)*

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Univariable

Model 11

-

-

-

1.686
(1.094, 2.598)*

1.571
(0.980, 2.517)*

1.518
(0.970, 2.378)
1.075
(0.500, 2.308)

Maternal Age
<21 years

1.206
(0.596, 2.439)
1.291
(0.767, 2.173)*
1.034
(0.946, 1.131)
1.494
(0.891, 2.505)
-

X
2

25.0-29.9 kg/m
>30.0 kg/m2

Odds Ratio (95% Confidence Interval)
Blockwise Model Building at p<.20
Model 22
Model 33

1.137
(0.549, 2.357)
2.326
(1.141, 4.744)
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Preeclampsia
No (ref)

-

-

-

-

1.014
(0.424, 2.423)

2.103
(1.153, 3.837)*

1.969
(1.082, 3.582)*

1.938
(1.040, 3.610)**

X

X

X

X

X

X

-

-

-

-

2.268
(1.216, 4.229)*

1.965
(1.033, 3.740)**

1.991
(1.027, 3.861)**

2.038
(1.323, 3.138)**

-

-

-

Cord around the neck or
body, knot in the cord,
prolapsed or lacerated
cord

1.545
(1.001, 2.386)

1.511
(0.969, 2.357)

1.453
(0.918, 2.298)*

Short, 2-vessel or
velamentous cord
Gestational Weight
Gain
<10lb at 30 weeks or <20
lbs at term

3.622
(1.269, 10.338)*

3.214
(1.096, 9.421)**

3.745
(1.240, 11.307)**

X
Preeclampsia
Gestational Diabetes
No (ref)
Yes
Placental Previa
No (ref)
Yes
Placental Abruption
No (ref)
Yes
Cord Complications
None (ref)

Normal (ref)
>40 lbs at term
Birth Weight Category

-

X

1.834
(1.026, 3.276)*
0.282
(0.038, 2.085)

X

∞
(0, ∞)
-

X

X

1.646
(0.752, 3.605)
X

X
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SGA
AGA (ref)
LGA
Anaemia
No (ref)

1.322
(0.654, 2.669)
1.462
(0.808, 2.647)
-

-

2.420
(1.170, 5.008)*

2.068
(0.961, 4.448)*

X
Yes
Placental Delivery
Spontaneous (ref)
Expressed or assisted
Manual
Retained
1

1.393
(0.604, 3.212)
1.329
(0.845, 2.090)
1.658
(0.196, 14.010)

X

-Baseline Factors; 2-Baseline +Mid-Pregnancy Factors; 3-Cord and Placental Complications; 4-Late and Post-Pregnancy Factors; 5-Only
Factors with a significance level of p<0.05;6-Variable remains in model despite not reaching statistical significance for the specified level
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of
p<0.20; **-Covariates with a significance level of p<0.05

X
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P.5. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight
Ratio ≤10th Percentile in Infants born at ≤32 Weeks

Predictors
Parity
0
≥1
Smoking During
Pregnancy
No (ref)
Yes
Maternal Asthma
No (ref)
Yes
Maternal Age
<21 years
21-34 years(ref)
>34 years
Maternal Height
For every 10cm increase
Pre-pregnancy BMI
≤18.5 kg/m2
18.5-24.9 kg/m2 (ref)
25.0-29.9 kg/m2
>30.0 kg/m2

Odds Ratio (95% Confidence Interval)
Blockwise Model Building at p<.20
Model 22
Model 33

Univariable

Model 11

-

-

-

0.604
(0.339, 1.077)*

0.544
(0.290, 1.020)*

0.548
(0.294, 1.021)*

0.938
(0.494, 1.779)

X

X

Model 44

Restricted to p<.05
Final Model5

-

-

-

0.617
(0.327, 1.162)*

0.576
(0.306, 1.084)*

0.537
(0.293, 0.986)**

X

X

X

X

X

X

X

X

0.679
(0.231, 2.000)
-

X

X

X

X

0.578
(0.237, 1.410)*
1.123
(1.004, 1.255)*

1.151
(1.023, 1.295)**

1.151
(1.023, 1.294)**

1.166
(1.035, 1.314)**

1.139
(0.984, 1.318)*

1.133
(1.011, 1.269)**

X

X

X

X

X

0.878
(0.331, 2.332)

0.569
(0.314, 1.030)
0.416
(0.151, 1.144)
0.313
(0.104, 0.942)*
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Preeclampsia
No (ref)

X

X

X

X

X

X

-

-

-

1.500
(0.415, 5.424)

1.590
(0.393, 6.437)6

2.045
(0.488, 8.574)6

X

X

-

-

-

Cord around the neck or
body, knot in the cord,
prolapsed or lacerated
cord

0.850
(0.439, 1.646)

0.780
(0.386, 1.576)

0.811
(0.407, 1.616)

Short, 2-vessel or
velamentous cord
Gestational Weight
Gain
<10lb at 30 weeks or <20
lbs at term

6.603
(1.835, 23.755)*

5.424
(1.439, 20.451)**

5.298
(1.395, 20.128)**

Preeclampsia
Gestational Diabetes
No (ref)
Yes
Placental Previa
No (ref)

X

0.475
(0.110, 2.052)
-

X

1.173
(0.615, 2.237)*

X
Yes
Placental Abruption
No (ref)
Yes
Cord Complications
None (ref)

Normal (ref)
>40 lbs at term
Birth Weight Category

X

0.592
(0.290, 1.212)*

X

1.278
(0.147, 11.131)
0.799
(0.098, 6.502)

X

X
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SGA
AGA (ref)
LGA
Anaemia
No (ref)
Yes
Placental Delivery
Spontaneous (ref)
Expressed or assisted
Manual
Retained
1

0.691
(0.262, 1.822)
-

X

X

X

X

1.110
(0.410, 3.006)
0.849
(0.320, 2.253)
-

-

1.144
(0.129, 10.114)
0.659
(0.369, 1.176)
3.119
(1.077, 9.033)*

0.813
(0.087, 7.567)6
0.616
(0.324, 1.174)6
3.452
(1.095, 10.881)**

-Baseline Factors; 2-Baseline +Mid-Pregnancy Factors; 3-Cord and Placental Complications; 4-Late and Post-Pregnancy Factors; 5-Only
Factors with a significance level of p<0.05;6-Variable remains in model despite not reaching statistical significance for the specified level
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of
p<0.20; **-Covariates with a significance level of p<0.05

X
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P.6. Blocked Logistic Regression Model of Baseline and Pregnancy Factors Hypothesized to Influence a Placental Weight
Ratio ≥90th Percentile in Infant Born at ≤32 Weeks

Predictors
Parity
0
≥1
Smoking During
Pregnancy
No (ref)
Yes
Maternal Asthma
No (ref)
Yes
Maternal Age
<21 years
21-34 years(ref)
>34 years
Maternal Height
For every 10cm increase
Pre-pregnancy BMI
≤18.5 kg/m2
18.5-24.9 kg/m2 (ref)
25.0-29.9 kg/m2
>30.0 kg/m2

Odds Ratio (95% Confidence Interval)
Blockwise Model Building at p<.20
Model 22
Model 33

Model 44

Restricted to p<.05
Final Model5

-

-

-

1.768
(0.848, 3.688)*

2.224
(1.060, 4.664)**

2.185
(1.084, 4.408)**

X

X

X

X

X

X

X

Univariable

Model 11

-

-

-

2.170
(1.128, 4.174)*

2.081
(1.006, 4.306)**

2.136
(1.026, 4.444)**

X

X

0.630
(0.271, 1.465)
0.492
(0.114, 2.119)

X

1.148
(0.381, 3.464)
-

X

X

X

X

X

1.139
(0.476, 2.721)
1.139
(0.993, 1.306)

1.119
(0.970, 1.290)*

1.120
(0.972, 1.291)*

1.104
(0.955, 1.275)*

1.139
(0.984, 1.318)*

1.125
(0.981, 1.290)*

X

X

X

X

X

0.898
(0.427, 1.891)
0.863
(0.292, 2.555)
0.814
(0.276, 2.403)
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Preeclampsia
No (ref)

X

X

X

X

X

X

-

-

-

3.919
(1.324, 11.601)*

3.944
(1.072, 14.507)**

3.333
(0.904, 12.285)**

X

X

-

-

-

Cord around the neck or
body, knot in the cord,
prolapsed or lacerated
cord

0.816
(0.376, 1.774)

0.720
(0.307, 1.691)6

0.694
(0.290, 1.663)6

Short, 2-vessel or
velamentous cord
Gestational Weight
Gain
<10lb at 30 weeks or <20
lbs at term

3.661
(0.681, 19.674)

1.281
(0.116, 14.137)6

1.932
(0.176, 21.260)6

Preeclampsia
Gestational Diabetes
No (ref)
Yes
Placental Previa
No (ref)

X

0.342
(0.045, 2.583)
X

1.397
(0.673, 2.902)

X
Yes
Placental Abruption
No (ref)
Yes
Cord Complications
None (ref)

Normal (ref)
>40 lbs at term
Birth Weight Category

X

1.678
(0.857, 3.285)*

X

∞
(0, ∞)
X

X

X

X

1.149
(0.140, 9.421)
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SGA
AGA (ref)
LGA
Anaemia
No (ref)

1.708
(0.742, 3.929)
0.343
(0.045, 2.603)
X

Yes
Placental Delivery
Spontaneous (ref)
Expressed or assisted
Manual
Retained
1

X

2.677
(1.187, 6.037)*
-

-

0
(0, ∞)
2.156
(1.060, 4.383)*
4.159
(1.022, 16.931)*

0
(0, ∞)
1.432
(0.628, 3.267)
2.204
(0.407, 11.937)

-Baseline Factors; 2-Baseline +Mid-Pregnancy Factors; 3-Cord and Placental Complications; 4-Late and Post-Pregnancy Factors; 5-Only
Factors with a significance level of p<0.05;6-Variable remains in model despite not reaching statistical significance for the specified level
of the outcome because for the other level of the outcome it reaches statistical significance; *-Covariates with a significance level of
p<0.20; **-Covariates with a significance level of p<0.05

X
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Appendix Q: Detailed Description of Missing Placental Weights
Overall, LGA infants had 22.03% missing, AGA infants had 22.71% missing, and
SGA infants had 23.48% missing. Therefore, since the missingness is evenly distributed
among categories it is speculated that the missingness was random. Furthermore, the
distribution of missingness by gestational age category was as follows: in term infants
22.81% had missing placental weight, in infants born between 33 and 36 weeks gestation
there was 25.50% missing, and in infants born at ≤32 weeks there was 9.85% missing for
placental weight. It was proposed that placentas were not weighed in high risk
pregnancies, but the missingness is less in extreme preterm and SGA babies, so that
theory is not likely plausible. The missingness by hospital revealed differences between
Victoria Hospital with 54.16% missing and, St. Joseph’s with 0.38% missing placental
weights. This discrepancy is due largely to the placental weight not being collected at
Victoria Hospital for the first 2 and a half year of the study time period. Furthermore, the
placental weights between the two hospitals revealed very close similarities. The mean
placental weight at Victoria Hospital is 670g (S.D.=161.32) and 660g (S.D.=160.94) at
St. Joseph’s hospital. The 10th and 90th percentiles are 505g and 486g and 885g and 872g
for Victoria and St. Joseph Hospital respectively. Therefore, the differences between the
two hospitals are not substantial.
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